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Cloning through somatic cell nuclear transfer (SCNT) remains highly inefficient 
twenty years after the first demonstration of the technology.  The technology could be 
more routinely utilized to enhance animal agriculture production by increasing efficiency 
and decreasing cost through the selection of embryos that are most likely to succeed 
following transfer.  We proposed the use of a non-toxic, non-invasive caspase activity 
reporter, SR-FLICA, to quantitatively assess embryo competency prior to transfer.  We 
hypothesized that following SCNT, a majority of embryos undergo altered epigenetic 
reprogramming compared to in vivo embryos, resulting in aberrant gene expression and 
incidentally increased levels of apoptosis.  Conversely, a fraction of the embryos undergo 
proper genome reprogramming, resulting in correct gene expression and low levels of 
apoptosis.  Using porcine embryos, the non-toxic nature of SR-FLICA was validated on 
oocytes and embryos.  No correlation between relative level of apoptosis and cell number 
was found in blastocysts.  DNA methylation and gene expression patterns were analyzed 
through reduced-representation bisulfite sequencing and RNA-seq to provide global 
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patterns in high and low apoptosis SCNT blastocysts.  No differences in global DNA 
methylation patterns were found between the high apoptosis SCNT, low apoptosis SCNT, 
and in vivo produced embryos.  Comparing high apoptosis and low apoptosis porcine 
SCNT blastocyst identified 4,346 100 bp tiles that were differentially methylated and 413 
genes that were differentially expressed.  Hierarchical clustering of differentially 
methylated tiles separated the high apoptosis from low apoptosis SCNT samples.  
However, hierarchical clustering of differentially expressed genes did not separate 
samples based on apoptosis.  Gene ontology analysis identified no significantly enriched 
terms or KEGG pathways from genes with a differentially methylated tile near the 
transcription start site or from differentially expressed genes.  Embryo competency was 
evaluated using day 7 bovine SCNT blastocysts that were transferred into females for 
evaluation of pregnancy establishment.  While SR-FLICA did not hinder pregnancy rates, 
apoptosis score was not an indicative measure for pregnancy establishment.  Together, 
these data support a stochastic nature of epigenetic reprogramming following SCNT and 
reinforce the necessity to identify embryos most likely to be successful due to proper 
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Cloning through somatic cell nuclear transfer (SCNT) remains highly inefficient 
twenty years after the first demonstration of the technology with the birth of Dolly.  By 
increasing efficiency by selecting the embryos early in development that are most likely 
to succeed following transfer into a surrogate mother, the technology could be more 
routinely utilized to enhance animal agriculture production.  SCNT is believed to be 
highly inefficient as a result of incorrect DNA methylation and gene expression that are 
accumulated because of the SCNT technique.  We proposed the use of a non-toxic, non-
invasive detector of cell death, to quantitatively assess embryo competency prior to 
embryo transfer.  We believed we could use SR-FLICA to identify the embryos with low 
levels of cell death as a result of proper DNA methylation and gene expression.  By 
analyzing the whole embryo, differences in gene expression and DNA methylation were 
identified in embryos with high and low levels of cell death.  However, the level of cell 
death did not prove to be a reliable indicator of embryo quality in predicting pregnancy 
outcome.  This data supports the commonly held hypothesis that DNA methylation and 
gene expression after SCNT have random defects as a result of the random nature of 
resetting the DNA for embryo development.  More research is required to identify the 
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REVIEW OF LITERATURE 
 While assisted reproductive technologies have become more common in 
agriculture and human medicine over the years, they could benefit from increased 
efficiency.  A need for increased efficiency is especially true for somatic cell nuclear 
transfer (SCNT), which remains highly inefficient two decades after first being reported 
with the birth of Dolly.  The poor efficiency of SCNT has limited its use in agricultural 
production.  Scientists believe that the poor efficiency of SCNT is the result of abnormal 
nuclear reprogramming.  Following normal fertilization, the epigenetic marks on the 
DNA of both the sperm and egg are erased and reprogrammed for proper embryo 
development to occur.  Epigenetic reprogramming is altered following SCNT as SCNT 
embryos have been shown to have altered DNA methylation and gene expression 
profiles, which is believed to increase apoptosis in SCNT embryos.  Apoptosis is cell-
directed, programmed cell death that is critical for proper development of the embryo and 
fetus.  Apoptosis could be a useful, non-invasive biomarker to determine which embryos 
have undergone proper genome reprogramming before embryo transfer as a tool to 
increase the overall efficiency of somatic cell nuclear transfer.  
 
Assisted Reproductive Technologies 
 Assisted reproductive technologies are commonly utilized in animal agriculture 
and human medicine.  Techniques, including artificial insemination (AI) and in vitro 
fertilization (IVF), have the potential to quickly advance the genetic merit of a herd in 
animal agriculture.  In artificial insemination, semen is collected from a male.  Through 
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the addition of extenders, the sperm cells are preserved and a single ejaculate can be 
extended for the insemination of many females.  With AI, an elite male can pass his 
genetics to many more offspring than he could naturally sire. For instance, a boar could 
typically mate 4 sows each week.  However, 10-20 sows can be bred from a single 
ejaculate using AI [1].  The use of AI in cattle has allowed genetic progress to increase up 
to 50% compared to natural mating [2].  AI also provides additional benefits such as 
reducing the risk of injury or disease spread during mating and eliminates the need to 
house a male for breeding purposes.  For this reason, over 85% of all Holstein births are 
the result of AI according to the Holstein Association USA [2].  By comparison, in 2009, 
only 7.6% of beef operations utilized AI as a reproductive tool  [3].  Similar to the dairy 
industry, most sows at operations over 500 pigs are bred through AI [1]. 
While AI provides a way to enhance the passage of male genetics to the next 
generation, IVF has provided a mechanism for an elite female to pass her genetics on to 
multiple offspring in a year.  Using ovum pick up (OPU), oocytes can be collected from a 
live female whose ovaries have been hormonally stimulated for increased follicular 
growth.  Following maturation, the oocytes are combined with sperm for in vitro 
fertilization to occur.  Following fertilization, a single cell zygote is formed, containing 
both the maternal and paternal DNA.  The zygote begins cleavage divisions, where a 
single cell divides into two cells without growing in size so the cells get progressively 
smaller.  The single cell zygote cleaves into first a two-cell embryo, then four-cell, eight-
cell and finally sixteen-cell embryo.  At this point, the cells begin to compact to form a 
morula.  At the morula stage, the first physiologic separation of cell type occurs, where 
the outer cells of the morula form tight junctions and begin to pump salts inside the 
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morula.  Water follows the salt forming a fluid filled cavity, called the blastocoel, which 
now makes the embryo a blastocyst.  Following embryo development, two-cell embryos 
or blastocysts are transferred into surrogate females. In 2011, over 450,000 IVF embryos 
were transferred into beef cows [3].  Additionally, a female could be superovulated using 
hormonal treatments and embryos can be flushed and transferred into surrogate females.  
Over 700,000 embryos were flushed and transferred in beef cows in 2011 [3].  Both AI 
and IVF can also utilize sex-sorted semen, which is when the X- and Y- bearing sperm 
cells are sorted based on slight differences in total DNA.  Sex-sorted sperm results in a 
95% gender bias but is also costly and results in decreased conception rates compared to 
conventional sperm [2].   
Assisted reproductive technologies are commonly used to treat fertility issues in 
humans as well.  In developed countries, studies estimated that 1-3% of all births are the 
result of assisted reproductive technologies [4].  In addition to IVF, intracytoplasmic 
sperm injection (ICSI) is commonly used to circumvent the need for sperm cells to 
successfully bind to and penetrate the oocyte, which is beneficial when fertility is 
decreased due to abnormalities in the sperm.  In ICSI, a single sperm cell is injected into 
the oocyte and fertilization follows.  ICSI is a common procedure in human fertility 
treatment and represented 63% of fertilization procedures in 2005 [5].   
While assisted reproductive technologies have the potential to be extremely 
beneficial to both agriculture and human medicine, their efficiencies remain low 
compared to natural fertilization.  In cattle for example, only 40-50% of immature 
oocytes collected from slaughtered animals, where the ovaries have not been stimulated, 
develop to the blastocyst stage following oocyte maturation, fertilization, and culture [6].  
4 
The number of embryos that successfully cleave into two-cells and then continue to 
progress to the blastocyst stage tends to decrease with each developmental stage.  In 
bovine IVF embryos, about 80% cleave into two-cell embryos, while only 30% 
developed to blastocysts [7, 8].  Pregnancy rates of 45% or higher following transfer of 
bovine IVF embryos have been reported [9].  However, even lower rates have been 
reported in bovine blastocysts with rates closer to 30% [8].  Abortion and fetal loss are 
more common with IVF pregnancies compared to in vivo produced pregnancies [9].  
Pregnancy rates at day 76 of gestation were reported as high as 50.5% following embryo 
transfer of a fresh IVF embryo, but only 45.6% calved [10].  Porcine IVF results in lower 
blastocyst rates of 15-30% in most cases [11-14].  About 25% of transferred blastocysts 
resulted in the birth of piglets [14].  In human IVF, blastocyst rates are between 30-40% 
[15, 16] and birth rates following blastocyst transfers between 30-50% [16].  Decreased 
developmental potential of in vitro produced embryos in multiple species points to clear 
differences between in vivo and in vitro produced embryos. 
The differences between in vivo (IVV) and in vitro produced (IVP) embryos has 
been investigated in depth.  These differences include changes in cell number, 
morphology, gene expression, and epigenetic marks.  In vivo produced blastocysts are 
known to have increased cell numbers, including inner cell mass cell number and 
trophoblast cell number, compared to in vitro produced blastocysts [17].  Increased cell 
numbers are correlated with increased embryo quality [18].  A microscopic analysis of 
IVV and IVP bovine embryos showed only slight structural differences, but it was noted 
that there was a developmental delay in the IVF embryos [19].  IVV and IVP embryos 
are known to show differences in gene expression [20].  A microarray study comparing 
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gene expression of in vivo and in vitro produced four-cell and blastocyst stage embryo 
discovered 1409 and 1696 differentially expressed genes between the in vivo and in vitro 
produced four-cell embryos and blastocysts, respectively [21].  Even the difference in site 
of fertilization, in vivo or in vitro, followed by embryo culture resulted in differences in 
gene expression in embryos [22].  Previous research found that epigenetic dysregulation 
occurs in IVP embryos, resulting in the altered gene expression patterns.  A change in 
gene expression almost becomes cyclical in nature.  Previous studies have shown that in 
vitro culture decreases the expression of genes that control the epigenetic remodeling of 
chromatin which would increase the methylation and acetylation of chromatin resulting 
in an overall decrease in gene transcription [23].  Gene repression does not occur in 
parthenogenetic embryos, supporting the hypothesis that the paternal chromosome 
reorganization is the potential source for aberrant reprogramming leading to altered gene 
expression in IVP embryos [23].  In vitro cultured embryos have also shown increases in 
DNA methylation, another epigenetic modification, specifically at CpG islands [24].  
Epigenetic regulation of embryo development is covered in depth below.   
With in vitro fertilization and culture having known negative impacts on embryo 
development, selecting the “best” embryo for transfer becomes even more important.  
Studies have focused on determining non-invasive indicators of embryo quality.  For 
instance, it is known that embryos that cleave into two-cells earlier are more likely to 
develop into blastocysts [25].  Current methods rely on a visual assessment of embryo 
quality.  In bovine blastocysts, the embryos are ranked as good, regular, or poor [26].  In 
humans, blastocysts are graded on expansion and hatching status, development of inner 
cell mass, and trophectoderm quality [27].  High quality blastocysts showed increased 
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pregnancy rates and chance of twins compared to low quality blastocysts [27].  
Morphological assessment of embryos is rather subjective, so more quantitative methods 
have been explored, such as the integrity of blastomere membranes, analysis of embryo 
metabolism, measurement of cellular respiration, and electron-microscopy analysis 
(reviewed in [26]  However, these techniques can either damage or kill the embryo or are 
cost prohibitive.  So, most embryo quality is performed through visual assessment. 
 
Somatic Cell Nuclear Transfer 
 Somatic cell nuclear transfer (SCNT) was first reported with the birth of Dolly the 
sheep, a clone produced using a mammary cell as the somatic donor [28].  While SCNT 
is now viewed as an advanced assisted reproductive technology with many applications, 
it was first used as a technology to understand basic biology.  Before the birth of Dolly, it 
was believed that somatic cells were too specialized to revert back to a totipotent state 
that would be required for proper embryonic and fetal development [29].  SCNT provided 
a way to investigate if cellular differentiation was a reversible genetic modification, 
which was proven with the reprogramming of the somatic cell to form an entire lamb 
from a mammary cell [28].  Before the successful birth of Dolly, embryonic stem cells 
had been used for cloning, but these cells are not differentiated [28].  Since the birth of 
Dolly, many species have been cloned using this technology including the mouse, cattle, 
goat, pig, mouflon, domestic cat, rabbit, rat, horse, mule, African wildcat, dog, wolf, 
ferret, red deer, buffalo, camel, and coyote [30]. 
 In 2001, a voluntary moratorium went into effect keeping milk and meat products 
from clones out of the food market until the Food and Drug Administration could 
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perform a risk assessment of the technology.  An Animal Cloning Risk Assessment by 
the Food and Drug Administration later found that there is no increased risk in 
consuming milk or meat from healthy clones or their offspring compared to sexually-
derived animals [31].  The report additionally stated that products from clones and their 
offspring are indistinguishable from those of sexually-derived animals [31].  However, 
the FDA does note that it is unlikely for food products of clones to enter the market as 
these animals would most likely serve as genetically superior breeders.  At this time, the 
FDA does not plan to require labeling of products from clones as there is not increased 
risk from consuming these products.  While there are no concerns to humans from animal 
cloning, there are animal welfare concerns associated with the technique. SCNT has 
increased health risks to both the surrogate female and the cloned offspring.  While there 
is an increased frequency of health risks, they are not different risks than what could 
occur with other assisted reproductive techniques and artificial insemination [31].  An 
explanation of the common risks associated with SCNT is discussed below. 
 Currently, SCNT has a variety of applications, including the duplication of 
animals with superior genetics or infertile or deceased animals, research or biomedical 
models including transgenic animal production, threatened or endangered species 
cloning, and commercial cloning.  The replication of animals provides producers with 
insurance on those genes and a way to increase the number of offspring with those genes.  
For example, animals with high genetic merit for traits such as milk production or carcass 
traits can be insured though the possibility of cloning following an untimely death.  
Cloning could also be used to increase the total number of animals that have the high 
genetic merit so those genes are then used in more breedings ensuring the genes are 
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present in a larger percentage of offspring than what would have occurred naturally or 
though other assisted reproductive technologies.  SCNT has also been shown to be an 
extremely valuable research tool.  For example, the aberrant epigenetic reprogramming 
that occurs following SCNT has provided a mechanism to study the normal 
reprogramming that occurs in early embryos following fertilization [32].  SCNT has also 
provided a more efficient and precise mechanism for gene transfer compared to 
microinjection of a zygote [32].  SCNT allows for site-directed genetic edits to a somatic 
cell, which can then be selected for, before use as the somatic donor.  Related to the 
production of transgenic animals is the production of transgenic animals for biomedical 
applications.  The transgene could allow a cloned animal to produce a product, such as a 
protein or drug, which it would not naturally make in order to harvest these products on a 
large-scale.  SCNT has also been used on a limited scale for the production of threatened 
or endangered species.  Utilizing interspecies SCNT, a donor oocyte and surrogate female 
of a closely related species can be used in the cloning process to produce an offspring 
very similar to the threatened or endangered species.  Finally, SCNT has taken a 
commercial aspect where clients can pay to have their pet cloned.  Several companies 
offer pet cloning services for dogs, cats, and horses.  However, until SCNT becomes a 
more efficient process, prices are likely to remain high for cloning services.  
 Somatic cell nuclear transfer utilizes a technical procedure to remove the genomic 
DNA of an oocyte and replace it with that of a somatic cell.  In SCNT, a mature oocyte is 
enucleated through the removal of the first polar body and the cytoplasm directly beneath 
the polar body which contains the nucleus.  Enucleation removes the genomic DNA of 
the oocyte.  Next, a somatic cell from the donor animal being cloned is inserted under the 
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zona pellucida of the oocyte in contact with the cell membrane of the oocyte.  An electric 
pulse stimulates the oocyte and somatic donor to fuse.  Oocyte activation is stimulated 
though electrical or chemical protocols following fusion to simulate a fertilization event 
of the oocyte.  Following activation, embryo development begins.  The embryo is then 
transferred into a surrogate female for gestation. 
 There are many factors of the SCNT protocol that can affect efficiency.  Oocyte 
quality is important as the oocyte must survive manipulations of enucleation and 
placement of the donor cell as well as fusion and activation.  The oocyte is then 
responsible for reprogramming the donor cell nucleus, which will be covered in depth 
later.  High oocyte quality results in increased blastocyst development rate following 
SCNT in human embryos [33].  In general, the more differentiated the donor cell type 
becomes, the less efficient SCNT becomes.  For example, a blastomere of a two cell 
embryo produces more live offspring per embryo transferred following SCNT compared 
to a mature neuron, which has not been successfully used for SCNT [34].  Donor cell 
cycle coordination is another critical aspect to ensure correct chromosome numbers.  
Most commonly, a donor cell in the G0/G1 phase of the cell cycle is used to ensure that 
the cell is not actively replicating DNA [34].  Cell cycle coordination can be achieved 
through serum starvation or confluent culture [35].   
 SCNT efficiency remains extremely low with the success rate averaging between 
1-5% depending on species [34, 36].  SCNT embryo production is compromised 
compared to IVF blastocyst development rates [37, 38].  In the first reported successful 
sheep cloning with the birth of Dolly, 277 fused couplets using mammary epithelium as 
donor cells resulted in the birth of one live lamb, a success rate of 0.36% [28].  However, 
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a 3.4% success rate was reported based on the number of morula or blastocysts 
transferred [28].  Low success rates have been linked to poor embryo transfer, pregnancy 
rates, and pregnancy loss [12, 39, 40].  In bovine SCNT pregnancies, a 75% loss has been 
reported by the end of gestation [40].  Porcine SCNT is limited by low blastocyst rates, 
typically ranging from 10-20% [12, 41].  Because high embryo death during the pre-
implantation development period would increase recipient cost, cloned embryos are often 
transferred at the blastocyst stage.  Therefore, being able to select blastocyst with an 
increased chance of developing into healthy offspring is an important goal for SCNT 
research [36].  Even when a cloned offspring does survive to birth, health concerns are 
typically present that have been linked to un-successful epigenetic reprogramming [29].  
Bovine SCNT pregnancies are often associated with hydrops and increased fetal and 
placental weight, increasing the risk of death due to dystocia during parturition [9].  
Porcine SCNT offspring tend to be undersized with decreased birthweight compared to 
offspring from natural mating [42].   
Understanding the low success rates of SCNT has been complex, with many 
aspects of the procedure and resulting embryo development analyzed.  Oocyte quality can 
affect the success of live births following SCNT.  In mice, oocytes that were naturally 
ovulated and used in SCNT resulted in live pups while oocytes that were collected 
following superovulation did not result in any live offspring following SCNT [43].  
Scientists believe that apoptosis plays a role in SCNT embryo development [12].  Porcine 
SCNT embryos had decreased cleavage and blastocyst rates compared to IVF embryos.  
SCNT embryos had increased apoptosis compared to IVF embryos. However, apoptosis 
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rates in SCNT and IVF blastocysts were similar, indicating that apoptosis could be 
limiting blastocyst development in SCNT embryos [12]. 
During the enucleation and placement of the somatic cell, micromanipulations of 
the oocyte can result in damage and effect downstream development.  However, it 
appears that micromanipulation is not the root of SCNT failure as ICSI embryos 
(undergoing similar micromanipulations) develop at a higher rate [44], pointing to gene 
regulation being the root of the problem.  SCNT embryos may be predisposed to altered 
gene expression of proteins responsible for establishing and maintaining donor cell 
epigenetic marks [36].  The resulting wide-spread gene mis-regulation alters many 
functions of the developing embryo, including oxidative phosphorylation, membrane 
transport, and mRNA transport and procession [36].  While transcript levels are known to 
differ between SCNT and IVP embryos, multiple small changes in transcript abundance 
were detected between individual bovine SCNT embryos, indicating a potential 
stochastic nature of gene expression in SCNT embryos [45].   
Gene expression differences could be the result of altered DNA methylation.  
SCNT embryos show increased DNA methylation compared to IVF embryos leading to 
the theory that DNMT1, the enzyme responsible for maintaining DNA methylation, 
introduced through the donor cell, maintains DNA methylation when the DNA should be 
cleared of methylation marks [46].  The theory is supported as the expression of DNMT1 
protein is misregulated in cloned embryos [47].  By down-regulating DNMT1 through 
the introduction of siRNA in bovine fibroblast cells used in SCNT, the resulting embryos 
had DNA methylation levels between the low methylation of the IVF embryos and the 
high methylation levels of the SCNT embryos.  However, this technique did not increase 
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blastocyst development rates [46].  In addition, SCNT embryos show problems with bi-
allelic expression of imprinted genes due to changes in DNA methylation of imprinted 
genes [42, 48].   
Aberrant DNA methylation and gene expression results from altered epigenetic 
reprogramming following SCNT.  Following fusion of the somatic cell with the oocyte, 
the somatic nucleus must stop expression of its gene products.  The nucleus begins to 
express gene products of developmental-specific genes following the directions provided 
by the oocyte cytoplasm as the donor-specific marks are erased  [29].  The donor nucleus 
is disassembled in response to high levels of maturation promoting factor (MPF) found in 
the cytoplasm of the MII-stage oocyte [29].  The reprogramming efficiency of the donor 
nucleus hinders the overall efficiency of SCNT, as evident by the fact that using an 
undifferentiated cell, a zygote, significantly increases the number of live births following 
SCNT in mice [43].  In order to increase the efficiency of nuclear reprogramming 
following SCNT, drugs have been used to alter the epigenetic mechanisms of the embryo.  
Treatment of a histone deacetylase inhibitor, Oxamflatin, increased blastocyst 
development rates in bovine embryos [49].  Oxamflatin treated embryos had increased 
H3K9 and H3K18 acetylation at the 2-cell, 4-cell, and 8-cell stage, changed gene 
expression, and decreased incidence of apoptosis [49].  5-aza-2’-deoxyctytidine (5-aza), a 
methylation inhibitor, and trichostatin (TSA), a histone deacetylase inhibitor, have been 
used in combined treatment on donor cells and early bovine SCNT embryos to increase 





 Epigenetic marks are heritable controls of gene expression that do not change 
DNA, but rather control how the DNA is expressed in the cell.  Epigenetic changes 
include histone modifications and DNA methylation; each will be discussed in depth 
below.  Following fertilization, epigenetic reprogramming occurs to turn on gene 
expression of developmentally important genes.  After SCNT, this epigenetic 
reprogramming must occur with the additional complexity of removing the somatic cell 
epigenetic marks before adding the marks for embryonic development.  Artificial culture 
conditions and SCNT are known to produce embryos with altered epigenetic marks [51, 
52]. 
 In order to condense DNA in the cell, DNA is packaged into chromatin which 
contains 147 bp of DNA wrapped around a histone octamer [53].  The histone octamer is 
composed of two of each histone protein, H2A and H2B, H3 and H4 [53, 54].  Each 
histone protein contains an N- and C- terminal tail, which can undergo post-translational 
modifications that can alter chromatin structure, in turn changing gene expression.  The 
most common post-translational histone modifications include acetylation, 
phosphorylation, methylation, and ubiquitylation [53].  Other less-common modifications 
include sumoylation, ADP-ribosylation, proline isomerization, citrullination, 
butyrylation, propionylation, and glycosylation [54].  The type and location of the histone 
modification will determine if it will activate or repress gene expression.  Typically, 
lysine methylation on the tail of H3 and H4, trimethylation of H3 lysine 4, trimethylation 
of H3 lysine 79, ubiquitylation of H3B, and trimethylation of H3 lysine 36 are associated 
with active gene expression [53].  Trimethylation of H3 lysine 27, ubiquitylation of H2A 
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on lysine 119, and trimethylation of H3 lysine 9 are typical marks of gene repression 
[53].  Histone modifications can occur in combination resulting in inactive, bimodal, and 
active chromatin states [54].  Bimodal states include a combination of active and 
repressive marks in the promoter region of a gene, allowing for rapid change in gene 
expression [54].  In vitro culture has been shown to change histone marks and alter gene 
expression of the Axin Fu gene in mice [51].  SCNT embryos show regions where 
epigenetic reprogramming is repressed due to increased levels of H3 lysine 9 
trimethylation, a repressive histone mark [55].  Additionally, histone methylation is 
altered in porcine SCNT early embryos in a developmentally stage-specific manner when 
compared to the IVF embryos [56].  
 DNA methylation is another epigenetic mechanism that results in gene silencing.  
In mammalian DNA, a methyl group can be added to the 5 position of cytosine in a CpG 
dinucleotide, creating a 5mC nucleotide. However, DNA methylation does rarely occur 
outside of a CpG dinucleotide [57].  About three-quarters of genes in the mammalian 
genome have a high CpG content in their promoter regions [52].  CpG dinucleotides are 
concentrated in areas called CpG islands, which are typically located in the promoter 
region of genes [54].  Unmethylated CpG islands allow gene transcription to occur while 
methylated CpG islands silence gene transcription [57].  Most CpG sites that are not 
contained within CpG islands are highly methylated [57].  DNA methylation plays a 
critical role during cell differentiation during development, X-chromosome inactivation, 
and maintenance of imprinted genes [57].  Enzymes responsible for DNA methylation 
include DNM1, DNMT3a, and DNMT3b.  DNMT1 is responsible for maintaining DNA 
methylation while DNMT3a and DNMT3b are responsible for de novo methylation [58].  
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DNMT1 restores methylation to symmetrical CpG nucleotides in a semi-conservative 
manner following DNA replication [59].  DNA can be de-methylated through passive 
DNA replication or actively through the TET enzymes [57]. 
 DNA methylation is directly responsible for imprinted genes.  While mammalian 
cells are diploid, containing two copies of every gene, certain imprinted genes are 
exclusively expressed from either the paternal or maternal copy of the gene.  DNA 
methylation of the imprinted control region (ICR) of either the maternal or paternal copy 
of a gene ensures expression from only the unmethylated copy of the gene.  These 
methylation marks are maintained through mitotic cell divisions and through epigenetic 
reprogramming following fertilization, which is discussed in depth in below [60].  Only 
during primordial germ cell development are imprints wiped clean in order for new 
imprints to be set prior to gamete development.  Imprinted genes are known to play a role 
in the growth of the embryo, placenta, and neonate [60].  Imprinted genes occur in 
clusters in the genome [61].  Paternally expressed imprinted genes include growth 
promoters such as Igf2, Peg1, and Peg3 [60].  Maternally expressed imprinted genes 
include growth inhibitors such as Igf2r, Gnas, Cdkn1c, H19 and Grb10 [60].  Alterations 
in the epigenetics of imprinted genes in humans are associated with clinical syndromes 
and connected to tumorigenesis [61].  Beckwith-Wiedemann syndrome (BWS) is an 
over-growth syndrome in humans that results from a loss of imprinting [61].  Assisted 
reproductive technologies, including SCNT, are known to alter imprinted gene 
methylation and gene expression.  Embryo culture and transfer affects imprinting in 
extraembryonic tissues in mice resulting in biallelic expression of several imprinted 
genes during midgestation [61].  Cloned, aborted piglets and placentas showed hyper 
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methylation of the imprinted gene Pre1 and demethylation of H19 compared to non-
aborted cloned piglets and placentas [62].  Additionally, 18 imprinted genes showed 
altered gene expression in aborted cloned pregnancies compared to controls [62] 
indicating that changes in methylation of imprinted regions could have an effect on gene 
expression and lead to ultimate failure of SCNT pregnancies.   
 Epigenetic reprogramming occurs at two times, primordial germ cell development 
and following fertilization.  During primordial germ cell development, DNA methylation 
is removed and imprinted marks are re-set in the developing germ cells.  Following 
fertilization, the maternal and paternal genomes must undergo epigenetic reprogramming 
to set up for proper embryo development.  At this point, imprinted methylation marks are 
maintained [59].  After the sperm has penetrated into the oocyte, the sperm must go 
through many alterations including nuclear envelope breakdown, protamines which have 
been used to condense the DNA must be replaced with histones for chromatin 
decondensation, and the male pronucleus must form [59].  Additionally, the maternal and 
paternal DNA is highly methylated at the time of fertilization and must be demethylated 
before new marks can be set for embryo development.  The paternal DNA is 
demethylated rapidly though active demethylation by action of the TET enzymes [57].  
Demethylation of the maternal DNA occurs more slowly through the exclusion of 
DNMT1 from the nucleus, preventing the maintenance of methylation marks over cell 
divisions.  Following demethylation of both the maternal and paternal genomes, de novo 
methylation occurs.  Cells that go on to form the inner cell mass are highly methylated 
[59].  For the maternal to zygotic transition (MZT) to occur, it is critical that epigenetic 
reprogramming occurs correctly and at the appropriate time. 
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 During the maternal to zygotic transition (MZT), the embryo stops relying on 
stored RNA molecules from the oocyte and begins to transcribe its own DNA.  The MZT 
occurs at a species-specific time-point.  In the mouse the MZT occurs at the two-cell 
stage and in porcine and human it occurs at the four to eight-cell stage and in bovine and 
ovine it occurs at the eight- to sixteen-cell stage [63].  The three main functions of the 
MZT are to first destroy all oocyte-specific RNA transcripts.  Next, the MZT replaces 
common RNA transcripts involved in cellular function from the oocyte with new 
transcripts from the embryo.  Finally, the MZT produces transcripts that are specific to 
embryo development.  The change from demethylation following fertilization to re-
methylation is associated with the major start of transcriptional activity of the embryo 
[52].  The MZT is delayed in cloned embryos, occurring at the eight-cell stage in porcine 
SCNT embryos compared to the normal four-cell stage [64].  Without proper gene 
expression starting during the MZT, the embryo will halt in development.  
 During SCNT, the differentiated somatic cell is inserted into an oocyte, which 
must first de-differentiate the cell by removing epigenetic marks before beginning 
embryo-specific gene expression, a process that involves complex epigenetic alterations 
[59].  To achieve embryo development following somatic cell nuclear transfer, the 
genome of the somatic cell must first be silenced and epigenetic marks of differentiation 
on the somatic cell must be completely erased.  The oocyte must be properly activated to 
start embryo development and embryonic genes must be turned on.  All of these steps 
involve complex epigenetic changes within the cell [59].  Typical nuclear reprogramming 
that occurs after fertilization is known to be altered in SCNT embryos.  DNA methylation 
patterns separating the ICM from the trophectoderm are obscured by overall increases in 
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DNA methylation [59].  Previous studies have been demonstrated that the somatic cell is 
generally de-methylated following SCNT, however not completely de-methylated which 
could be driving the low efficiency of SCNT [52].  When analyzing five pluripotency 
genes in bovine cloned embryos, SCNT embryos showed weak reprogramming 
capabilities of four of the five genes analyzed [7].  Oct4 had correct reprogramming 
while Nanog was hypomethylated and Rex1, Fgf4, and Sox2 were hypermethylated [7].  
Alternatively, in cloned mouse embryos, the Oct4 promoter was gradually de-methylated 
during early embryo development but remained elevated compared to normal 
development [65].  Embryos with delayed development showed higher levels of Oct4 
methylation compared to SCNT embryos that showed normal development [65].  
Problems with reprogramming of SCNT embryos could be a result of altered gene 
expression of enzymes responsible for epigenetic regulation.  Bovine cloned embryos 
showed increased expression of HDAC genes and decreased expression of DNMT3A 
compared to IVF embryos [66].  Understanding the changes in epigenetic reprogramming 
following SCNT provides opportunity to increase the efficiency of the technique.   
 Epigenetic reprogramming of the donor cell in SCNT is critical to ensure proper 
gene expression in SCNT embryos.  Data suggest that most genes are properly 
reprogrammed following SCNT as 95% of genes show similar transcript abundance 
between SCNT and IVF embryos [36].  Misexpressed genes seem to be random as no 
distinct set of genes has been found to be consistently misexpressed across studies and 
the gene expression changes that have been reported are on average a two-fold change 
with less than 3% showing more than a four-fold change [36].  These observations 
strengthen the hypothesis that epigenetic reprogramming following SCNT occurs in a 
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random nature leading to random differences in gene expression.  A wide range of gene 
expression patterns in individual bovine SCNT embryos indicated that some blastocysts 
contain gene expression patterns much closer to in vitro produced controls than others 
[67].  However, in vivo produced embryos had decreased variability in gene expression 
compared to SCNT and in vitro produced counterparts [67].  A tool to predict SCNT 
embryos with epigenetic marks and gene expression patterns close to “normal” could 
provide a way to select blastocysts most likely to succeed following embryo transfer. 
 
Apoptosis 
 Apoptosis, or programmed cell death, is the natural response to destroy 
compromised cells during development and disease states.  Apoptosis is characterized by 
morphological changes in the cell resulting from the activation of enzymes called 
caspases, ending in eventual DNA degradation.  Specific stimuli trigger apoptosis, 
resulting in a series of morphological events including cell shrinkage, appearance of 
membrane-bound apoptotic bodies, and phagocytosis by nearby cells [68].  The initiation 
phase of apoptosis begins when pro-apoptotic stimuli trigger the machinery involved in 
apoptosis [68].  In the effector phase, the apoptosis machinery becomes fully activated 
and results in apoptotic changes in the nucleus.  Finally, in the degradation phase, the 
morphological changes of the cell become evident [68].  Apoptosis typically affects 
single cells rather than large groupings of cells. 
 As previously mentioned, apoptotic cells undergo characteristic morphological 
changes.  The cell shrinks and the nucleus condenses and eventually breaks up.  The 
cytoplasm condenses and any microvilli that were present disappear [69].  The cell 
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detaches from surrounding tissue at this point.  Apoptotic bodies are formed containing 
organelles, cytoplasm, and fragments of the nucleus.  The apoptotic bodies are released 
and phagocytosed and degraded by nearby cells.  The fragmented cell is then 
phagocytosed by neighboring cells.  Phagocytosis prevents an inflammatory response 
because the apoptotic cells do not release their cellular contents, they are quickly taken 
up by surrounding cells, and the engulfing cells do not produce anti-inflammatory 
cytokines [70]. 
 In addition to morphological changes, specific biochemical changes are also 
associated with apoptosis, including protein cleavage, protein cross-linking, DNA 
degradation, and membrane markers for phagocytic recognition [70].  Protein cross-
linking is carried out by the expression and activation of transglutaminase.  DNA 
breakdown results from the activation endogenous DNase enzymes, including DFF40 and 
CAD [68].  The DNA is degraded into 180-200 base pairs fragments which creates a 
characteristic ladder when run on an agarose gel with ethidium bromide and exposed to 
ultraviolet light.  Apoptotic cells are quickly phagocytized by neighboring cells due to the 
external expression of phosphatidylserine on the cell membrane.  Combined, 
morphological changes and biochemical changes of apoptotic cells can be used for the 
detection of apoptosis.  
 In contrast to apoptosis is necrosis, which effects a large number of cells at once.  
Necrosis is a toxic process where the cell falls victim to damage resulting in an energy-
independent form of death.  Necrosis in uncontrolled and passive while apoptosis is 
controlled and energy-dependent [70].  Necrosis results from “interference with the 
energy supply of the cell or direct damage to cell membranes” [70].  Direct damage of 
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cells resulting in necrosis can include extreme environmental insults including hypoxia, 
heat shock, and exposure to environmental toxins [71].  Ultimately, necrosis results in 
cell swelling, cytoplasmic vacuoles and blebs, damaged mitochondria, ruptured organelle 
membranes, and eventual disruption of the cell membrane [70].  Necrosis lacks the 
budding of apoptotic bodies and the chromatin is irregularly clumped [68].  It is worth 
noting that apoptosis and necrosis, while the most commonly discussed forms of cell 
death, are not the only forms.  Other, less studied forms of cell death include necroptosis, 
autophagic cell death, pyroptosis and caspase-independent cell death [72]. 
 Apoptosis is carried out by a group of enzymes called caspases.  Caspases are 
always present in the form of inactivated proenzymes.  Cleavage at specific internal 
aspartate residues activates the enzymes [68].  Caspases can be classified as non-
apoptotic, initiators, or effectors [73].  Non-apoptotic caspases include caspase-1, -4, -5, 
and -11.  Initiator caspases include caspase-2, -8, -9, and -10.  Initiator caspases are 
activated by “induced proximity” though the interaction of adaptor proteins and the 
prodomains to promote caspase dimerization [74].  Effector caspases include caspase-3, -
6, and -7.  Effector caspases form homodimers in their inactive forms.  Once cleaved by 
initiator caspases, effector caspases act on specific cellular substrates in order to 
dismantle the cell [74].  Two major pathways exist to activate the initiator caspases to 
start the apoptosis cascade.  One pathway, the extrinsic pathway, starts with the ligation 
of the death receptors, including Fas and TNF receptors.  The other intrinsic or 
mitochondrial pathway releases cytochrome C and the apoptosis inducing factor (AIF) to 
activate initiator caspases.  
22 
 The extrinsic pathway of apoptosis is activated when death receptors are activated 
by their respective ligands.  The death receptors are members of the tumor necrosis factor 
(TNF) receptor superfamily and contain a cytoplasmic “death domain” containing about 
80 amino acids [70].  The “death domain” transmits the signal from the cell membrane to 
an intracellular signaling pathway.  Characterized death receptors include FasR, TNFR1, 
DR3, DR4, and DR5 and their respective ligands are FasL, TNF-α, Apo3L, Apo2L, and 
Apo2L [70].  When the ligand binds to its receptor, cytoplasmic adaptor proteins are 
recruited that contain death domains.  For instance, when Fas ligand binds to the Fas 
receptor, the adapter protein FADD is recruited.  Likewise, when the TNF ligand binds to 
the TNF receptor, the adapter protein TRADD is bound and recruits FADD and RIP [70].  
These recruited adaptor proteins then promote the dimerization and activation of initiator 
caspases by binding their prodomains, forming structures called DISCs [74].  FADD 
dimerizes its death domain with procaspase-8, forming a death-induced signaling 
complex (DISC) resulting in the auto-catalytic activation of procaspase-8 and -10, which 
then cleave and activate the effector caspases [75].  In certain cells, activation of caspase-
8 results in the activation of the intrinsic pathway of apoptosis through the cleavage of 
BID, a pro-apoptotic protein of the intrinsic pathway that then translocates to the 
mitochondria [75].  The execution phase of apoptosis is triggered with the activation of 
caspase-8 [70].   
 The intrinsic signaling pathway of apoptosis does not involve activation of 
receptors, but rather intracellular signals that act directly within the cell.  The stimuli for 
the intrinsic pathway can work either in a positive or negative way.  Negative signals lead 
to the failure to suppress apoptosis when signals such as growth factors, hormones, and 
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cytokines are absent [70].  Positive signals stimulate apoptosis in response to a stimulus 
such as radiation, toxins, hypoxia hyperthermia, viral infections, or free radicals being 
present [70].  These stimuli cause changes to the inner mitochondrial membrane and the 
opening of the mitochondrial permeability transition pore, loss of membrane potential 
and release of pro-apoptotic proteins into the cytosol [70].  Two groups of proteins are 
released.  The first containing cytochrome c, Smac/DIABLO, and protease HtrA2/Omi.  
The second containing AIF, endonuclease G, and CAD are released when the cell has 
committed to die.  Cytochrome c binds to and activates Apaf-1 and procaspase-9, which 
forms a structure called an “apoptosome.”  The apoptosome contains 7 molecules of 
Apaf-1 and 2 molecules of caspase-9 [74].  Caspase-9 then cleaves and activates effector 
caspases, such as caspase-3.  Smac/DIABLO and HtrA2/Omi inhibit inhibitors of 
apoptosis proteins (IAP) action to promote apoptosis.  After release from the 
mitochondria, AIF moves to the nucleus and causes DNA degradation into 50-300 kb 
fragments.  Endonuclease G also moves to the nucleus and also has a role in cleavage of 
chromatin and DNA fragmentation.  CAD is cleaved by caspase-3 in the nucleus and also 
aids in DNA fragmentation.  The intrinsic pathway of apoptosis is controlled by the Bcl-2 
protein family.  The Bcl-2 family consists of anti- and pro-apoptotic members and BH3-
only proteins.  Anti-apoptotic proteins include Bcl-2, Bcl-x, Bcl-XL, Bcl-XS, Bcl-w and 
BAG.  Pro-apoptotic proteins include Bcl-10, Bax Bak, Bid, Bad, Bim, Bik, and Blk.  
Apoptotic stimuli activate the BH3-only proteins, or initiators, which inhibit the anti-
apoptosis members allowing for the activation of the pro-apoptosis members, BAX and 
BAK that disrupt the mitochondrial membrane allowing for release of cytochrome c [76]. 
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Detecting apoptosis can be a relative challenge due to the fast time course of 
apoptosis.  Previous reports have suggested that clearance times of apoptotic cells can be 
less than an hour depending on cell type and type of insult [77].  Even with this 
challenge, several techniques have commonly been used to detect apoptosis, including 
morphology, DNA fragmentation, TUNEL, and active caspases.  Using morphology, the 
classic features of apoptosis can be visualized by electron microscopy or light 
microscopy using nucleic acid-binding dyes [77].  Microscopy looks for the classic 
morphologic signs of apoptosis including nuclear condensation, cell shrinkage, 
cytoplasmic blebs, and cell detachment.  However, because cells are so rapidly 
phagocytized by neighboring cells, the most common sign of apoptosis is the appearance 
of apoptotic bodies inside other cells [77].  The advantage of morphological detection of 
apoptosis is the reliability and inexpensive nature of the method.  However, the 
quantitative measurement lacks objectivity and reproducibility and the method is less 
sensitive and prone to errors [78].  DNA fragmentation assays detect the characteristic 
DNA fragmentation associated with apoptosis.  Agarose electrophoresis reveals the 
distinct DNA ladder of 180-200 bp fragments.  DNA fragmentation assays can identify 
apoptosis from necrosis as the DNA ladder is specific to apoptosis while necrosis would 
show a smear of DNA on agarose electrophoresis.  Single cell gel electrophoresis is used 
to visualize DNA damage of individual cells and is known as the comet assay [78].  
Using the comet method, apoptotic cells appear as comet-like structures while viable 
cells have large heads and only a small tail [78].  Terminal deoxynucleotidyl transferase 
dUTP nick end labeling, or TUNEL, is used to identify cells undergoing DNA 
fragmentation using enzymes that add labeled nucleotide to the DNA ends [77].  TUNEL 
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labels both double and single-stranded DNA breaks [78].  More recently, 
immunohistochemical methods have become more common as antibodies have been 
marketed for apoptosis research.  Antibodies designed against caspases must be specific 
to activated caspases rather than pro-caspases, as pro-caspases are common in cells.  
Staining of caspases would also allow for the identification of the early stages of 
apoptosis rather than relying on the end stages such as nuclear condensation and can 
therefore identify a different population of cells that are beginning the apoptosis 
pathways [77].  Most recently, fluorescent tagging of activated caspases has been 
developed.  SR-FLICA (Immunohistochemistry Technologies, Bloomington, MN, USA) 
uses SR-VAD-FMK reagent that covalently binds to active caspases for fluorescent 
detection.  Additionally, this method is non-invasive and non-toxic, allowing for the 
analysis of live cells. 
 Apoptosis in embryos follows the morphologic characteristics observed in other 
cells.  Dying cells in blastocysts of many species including mouse, cow, baboon, rhesus 
monkey and human showed nuclear condensation, nuclear and cytoplasmic 
fragmentation, and loss of the nuclear membrane [79].  Dying cells of the blastocyst are 
then engulfed by healthy neighboring cells.  In pre-compaction human embryos, 
phagocytosis was not observed suggesting that apoptotic cells are not taken up by 
neighboring cells until the blastocyst stage [79].  In human embryos, it is not uncommon 
to find excluded cells between the developing embryo and the zona pellucida at 
compaction and blastocyst formation [80].  TUNEL staining confirmed that cells of the 
mouse blastocyst are undergoing apoptosis [79].  Even in in vivo produced embryos, over 
80% of blastocysts had one or more dead cells [79].  In human in vitro produced 
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blastocysts, 75% had one or more dead cells on day 6 [80].  While some embryos had a 
significant incidence of apoptosis of greater than 15%, most had less than 10 apoptotic 
cells [80].  Cell death occurred equally in the trophectoderm and the cells of the inner cell 
mass and the incidence of cell death was correlated with embryo quality [80].  Apoptosis 
in blastocysts can be the result of gamete quality, suboptimal culture conditions, lack of 
survival factors, chromosomal and nuclear abnormalities, and elimination of cells that are 
no longer required.   
 Apoptosis in embryos can result from suboptimal culture conditions.  While cell 
death has been observed in in vivo produced embryos, the in vitro environment also has 
an effect on cell death.  Brison and Schultz showed that mouse embryos cultured in vitro 
had increased levels of apoptosis compared to in vivo embryos and the amount of cell 
death was higher in embryos cultured individually compared to those cultured in groups 
[79].  Various studies have also shown that the composition of culture media is important 
for apoptosis [79].  Even outside of the culture environment, the uterine environment 
during early development could have an effect on cell death in the developing embryos.  
Alterations such as heat stress could change the uterine environment.  Heat stress in the 
first 22 hours of development induced by increasing the temperature of in vitro culture 
increased apoptosis in both IVF and parthenogenetic porcine embryos [13].  Culture 
systems are constantly evolving to try and optimize embryo growth for increased 
developmental success. 
 Embryonic apoptosis can also result from a lack of growth or survival factors.  
During in vitro culture, embryos are lacking paracrine factors produced by the maternal 
reproductive tract.  Embryos express growth factor receptors and secrete numerous 
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growth factor ligands [79].  Supplementing culture media with growth factors, including 
epidermal growth factor, transforming growth factor-α, and transforming growth factor-
β1 have been shown to improve embryo development in vitro [79].  Mouse embryos had 
an increased incidence of apoptosis when cultured individually.  However, the incidence 
of apoptosis in the ICM was decreased when the embryos were cultured with 
transforming growth factor-α.  If embryos do not have a high enough concentration of the 
embryo-derived factors that act in an autocrine action, the embryos will have an increased 
incidence of apoptosis [81].   
 Apoptosis has been detected in embryos from numerous species, including pigs 
[12], rabbits [82], mouse [83], cattle [39], and humans [84].  Embryos produced in vivo 
show low levels of apoptosis, indicating that it is a normal part of embryonic 
development [83].  Early in development, embryos are unable to undergo apoptosis as 
TUNEL detection found apoptotic cells in the morula and blastocyst stage bovine 
embryos, but not in zygotes or cleavage stage embryos [71].  In these bovine embryos, 
apoptosis became apparent in the 8-16 cell stage of development, coinciding with the 
MZT [71].  Bovine SCNT embryos show earlier and increased levels of apoptosis 
compared to IVF controls [39].  Additionally, apoptosis increased in bovine SCNT 
embryos as development continued [85].  One possibility is that the P53-induced pathway 
of apoptosis is activated during reprogramming in SCNT embryos leading to the 
increased incidence of apoptosis as this pathway is activated during induced pluripotent 
stem cell reprogramming [86].  Treating donor cells with an apoptosis inhibitor improved 
development following SCNT [85]  Mouse blastocysts with fragmentation had increased 
DNA strand breaks that were detected with TUNEL staining, indicating an increase in 
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apoptosis in fragmented embryos [87].  Together indicating that apoptosis could be a 
novel predictor of embryo quality. 
 
Significance of project 
 This project aims to use a non-toxic, non-invasive biomarker for active caspase 
activity to differentiate the good from bad blastocysts following SCNT.  The primary 
goal of the project is to understand the relationship between apoptosis and nuclear 
reprogramming as it relates to embryo competence following SCNT.  We hypothesize 
that following SCNT, a majority of embryos undergo aberrant genome reprogramming, 
resulting in altered DNA methylation and gene expression, increased incidence of 
apoptosis as a result of the activation of the P53 pathway, and eventual embryo failure 
following transfer.  On the other hand, a small subset of the embryos undergo proper 
genome reprogramming, correct DNA methylation and gene expression, low levels of 
apoptosis, and eventual success of a live offspring following transfer.  Analyzing 
individual SCNT embryos with high and low levels of apoptosis for DNA methylation 
patterns and gene expression profiles will provide evidence for differences in 
reprogramming that have occurred following SCNT in each individual embryo.  
Additionally, transfer of high and low incidence of apoptosis SCNT embryos will 
indicate differences in developmental potential of the embryos.   
By using a non-toxic and non-invasive stain to detect active caspases, embryos 
will be analyzed for apoptosis without sacrificing the embryo, which has tremendous 
benefits compared to the classical approaches for detecting apoptosis, such as TUNEL, 
that require the fixing of the embryo before analysis rendering the embryo useless for 
29 
future use.  This staining system allows for analysis of live embryos that can then be 
transferred following fluorescent microscopy analysis.  Allowing for the first time, a non-
invasive stain to analyze apoptosis in embryos.   
The staining of embryos for level of apoptosis as another marker of embryo 
viability could be a valuable assessment not only for SCNT embryos, but also IVF and 
ISCI embryos.  Identification of competent embryos is especially valuable in species 
where a very limited number of embryos can be transferred to each recipient, such as 
horses and cattle.  Staining of active caspases could provide an additional biometric to 
determine the most appropriate embryo to transfer to obtain a pregnancy.  In the future, 
this tool could even become a critical assessment in human infertility clinics, where 
multiple embryos are produced and only a limited number can be transferred into the 
patient.  Increasing understanding of which embryos are most viable could drastically 
change the success of assisted reproductive technologies.   
As evident by low success rates of assisted reproductive technologies, especially 
cloning through SCNT, there is vast room for improvement of the technologies in 
agriculturally important species.  Increasing the efficacy of SCNT would allow the 
technology to be utilized for not only scientific research, but also by producers as a way 
to propagate superior genetics and an insurance policy on genetically superior 
individuals.  However, until the technology becomes more efficient, the cost of the 
technology remains too high for most producers to utilize. Therefore, many different 
approaches are being studied at this time to optimize the technology, typically aiming at 
enhancing the reprogramming following SCNT for increased embryo development.  By 
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being able to select the embryos that will be most successful following transfer, fewer 
recipient females are required, decreasing the cost of a large recipient herd.   
 In addition to the practical aspect of improving SCNT for production of cloned 
offspring, a greater understanding of the epigenetic reprogramming associated with 
SCNT increases the understanding of the epigenetic reprogramming of early embryo 
development.  Uncertainty still exists if epigenetic reprogramming occurs in a directed 
manner or in a random fashion following SCNT.  DNA methylation and gene expression 
analysis of individual blastocysts in this project will allow for greater understanding of 
the differences in reprogramming occurring in each individual embryo, compared to a 
pool of embryos that is typically used.   
 The key goals of this project are to determine if key developmental genes are 
differentially expressed in individual SCNT embryos with high and low levels of 
apoptosis, identify differences in DNA methylation patterns in individual embryos with 
high and low levels of apoptosis, and validate the use of a non-invasive apoptosis 
bioassay as a tool to improve the assessment of developmental competence in SCNT 
embryos.  The study will yield a wealth of new knowledge concerning the apoptosis and 
developmental potential of SCNT embryos.   
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CHARACTERIZING PORCINE SOMATIC CELL NUCLEAR TRANSFER 
BLASTOCYSTS WITH HIGH AND LOW INCIDENCE OF APOPTOSIS 
 
Abstract 
 Cloning through somatic cell nuclear transfer (SCNT) remains highly inefficient 
twenty years after the first demonstration of the technology with the birth of Dolly.  
Increasing the efficiency of the technology would allow its utilization in the animal 
agriculture industry.  Identifying the embryos most likely to succeed following embryo 
transfer is one way to increase the efficiency of the technology.  Current methods to do 
this include culturing embryos to the blastocyst stage and then morphologically assessing 
the embryos, which is qualitative and inconsistent.  We propose the use of a non-toxic, 
non-invasive caspase activity reporter, SR-FLICA, to quantitatively assess embryo 
competency prior to transfer.  In this study, SR-FLICA staining to detect apoptotic cells 
was validated through comparison to TUNEL, a more traditionally used apoptosis 
detection method.  The non-toxic nature of SR-FLICA was tested on oocytes and 
development compared to a control group found no difference in development rates.  
High and low apoptosis embryos were characterized on day 3 and 6 of development. No 
correlation between relative level of apoptosis and cell number was found and high and 
low apoptosis embryos on day 3 of development had no statistical difference in blastocyst 
rates on day 5, 6, or 7 of development.  And finally gene expression of 65 genes in high 
and low apoptosis SCNT blastocysts was analyzed compared to in vivo produced 
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blastocysts.  High and low apoptosis blastocysts showed no significant difference in gene 
expression.  Taken together, SR-FLICA could provide a novel biomarker for embryo 
competency.  However, it is still unclear how relative apoptosis level will affect 
development following embryo transfer. 
 
Introduction 
 Assisted reproductive technologies such as in vitro fertilization (IVF) and somatic 
cell nuclear transfer (SCNT) remain inefficient and overall efficiency could be increased 
through improving the technologies.  SCNT, in particular, remains highly inefficient with 
success rates between 1-5% depending on the species [34].  The low efficiency of SCNT 
has limited its use in the animal agriculture industry as the cost of the technology remains 
high and improving SCNT efficiency would allow for its application in the animal 
agriculture industry.  Many factors influence SCNT efficiency, including oocyte quality 
[43], micromanipulations [44], and nuclear reprogramming [36].  Altered nuclear 
reprogramming following SCNT has been shown to lead to altered gene expression 
leading to changed functions of the developing embryo, including oxidative 
phosphorylation, membrane transport, and mRNA transport and processing [36].   
 Nuclear reprogramming occurs following the fusion of the donor, somatic cell 
with the oocyte.  In order for normal embryo development to occur, DNA methylation 
must be reset for proper gene expression to occur.  First, the donor cell DNA must be 
erased of donor-specific marks so that developmental-specific genes can be turned on and 
properly expressed [29].  This reprogramming involves complicated epigenetic changes 
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in the donor cell nucleus [59].  Following normal fertilization of an oocyte, the DNA 
methylation of the maternal and paternal genome is erased before new, embryonic 
specific DNA methylation patterns are established [59].  Previous studies have shown 
that the somatic cell is generally de-methylated following SCNT, however the donor cell 
is not completely de-methylated [52].  The result of this altered methylation status is 
misexpressed genes, where up to 5% of genes have altered transcript abundance between 
SCNT and IVF embryos [36].  However, a wide range of gene expression patterns have 
been demonstrated in bovine SCNT blastocysts, indicating that some embryos may have 
gene expression patterns which more closely resemble that of an in vivo produced 
embryo [67]. 
Often as a means to reduce the cost of failed pregnancies in surrogate animals, 
SCNT embryos are allowed to develop to the blastocyst stage before transfer, making it 
clear which embryos have undergone successful development to that point.  However, 
once embryos reach the blastocyst stage, it is not clear which blastocysts will go on to 
have successful development following transfer into a surrogate.  Current assessment of 
blastocyst before transfer involves a morphological evaluation which is subjective and 
qualitative [26].  More quantitative assessments of embryo quality, such as measurement 
of cellular respiration or analysis of embryo metabolism, can be detrimental to the 
developing embryo or are cost prohibitive [26].  Therefore, developing the use of a 
biomarker to quantify the health and overall quality of a blastocyst could provide the 
necessary tool needed to increase the efficiency of reproductive technologies, including 
SCNT.  With this in mind, we propose the use of SR-FLICA (Immunochemistry 
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Technologies, Bloomington, MN), a non-toxic, non-invasive caspase activity reporter 
with a fluorescent tag to quantify the level of apoptosis to better evaluate embryo quality.   
 SR-FLICA covalently binds to active caspases, which are proteins involved in the 
final stages of apoptosis and are responsible for activating the proteases and nucleases 
that carryout apoptosis in the cell [73].  Caspases are always present in cells in their 
inactive pro-enzyme form [68].  Cleavage of the caspase activates its enzymatic activity 
following the intrinsic or extrinsic pathway of apoptosis [70].  The intrinsic pathway of 
apoptosis is also referred to as the mitochondrial pathway and releases cytochrome C and 
the apoptosis inducing factor to activate initiator caspases [70].  The extrinsic pathway of 
apoptosis begins with the ligation of death receptors as a result of an external stimulus 
activating initiator caspases [70].  Initiator caspases in turn activate effector caspases 
which act on specific cellular substrates to dismantle the cell [74].  While embryos have 
been shown to contain cells undergoing apoptosis [79], this is the first reported use of 
SR-FLICA to analyze active caspase activity in mammalian embryos.   
Methods that have been previously used to analyze apoptosis in embryos, 
including TUNEL analysis, have the disadvantage of requiring the embryo to be fixed or 
destroyed prior to analysis so that subsequent transfer of the embryo into a surrogate is 
not possible.  Traditional methods to detect apoptosis include morphological assessment, 
DNA fragmentation, or TUNEL.  While morphological assessment is an inexpensive 
method to detect apoptosis through visual assessment using microscopy, it lacks 
objectivity and reproducibility and is prone to errors, which could be enhanced in 
fragmented embryos as visual indications of apoptosis, including nuclear condensation, 
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cell shrinkage, cytoplasmic blebs, and cell detachment, could be difficult to assess in 
fragmented embryos.  Cells undergoing apoptosis show a distinctive DNA fragmentation 
ladder.  However, to visualize this ladder, the cell must be destroyed so the DNA can be 
run using agarose electrophoresis, which is not compatible with selecting embryos most 
likely to succeed following transfer.  Finally, TUNEL (terminal deoxynucleotidyl 
transferase dUTP nick end labeling) is used to identify cells undergoing DNA 
fragmentation by using enzymes that add a labeled nucleotide to the ends of DNA to 
identify DNA breaks.  While effective and commonly reported as a tool to identify 
individual cells undergoing apoptosis, TUNEL requires the cells to be fixed and 
permeabilized before the staining can be performed, making it impossible for further 
development  following staining.  By using SR-FLICA, we have developed a protocol to 
analyze apoptosis levels in live embryos that can be analyzed for future developmental 
potential.  
 Our main hypothesis is that, following SCNT, most embryos undergo erroneous 
epigenetic reprogramming resulting in aberrant gene expression.  As a result, these 
embryos will have an increased incidence of apoptosis and eventual failure following 
transfer.  However, a subset of embryos following SCNT undergo proper epigenetic 
reprogramming leading to appropriate gene expression.  These embryos will have a low 
level of apoptosis and successful development following transfer.  The specific objectives 
of this study were carried out in four experiments.  The first experiment was to compare 
SR-FLICA staining to the commonly reported TUNEL staining in porcine fetal fibroblast 
cells and blastocysts.  The second experiment was to verify the non-toxic nature of SR-
FLICA during embryo development by treating embryos on day 3 of development.  The 
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third experiment was to evaluate embryo development by means of the number of cells 
and blastocyst development rate in embryos with a high and low level of apoptosis.  
Finally, the fourth experiment was designed to understand gene expression patterns in 
blastocysts showing high and low levels of apoptosis.   
 
Materials and Methods 
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise noted.  All procedures performed with animals were in agreement with 
principles of animal welfare as approved by the veterinary staff and Institutional Animal 
Care and Use Committee at Utah State University (IACUC protocol #2636). 
 
Oocyte collection and in vitro maturation 
 Cumulus oocyte complexes for SCNT were purchased from Desoto Biosciences 
(Seymore, TN).  Cumulus oocyte complexes for parthenogenetic (PA) embryo production 
were aspirated from 3-6 mm antral follicles of ovaries collected from a local abattoir 
using 18 gauge needles.  Oocyte maturation, manipulation, activation, and embryo 
culture were performed as described previously [88].  Briefly, oocytes with multiple 
layers of cumulus cells were collected, washed in maturation media, and allowed to 
mature for 40-44 hours at 39°C and 6.2% CO2.  Increased CO2 concentrations (compared 
to the commonly reported 5.0%) were used to account for the higher elevation of Utah 
State University.  Maturation media was composed of a base of m199 with Earl’s 
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Balanced Salts and L-Glutamine  (Fisher Scientific; Waltham, MA) supplemented with 
0.1% PVA, 0.05 mM D-glucose, 0.91 mM sodium pyruvate, and 0.02 mg/ml gentamicin 
(Caisson Labs; Smithfield, UT).  Additionally, 0.57 mM cysteine (Thermo Fisher 
Scientific; New Jersey, USA), 0.5 µg/mL of follicle stimulating hormone (Sioux 
Biochemical, Sioux Center, IA), 0.5 µg/mL of luteinizing hormone (Sioux Biochemical), 
10 ng/mL epidermal growth factor, and 10% (v:v) porcine follicular fluid were added 
fresh each time.   
 
Donor Cell Preparation 
 Porcine fetal fibroblasts (PFF) cells served as donor cells for nuclear transfer.  
The PFF cells had been isolated and frozen previously.  For SCNT, the PFF cells were 
expanded and frozen for subsequent cloning using the same cell line at passage six.  PFF 
culture media was prepared using DMEM (Fisher Scientific) as the base supplemented 
with 15% fetal bovine serum, 25 µg/ml basic human fibroblast growth factor, and 40 
mg/ml gentamicin. PFF cells were seeded in a 4-well dish one week prior to SCNT and 
allowed to become confluent for several days for cell synchronization before cloning.  To 
prepare for donor cell injection, medium was removed from the well, rinsed with PBS, 
and trypsin was added for 3 minutes.  The cells were then collected by centrifugation at 





SCNT and Parthenogenetic Activation 
 Following oocyte maturation, oocytes were denuded of cumulus cells in medium 
containing 100 mg Hyaluronidase, 6 g mannitol, 5 mL PVA-TL-Hepes stock, and 95 mL 
double distilled water.  Oocytes were placed in the hyaluronidase media at 39 °C for 5 
minutes then pipetted 40 times to remove the cumulus cells.  Oocytes were washed 
through manipulation medium containing a base of m199 supplemented with 5.95 mM 
sodium bicarbonate, 3.14 mM HEPES, 30 mM NaCl, 0.3% BSA, and 0.04 mg/ml 
gentamicin.  Oocytes with an extruded polar body were selected for SCNT or 
parthenogenetic activation.   
 Oocytes undergoing SCNT were enucleated in drops of enucleation media under 
light mineral oil.  Enucleation took place using a beveled glass pipette to aspirate the first 
polar body and the metaphase II plate by removing a small amount of the cytoplasm 
adjacent to the polar body.  Following enucleation, the donor cell was injected into the 
perivitelline space.  Donor cell injection was performed by placing the donor cells into 
the droplet with the enucleated oocytes.  A single donor cell was picked up with the glass 
pipette and inserted through the same slit in the zona pellucida that was created during 
enucleation.  Donor cells were fused with oocytes at the same time of oocyte activation in 
activation media composed of 0.3 M mannitol, 1.0 mM CaCl2, 0.1 mM MgCl2, and 0.5 
mM HEPES (pH 7.0-7.4).  Fusion and activation occurred with two direct current pulses 
of 1.2 kV/cm2 for 30 µsec.  Fusion of the donor cell was checked after 30 minutes. 
 Parthenogenetic (PA) embryos were produced in the same manner.  In activation 
media, oocytes were exposed to two direct current pulses of 1.2 kV/cm2 for 30 µsec. 
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 Embryos were cultured at 39°C and 6.2% CO2 in PZM3 media up to day 7 of 
development.  PZM3 media [89] was composed of 108 mM NaCl, 10 mM KCl, 0.35 mM 
KH2PO4, 0.4 mM MgSO4, 25.07 mM NaHCO3, 0.2 mM sodium pyruvate, 2 mM calcium 
lactate, 1 mM L-Glutamine, 5 mM hypotaurine, 2% (v/v) BME amino acids (Fisher 
Scientific), 1% (v/v), MEM amino acids (Fischer Scientific), 0.005% (w/v) gentamicin, 
and 0.3% (w/v) FA-free BSA.  The pH was adjusted to 7.3-7.4.   
 
SR-FLICA and Hoechst 33342 Staining 
 SR-FLICA was resuspended as recommended by the manufacturer.  Briefly, 50 
µL DMSO was added to one vial SR-FLICA. Embryos were stained in 500 µL PZM3 
culture media with 2 µL reconstituted SR-FLICA for 2 hours in the incubator.  Embryos 
were moved to a fresh 500 µL PZM3 and placed back in the incubator for 30 minutes.  
Next, embryos were stained to visualize nuclei in order to count number of cells.  
Embryos were stained in 1 µg/ml of Hoechst 33342 for 10 minutes in the incubator.  
Embryos were then washed in PZM3 and transferred to individual 10 µL PZM3 droplets 
under mineral oil for fluorescent microscopy. 
 
Microscopy and Image Analysis 
 Individual embryos were imaged at the 10X objective using the Zeiss Axio 
Observer.Z1 (Carl Zeiss Microscopy; Thornwood, NY).  Fluorescent images of SR-
FLICA (excitation 550-580 nm, emission 590-600 nm) and Hoechst 33342 (excitation 
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350 nm, emission 461 nm) stained embryos were captured with an Axiocam HRc (Carl 
Zeiss Microscopy) creating a black and white image and color was artificially added 
using Zen software (Carl Zeiss Microscopy; v. 2.0).  SR-FLICA was assigned a red color 
and Hoechst 33342 a blue color.  Both SR-FLICA and Hoechst 33342 images had a 1 
second exposure time and light excitation intensity remained constant between embryos 
for accurate comparisons of incidence of apoptosis.  SR-FLICA was analyzed using 
Adobe Photoshop (v. 2017.1.1.20174025) to determine the average red pixel intensity 
within the space of the zona pellucida of the embryo.  In blastocysts that were hatching, 
both the space inside the zona pellucida and the hatching extrusion was included in the 
analysis.  Average red pixel intensity for each embryo was ranked, and the top and 
bottom 20% were considered high and low apoptosis, respectively.  For cell counts, 
embryos were transferred onto a glass slide and the number of nuclei were counted to 
ensure accurate cell counts. 
 
Experiment 1 
 Experiment 1 aimed to validate SR-FLICA staining with the more commonly 
used method of TUNEL staining.  Apoptosis was induced in PFF cells (P6) and PA 
blastocysts using staurosporine treatments.  For PFF cell analysis, cells were treated with 
0 µM, 0.08 µM, 0.4 µM, and 2 µM staurosporine in PFF cell media for 3 hours in the 
incubator.  The PFF cell media was changed and the cells were treated with FLICA for 1 
hour in the incubator.  The media was again changed and the cells were allowed to rest 
for 30 minutes in the incubator.  The cells were then treated with 1mg/ml Hoechst 33342 
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for 10 minutes in the incubator.  The cell culture media was again removed and the cells 
were rinsed with PBS.  The cells were fixed in formalin for 1 hour at room temperature.  
The cells were again rinsed with PBS then incubated with a permeabilization solution for 
2 minutes on ice, as per TUNEL manufacturer directions (In Situ Cell Death Kit- 
Fluorescein).  The cells were washed with PBS twice.  95 µL of TUNEL reaction mixture 
was then added to each well and allowed to incubate at 39°C for one hour.  The cells 
were again washed with PBS twice then covered in 500 µL PBS for imaging.  Exposure 
times for TUNEL, SR-FLICA, and DAPI were 3.31 seconds, 7.85 seconds, and 2.49 
seconds, respectively.  Three different regions of the well were imaged for analysis and 
results were averaged. Staining of the 4 staurosporine treatments was replicated 3 times 
(n = 3).  The number of cells in each photo was counted from the Hoechst 33342 staining 
as well as the number of apoptosis positive cells in both the TUNEL and SR-FLICA 
staining to determine a percentage of cells that were apoptosis positive.  Correlation 
between percent of cells positive for SR-FLICA staining and TUNEL staining was 
calculated using GraphPad Prism (version 7.04; GraphPad Software, Inc; La Jolla, CA).  
  
Experiment 2  
 The aim of experiment 2 was to confirm the non-toxic nature of SR-FLICA 
during embryo development.  Oocytes were treated with SR-FLICA (n = 4, total 237 
oocytes) or remained un-treated to serve as a control group (n = 4, total 237 oocytes).  
Oocytes were then parthenogenetically activated and cleavage rates at 24 hours and 
blastocyst development at day 5, 6, and 7 were recorded.  Student’s t-tests at each 
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developmental stage were conducted using Graphpad Prism to determine if treated and 
control groups developed differently.  P-values were corrected for multiple comparisons 
using the Holm-Sidak method with an alpha value of 0.05. 
 
Experiment 3 
 The aim of experiment 3 was to characterize the development of high and low 
apoptosis embryos.  SCNT embryos were stained with SR-FLICA and Hoechst 33342 on 
day 3 of development.  SR-FLICA exposure time was 1 second and Hoechst 33342 was 
used for counting of nuclei once embryos were mounted onto slides.  Day 3 SCNT 
embryos (n = 3, total 156 embryos) were fixed following SR-FLICA imaging and cell 
numbers were counted to determine if there was a correlation between incidence of 
apoptosis and cell number on day 3 of development.  Additionally, embryos were 
classified as high (n = 31) or low (n = 31) incidence of apoptosis and average cell number 
was compared between groups using a student t-test for statistical analysis.  Both 
correlation analysis and t-test were performed using GraphPad Prism.  In four separate 
replicates, day 3 embryos that had cleaved by 24 hours (732 embryos) were stained with 
SR-FLICA, sorted by incidence of apoptosis (high and low, 156 and 150 embryos 
respectively), and allowed to continue development to day 7.  Blastocyst rates were 
recorded for the high and low incidence of apoptosis groups.  On day 7, all embryos, 
whether they had reached the blastocyst stage or not, were stained with Hoechst 33342 
and cell numbers were recorded.  Average cell number for embryos with high and low 
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levels of apoptosis on day 3 were recorded on day 7.  A student t-test was used for 
statistical analysis using GraphPad Prism.  
 Additionally, cell number was analyzed using blastocysts (3 replicates, total n = 
132) with apoptosis analyzed on day 7 of development.  PA embryos were allowed to 
develop to day 7, then blastocysts were collected and stained with SR-FLICA and 
Hoechst 33342.  Apoptosis level was determined for each blastocyst as well as total cell 
number.  The correlation between apoptosis and cell number was examined as well as a 




 The goal of experiment 4 was to understand gene expression patterns in high and 
low incidence of apoptosis day 6 SCNT blastocysts.  Following three cloning sessions, 
embryos developed to day 6.  Blastocysts were stained with SR-FLICA and Hoechst 
33342 and the top and bottom 20% of average red pixel intensity were classified as high 
(n = 13) and low (n = 13) apoptosis blastocysts.  Additionally, in vivo produced 
blastocysts were collected 5 days after natural mating of the sow (2 sows, total n = 11 
blastocysts collected).  Blastocysts were stored at -80°C until RNA extraction could be 
performed.  RNA extraction and cDNA conversion was performed on individual 
blastocysts as reported previously in individual oocytes [90].  Briefly, RNA was isolated 
using the ZR-DUET DNA/RNA MiniPrep (Zymo Research; Irvine, CA) following 
manufacturer instructions except the final elution was performed using 20 µL 
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DNase/RNase-free water.  RNA was converted to cDNA using GoScript Reverse 
Transcriptase System (Promega; Madison, WI) again with minor modifications to the 
manufacturer’s protocol.  8 µL of RNA was combined with 1 µL of oligo primers and 1 
µL of random primers and water was then left out of the reverse transcription reaction 
mix; otherwise the reaction was performed as per the manufacturer’s recommended 
protocol.   
 Gene expression analysis was performed through qPCR using the Fluidigm 
(South San Francisco, CA) 96.96 TaqMan Assay.  The Fluidigm platform follows 
standard PCR chemistry in nanoliter-scale reactions to evaluate 96 genes for each of 96 
samples using the 96.96 Dynamic Array integrated fluidic circuit (IFC) chip.  Gene 
categories evaluated include apoptosis (AIFM1, APAF1, ATM, BAD, BAX, BACL2, 
BCLX, BID, CASP3, CASP9, CDKN1A, HSP70, P53, and XIAP) , epigenetic regulation 
(ASH2L, DMAP1, DNMT1, DNMT3A, DNMT3B, EHMT2, EZH2, HAT1, HDAC1, 
HDAC2, HDAC3, KAT2A, KDM3A, KDM4C, KDM5B, MECP2, SIRT1, and SUV39H1), 
imprinted genes (ASCL2, DIRAS3, GNAS, GRB10, HAND1, IGF2, IGF2R, IMPACT, 
MEG3, NECD, NNAT, PEG3, PEG10, RTL1, SNRPN, and UBE3A), maternal effect 
(BMP15, DAZL, DDX4, FIGLA, GDF9, MOS, NLRP5, ZAR1, ZP2, and ZP3), 
pluripotency (CMYC, ID1, ID3, KLF4, LIN28, NANOG, POU5F1, SOX2, and ZIC1),  
trophoblast differentiation and function (CDX2, CYP17A1, DLX3, ELF5, ESRRB, ETS2, 
HSD17B1, KRT8, SFN, TACSTD2, TEAD4, and VIM), and housekeeping (ACTB, 
EIF4A1, GAPDH, HSP90, RPS5, SF3A1, TAF11, and YWHAZ).  Fluidigm Corporation’s 
DeltaGene assay design service designed custom primers based on NCBI’s reference 
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sequence for pigs.  Gene names and PCR primer sequence for each gene symbol can be 
found on Supplementary Table 2-2 and 2-3, respectively.   
 To perform quantitative PCR gene expression analysis using the Biomark system, 
Fludigm’s protocol (PN 68000130) was followed.  Specific target amplification was 
performed to each sample before qPCR by created a 200 nM primer mix by pooling 1 µL 
of each combined forward and reverse primer set (20 µM each).  The specific target 
amplification is performed by combining 1.25 µL of the pooled primer mix, 2.5 µL of 
TaqMan PreAmp Master Mix (Applied Biosystems; Foster City, CA) and 1.25 µL of 
cDNA.  The polymerase is activated at 95°C for 10 minutes and then the reaction is 
amplified for 14 cycles of 95°C for 15 seconds then 60°C for 4 minutes.  The reaction is 
then treated with Endonuclease I (ExoI; New England Biolabs; Ipswich, MA) to remove 
any primers that were not integrated in the specific target amplification.  The ExoI 
treatment added 1.4 µL of water, 0.2 µL of ExoI reaction buffer, and 0.4 µL ExoI enzyme 
to each specific target amplification reaction.  The reactions were incubated at 37°C for 
30 minutes to allow for complete digestion of the non-integrated primers.  Then, 
reactions were inactivated at 80°C for 15 minutes.  Following ExoI treatment, each 
reaction was diluted 5-fold to a total volume of 25 µL.  Reactions were stored at -20°C 
until further gene expression analysis was performed.   
 Next, individual sample and primer solutions were prepared for qPCR.  Two 
microliters of the diluted specific target amplification were combined with 2.5 µL of  2X 
TaqMan Gene Expression Master Mix (Applied Biosystems), 0.25 µL of 20x DNA 
binding dye sample loading reagent (Fluidigm), and 0.25 µL of 20X EvaGreen DNA 
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Binding Dye (Biotium; Hayward, CA).  Primer mixes were made by combining 2.25 µL 
each primer (20 µM) with 2.5 µL of 2x Assay loading reagent (Fluidigm) and 0.25 µL 
water.  The IFC chip was primed prior to loading samples and primers using the Prime 
Script (136X) of the HX IFC controller.  Once priming was complete, 5 µL of each 
primer mix and 5 µL of each sample mix were pipetted into their correct inlets on the 
chip.  The chip was again inserted into the IFC controller and the samples and primers 
were loaded into the chip using the Load Mix Script (136X) so that the samples and 
primers were moved into the reaction chambers.  After the chip was loaded, the chip was 
placed in the BioMark thermal cycler for quantitative PCR where cycles consisted of 5 
minutes of enzyme activation at 95°C, followed by 35 cycles of 95°C for 15 seconds then 
60°C for 60 seconds for denaturation and extension, and finished with a 3 minute final 
extension cycle at 60°C.  Following PCR amplification, a melt curve analysis was 
performed to assess the quality of each product.  Each sample was run in duplicate on the 
chip and the chip run was duplicated yielding 4 reactions of each sample and primer.  
Downstream analysis averaged ΔΔCT values for statistical analysis.   
 Analysis of qPCR data was performed using the Fluidigm Real-Time PCR 
Analysis Software (v 4.3.1).  Delta-delta CT values were calculated using a positive 
control sample containing cDNA from day7 PA blastocysts, MII oocytes, and cumulus 
cells as reference and multiple housekeeping genes.  While 96 different primers were run 
on the Fluidigm chip, primers were removed from analysis if they yielded a signal in 
more than 40% of the negative control samples, failed to work in more than 60% of the 
IVV sample reactions, or failed to work in at least 3 high and 3 low SCNT samples.  
These criteria removed 31 genes from further analysis.  Sixty-five genes were analyzed 
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for difference in expression between high and low apoptosis embryos and in vivo (IVV) 
samples.  Statistical analysis was performed in SAS by fitting a generalized linear mixed 
model (proc glimmix) to analyze ΔΔCT values for each group type.  Sample type (high 
apoptosis, low apoptosis, or in vivo) and collection day were class variables. 
Additionally, collection day was considered a random variable.  Four estimates were 
performed.  The first compared high apoptosis to low apoptosis samples.  The second 
compared high apoptosis and IVV samples.  The third compared low apoptosis and IVV 
samples.  And the final compared cloned (including high and low apoptosis samples) to 
IVV samples.  Because not all reactions worked properly, the number of samples 
analyzed in each group for each gene has been provided in Supplementary Table 2-1.  All 
p-values were corrected for false discovery rate (FDR) as described by Benjamini and 
Hochberg [91].  Fold change values were calculated from ΔΔCT values and normalized 
to the average IVV fold change.  Log2 fold change values were then graphed. 
 Hierarchical clustering was analyzed through an unsupervised hierarchical 
clustering created through the ClustVis program [92].  Raw ΔΔCT values, before 
normalization to the IVV samples, for each sample and gene analyzed were uploaded into 
the program.  Clustering analysis was performed using the correlation metric with 
average linkage clustering.  Additionally, ClustVis was used to perform PCA using raw 
ΔΔCT values.  For both analyses, no scaling was performed on rows and SVD with 






 Induction of apoptosis through staurosporine treatment of PFF cells resulted in a 
statistically significant correlation (Figure 2-1a) between the percentages of SR-FLICA 
and TUNEL positive cells (R2 = 0.69, P = 0.00079).  The relationship is visible in the 
percent of SR-FLICA and TUNEL positive cells when graphed by concentration of 
staurosporine treatment (Figure 2-1b).  With no staurosporine treatment (0 µM), 1.29% 
(± 0.2) of cells were TUNEL positive while 7.30% (± 2.15) of cells were SR-FLICA 
positive.  These values increase with a 0.08 µM staurosporine treatment to 3.92% (± 
1.08) of cells being TUNEL positive and 16.36% (± 3.8) of cells being SR-FLICA 
positive.  At a staurosporine treatment level of 0.4 µM, 39.42% (± 9.8) of cells were 
positive for TUNEL and 46.14% (± 7.0) for SR-FLICA.  Finally, after a 2 µM 
staurosporine treatment, 36.56% (± 5.7) of cells were positive for TUNEL while 41.85% 
(± 5.7) were positive for SR-FLICA.  These results indicate a dose response from 0-0.4 
µM of staurosporine.   
 
Experiment 2 
 Oocytes stained with SR-FLICA developed at the same rates compared to those 
not stained (Figure 2-2 and Table 2-1).  At 24 hours of development, 81.42% (± 3.3) of 
oocytes that had been treated with SR-FLICA had cleaved compared to 82.23% (± 4.8) of 
control oocytes.  On day 5 of development, 5.3% (± 0.6) of oocytes treated with SR-
FLICA had developed into blastocysts compared to 6.23% (± 2.5) of the control oocytes.  
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The following day on day 6 of development, 15.30% (± 3.3) of the SR-FLICA stained 
oocytes had developed to blastocysts compared to 12.2% (± 2.4) of the control oocytes.  
By day 7, 17.73% (± 4.4) of SR-FLICA stained oocytes had developed into blastocysts 
compared to 16.40% (± 3.9) of oocytes not exposed to the stain.  No statistical 
differences were identified at any of the 4 stages of development (P ≥ 0.95).   
 
Experiment 3 
 Embryos stained with SR-FLICA on day 3 of development (Figure 2-3) showed 
no significant correlation between SR-FLICA score that indicates the relative level of 
apoptosis and number of cells (R2 = 0.01, P = 0.2).  On day 3 of development, SR-FLICA 
scores appear to be normally distributed with a skew towards high SR-FLICA values 
(Supplemental Figure 2-1a).  Day 3 embryos that were sorted into high and low incidence 
of apoptosis groups had a statistically different relative level of apoptosis (P < 0.0001) 
with the average high apoptosis SR-FLICA score of 54.93 (± 2.7) and the average low 
apoptosis SR-FLICA score of 33.76 (± 0.3) (Supplemental Figure 2-1b).   
 When day 3 embryos were sorted into high and low apoptosis groups and then 
followed for development (Figure 2-4, Table 2-2), no significant differences in blastocyst 
rates occurred on day 5 (P = 0.49), day 6 (P = 0.99), or day 7 (P = 0.49).  On day 5, 
7.73% (± 2.1) of the embryos sorted into the high apoptosis group on day 3 of 
development had reached the blastocyst stage while 13.74% (± 3.8) of the embryos 
considered low apoptosis on day 3 had reached the blastocyst stage.  On day 6 of 
development, 22.48% (± 1.7) of the high apoptosis embryos were blastocysts while 
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22.53% (± 4.8) of the low apoptosis embryo had reached the blastocyst stage.  On day 7 
of development, 21.68% (± 1.3) of the high apoptosis embryos had reached the blastocyst 
stage of development and 27.9% (± 4.4) of the low apoptosis embryos had reached this 
stage.   
 After tracking development of day 3 sorted embryos through day 7 of 
development, cell numbers were counted for all embryos in the high and low apoptosis 
groups (Figure 2-5), whether they had reached the blastocyst stage or not.  The average 
number of cells in day 7 embryos was 7.70 ± 0.6 for high apoptosis embryos and 8.13 ± 
0.7 for low apoptosis embryos with no statistical difference between the two groups (P = 
0.63).  Cell numbers per embryo were low because a majority of the embryos stalled in 
development and failed to reach the blastocyst stage of development.   
 When embryos were not stained until the blastocyst stage on day 6 of 
development, again no statistically significant correlation was found between the relative 
level of apoptosis and cell number per blastocysts (R2 = 0.003, P = 0.53; Figure 2-6a).  
Sorting these blastocysts into high and low incidence of apoptosis showed no significant 
difference in cell numbers (P = 0.18) with high apoptosis blastocysts containing an 
average of 34.22 ± 2.6 cells and low apoptosis embryos containing an average of 39.54 
±3.0 cells (Figure 2-6b).  For reference, in vivo produced porcine blastocysts typically 
contain more than 50 cells per embryo [93, 94].  Again there was a significant statistical 
difference in SR-FLICA scores for the high compared to low apoptosis blastocyst (P < 
0.0001, Supplemental Figure 2-2b).  SR-FLICA staining of day 6 embryos again showed 
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SR-FLICA scores with a close to normal distribution but skewed towards high SR-
FLICA scores (Supplemental Figure 2-2a).   
 
Experiment 4 
 Comparing gene expression of high to low apoptosis SCNT blastocysts found no 
genes with significantly different gene expression (Table 2-3).  High apoptosis SCNT 
blastocyst and in vivo blastocysts had 5 genes with significantly different levels of 
expression (AIFM1, P = 0.05; BAX, P = 0.004, CDKN1A, P = 0.007, GNAS, P = 0.047, 
and GRB10, P = 0.004).  Interestingly, 3 of these genes have a function in apoptosis 
while 2 are imprinted genes.  Low apoptosis SCNT blastocysts and in vivo blastocysts 
had 5 genes with significantly different expression levels (ATM, P = 0.02; BAX, P = 
0.004; CDKN1A, P = 0.005; GRB10, P = 0.004; and IGF2, P = 0.02).  Again, it is 
noteworthy that 3 of these genes have a functional classification of apoptosis and 2 of 
imprinted genes.  Finally, comparing SCNT blastocysts (combining the high and low 
apoptosis blastocysts) to in vivo produced blastocysts, 6 genes are statistically different in 
gene expression level (ATM, P = 0.02; BAX, P = 0.002, CDKN1A, P = 0.002, GNAS, P = 
0.04, GRB10, 0.002, and CMYC, P = 0.04). 
 In the apoptosis gene functional class, statistically different expression was found 
in AIFM1 [high vs IVV (FDR P = 0.047)], ATM [low vs. IVV (FDR P = 0.02) and SCNT 
vs. IVV (FDR P = 0.02)], BAX [high vs. IVV (FDR P = 0.003), low vs. IVV (FDR P = 
0.003) and SCNT vs. IVV (FDR P = 0.002)], and CDKN1A [high vs. IVV (FDR P = 
0.007), low vs. IVV (FDR P = 0.005), and SCNT vs. IVV (FDR P = 0.002)] (Figure 2-7). 
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 Genes involved in epigenetic regulation had no statistical differences in any of the 
comparisons.  However, three comparisons trended towards significance [DNMT1A low 
vs. IVV (FDR P = 0.07), DNMT1A SCNT vs. IVV (FDR P = 0.09), and KDM4C SCNT 
vs. IVV (FDR P = 0.09)] (Figure 2-8).  In the imprinted gene category, statistically 
different expression was found in GNAS [high vs. IVV (FDR P = 0.047) and SCNT vs. 
IVV (FDR P = 0.042)], GRB10 [high vs. IVV (FDR P = 0.004), low vs. IVV (FDR P = 
0.004), and SCNT vs. IVV (FDR P = 0.002)], and IGF2 [low vs. IVV (FDR P = 0.012)]. 
(Figure 2-9).  No maternal effect genes showed significantly different expression levels 
in any of the comparisons (Figure 2-10).  In the pluripotency genes, one statistically 
different comparison was identified and three trended towards significance [CMYC 
SCNT vs. IVV (FDR P = 0.04), CMYC low vs. IVV (FDR P = 0.06), LIN28 low vs. IVV 
(FDR P = 0.08), and LIN28 SCNT vs. IVV (FDR P = .052)]. (Figure 2-11).  In 
trophoblast differentiation and function genes, no significantly differentially expressed 
genes were identified (Figure 2-12).  Housekeeping genes showed relatively consistent 
gene expression as intended and no significant differences in expression were identified 
in any of the analyses (Figure 2-13).   
 Unsupervised hierarchical clustering of gene expression data using ΔΔCT values 
indicated that the in vivo blastocysts generally clustered separately from the SCNT 
blastocysts (Figure 2-14).  IVV samples additionally clustered separately based on the 
sow they were collected from (IVV 1-6 were collected from sow 1 while IVV 7-11 were 
collected from sow 2) which was expected as there were clear morphological differences 
in the embryos from each collection.  However, there was no clear separation of the high 
and low apoptosis SCNT blastocysts.   
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 PCA found that PC1 accounted for 36.1% of the variation while PC2 accounted 
for 10.8% of variation (Figure 2-15).  SCNT blastocysts separated away from the IVV 
samples.  But again there was no clear separation of the high and low apoptosis 
blastocysts as the prediction ellipses were nearly identical.  
 
Discussion 
 While SR-FLICA has been used to detect active caspase activity in other cell 
lines, this is the first report of its use in fetal fibroblasts and developing embryos.  The 
potential to evaluate apoptosis in live, developing embryos could prove to be a vital non-
invasive biomarker for embryo competence following transfer.  However, before this 
technology can be used to identify healthy embryos, it had to first be validated to 
accurately mark embryos undergoing apoptosis and prove to be non-toxic during the 
sensitive period accompanying early embryo development.  SR-FLICA staining of 
porcine fetal fibroblast (PFF) cells showed a significant correlation with the more 
traditionally used TUNEL staining.  By inducing cells to undergo apoptosis through 
staurosporine treatment, a dose response was seen in both SR-FLICA and TUNEL 
staining from 0 µM to 0.4 µM of staurosporine treatment.  The percent of cells positive 
for SR-FLICA and TUNEL staining following 2 µM staurosporine treatment was equal 
to or even a little less than the percent of positive cells after 0.4 µM staurosporine 
treatment.  The decrease in percent of apoptotic cells could be an effect of the highest 
dose of staurosporine inducing apoptosis earlier than the lower doses, the cells 
completing apoptosis, and being sloughed off before the staining procedure was 
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performed.  These results validate the use of SR-FLICA to identify cells undergoing 
apoptosis. 
 In order for SR-FLICA to be a relevant biomarker of embryo competency, it must 
be compatible with early embryo development.  Oocytes treated with SR-FLICA 
developed at equivalent rates at cleavage and the blastocyst stage compared to oocytes 
that were not treated.  The lack of hindrance on development is one early indication that 
the staining process is non-toxic at these early stages of development.  However, until 
embryo transfers are performed following SR-FLICA staining, it is impossible to know 
the long-term effects of the treatment during this critical window of development.  
Additionally, it is unknown if the specific timing of staining will have an effect different 
from treatment at the oocyte stage and what stage will provide the best time point to use 
apoptosis as a biomarker for future development. 
 Previous studies have noted that apoptosis detected by TUNEL staining is not 
apparent in  zygote and cleavage stage embryos and does not appear until around the time 
of the maternal-to-zygotic transition [71].  With the maternal-to-zygotic transition 
occurring at the 4-8 cell stage in porcine embryos, we performed staining on day 3 of 
development, as this process should be beginning.  At day 3 of development, there was 
no correlation between the relative level of apoptosis and number of cells in the embryo.  
Additionally, sorting these embryos into high and low incidence of apoptosis groups 
showed no difference in blastocyst rates on day 5, 6, and 7 of development.  On day 7 of 
development, embryos from high and low incidence of apoptosis groups had no 
significant difference in total number of cells per embryo.  Together, these results 
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indicate that sorting SCNT embryos on day 3 of development based on incidence of 
apoptosis does not isolate the embryos most likely to develop into blastocysts or develop 
more cells by day 7, an indication of embryo quality.   
 Therefore, we turned our attention from day 3 embryos to day 6 blastocysts, a 
stage commonly transferred into surrogate females.  By waiting until day 6 of 
development, the embryos have proved some level of developmental competence by 
reaching the blastocyst stage.  Day 6 PA blastocysts showed no correlation between 
relative level of apoptosis and cell number.  In addition, high apoptosis blastocysts and 
low apoptosis blastocysts had no significant difference in cell number which is related to 
embryo quality.  To better understand embryo competence based on relative incidence of 
apoptosis, gene expression analysis of individual blastocysts was performed. 
 Quantitative PCR was used to analyze relative gene expression of high and low 
apoptosis day 6 SCNT blastocysts relative to in vivo produced blastocysts.  Seven 
functional gene classes were analyzed including apoptosis genes, epigenetic regulation 
genes, imprinted genes, maternal effect genes, pluripotency genes, trophoblast 
differentiation and function genes, and housekeeping genes.  Fold change values were 
normalized to in vivo produced blastocysts and average log2 fold change values were 
graphed for each group.  Notably, no genes were differentially expressed between the 
high and low apoptosis groups.  One possibility is that we did not select the correct genes 
for analysis, and as a result missed finding gene expression differences that are present 
between the high and low apoptosis blastocysts.  It is also possible that changes in gene 
expression in high quality embryos are not consistent, and thus, not discernable by the 
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statistical methods used in this study for data analyses.  Further studies using RNA-seq 
would provide a more complete picture of the gene expression differences between high 
and low apoptosis embryos. 
 SCNT compared to in vivo produced embryos are expected to show more gene 
expression differences as it has already been reported in numerous studies that cloned 
embryos show altered gene expression patterns compared to in vivo produced embryos 
[21, 64, 95].   In this case, 6 of 65 genes were significantly differentially expressed in 
SCNT embryos compared to in vivo embryos, including ATM, BAX, CDKN1A, GNAS, 
GRB10, and CMYC.  Interestingly, half of these genes are related to apoptosis, two are 
imprinted genes, and one is related to pluripotency.  All three apoptosis genes, ATM, 
BAX, and CDKN1A, have increased expression in SCNT blastocysts compared to in vivo 
blastocysts.  GNAS and GRB10, both imprinted genes, also show increased expression 
levels in SCNT embryos compared to the in vivo blastocysts.  Finally, CMYC, a 
pluripotency gene, had decreased expression in SCNT blastocysts compared to the in vivo 
reference samples.  Together, these altered gene expression patterns of SCNT blastocysts 
compared to in vivo blastocysts indicate the possibility of less competent embryos due to 
increased apoptosis gene expression, increased imprinted gene expression, and decreased 
pluripotency gene expression.  
 Unsupervised hierarchical clustering analysis also indicated no clear difference 
between high and low apoptosis SCNT blastocysts.  Rather than sorting by incidence of 
apoptosis, high and low apoptosis blastocysts were muddled together while in vivo 
blastocysts sorted on their own.  There were two clear groups of in vivo produced 
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blastocysts that sorted based on the collection day, indicating that there could have been a 
slight difference in developmental timing between each collection.  Similar clustering 
patterns were also evident in principal component analysis.     
 In conclusion, these data indicate that SR-FLICA could be a useful biomarker of 
apoptosis during embryo development.  Initial data supports the non-toxic nature of SR-
FLICA, even during early embryo development.  Induction of apoptosis in PFF cells 
validates that SR-FLICA identifies apoptosis similarly to the more traditionally used 
TUNEL method, without the need to sacrifice the cells prior to staining.  These in vitro 
experiments did not find a difference in high and low apoptosis embryos in terms of cell 
numbers, developmental potential, or gene expression patterns.  But it is still unknown 
how high and low apoptosis embryos would develop in vivo following embryo transfer.  
Future studies focusing on global gene expression patterns and epigenetic reprogramming 
as indicated by DNA methylation will provide a more complete explanation of the 
differences between high and low apoptosis embryos.  Additional studies following high 
and low apoptosis embryos after transfer will provide insight into the developmental 
potential of these embryos at both establishing and maintaining pregnancy following 
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No. of Oocytes Cleaved1, n (%) D52, n (%) D62, n (%) D72, n (%) 
SR-FLICA 237 190 (80.2%) 12 (5.1%) 35 (14.8%) 41 (17.3%) 
Control 227 180 (79.3%) 16 (7.0%) 29 (12.8%) 40 (17.6%) 
1 Cleaved within 24 hours 

















Table 2-2.  Blastocyst development rates from SCNT embryos sorted on day 3 of development. 
Level of Apoptosis No. of Embryos D51, n (%) D61, n (%) D71, n (%) 
High 153 13 (8.5%) 34 (22.2%) 33 (21.6%) 
Low 153 22 (14.4%) 37 (24.2%) 43 (28.1%) 


















Table 2-3.  FDR-corrected P-values following differential gene expression analysis1. 
Category and gene High vs. Low High vs. IVV Low vs. IVV SCNT vs. IVV 
Apoptosis 
AIFM1 0.6926 0.0469* 0.2038 0.0529# 
APAF1 0.9936 0.1302 0.1689 0.0931# 
ATM 0.9511 0.1013 0.0189* 0.0185* 
BAD 0.9511 0.7499 0.7965 0.7369 
BAX 0.9511 0.0036* 0.0036* 0.0024* 
BCLX 0.9511 0.2182 0.2879 0.2101 
BID 0.6926 0.4728 0.9365 0.6894 
CDKN1A 0.9936 0.0071* 0.0047* 0.0024* 
HSP70 0.9511 0.4583 0.6673 0.5454 
P53 0.9936 0.9259 0.8832 0.8888 
XIAP 0.9936 0.3933 0.3296 0.2999 
Epigenetic Regulation 
ASH2L 0.7745 0.2904 0.1529 0.1840 
DMAP1 0.9936 0.2182 0.1809 0.1199 
DNMT1A 0.6926 0.3379 0.0737# 0.0931# 
DNMT3A 0.6869 0.6253 0.8326 0.8616 
EHMT2 0.6869 0.2904 0.8703 0.5975 
EZH2 0.6926 0.1302 0.4214 0.2093 
HAT1 0.5148 0.1302 0.7553 0.2619 
HDAC1 0.9936 0.6253 0.4775 0.4952 
HDAC2 0.3962 0.6253 0.2879 0.7049 
HDAC3 0.9931 0.5782 0.3296 0.3600 
KAT2A 0.9936 0.6253 0.6371 0.5975 
KDM3A 0.9936 0.3379 0.2997 0.2907 
KDM4C 0.9936 0.2182 0.1529 0.0931# 
MECP2 0.9511 0.4583 0.8437 0.5995 
SIRT1 0.3745 0.8949 0.4160 0.6099 







Category and gene High vs. Low High vs. IVV Low vs. IVV SCNT vs. IVV 
Imprinted Genes 
GNAS 0.9511 0.0469* 0.0813# 0.0416* 
GRB10 0.6919 0.0036* 0.0036* 0.0024* 
IGF2 0.2734 0.2375 0.0189* 0.0529# 
IGF2R 0.9936 0.6002 0.5697 0.5829 
IMPACT 0.9511 0.9259 0.6911 0.8615 
NECT 0.9936 0.2182 0.1809 0.1840 
NNAT 0.9511 0.1013 0.2879 0.0931# 
RTL1 0.9511 0.3930 0.2997 0.3209 
SNRPN 0.6926 0.8525 0.2734 0.4370 
UBE3A 0.7452 0.6177 0.9365 0.7621 
Maternal Effect 
BMP15 0.9931 0.2375 0.2879 0.2168 
GDF9 0.9936 0.2375 0.2157 0.2101 
MOS 0.9511 0.2375 0.2019 0.2093 
ZP2 0.9931 0.2599 0.2157 0.2101 
ZP3 0.6926 0.8949 0.3515 0.5959 
Pluripotency 
CMYC 0.9936 0.1013 0.0619# 0.0416* 
ID1 0.6926 0.8525 0.3296 0.5975 
ID3 0.9931 0.4280 0.3296 0.3600 
KLF4 0.9936 0.7558 0.6766 0.6886 
LIN28 0.9936 0.1013 0.0838# 0.0515# 
NANOG 0.9936 0.2904 0.2997 0.2168 
POU5F1 0.9936 0.3379 0.3195 0.3104 
SOX2 0.8887 0.4467 0.2879 0.3250 
Trophoblast Differentiation and Function 
DLX3 0.9936 0.5782 0.487 0.5309 
ESRRB 0.9936 0.5782 0.6673 0.5975 
ETS2 0.7452 0.1750 0.5448 0.2168 
KRT8 0.9511 0.3379 0.1598 0.1840 
SFN 0.9936 0.6745 0.6673 0.6292 
TACSTD2 0.6926 0.3379 0.2019 0.2168 
TEAD4 0.9936 0.6414 0.6371 0.5995 




Category and gene High vs. Low High vs. IVV Low vs. IVV SCNT vs. IVV 
Housekeeping 
ACTB 0.3745 0.2874 0.6911 0.4370 
EIF4a1 0.9931 0.1509 0.0983# 0.0931# 
HSP90 0.9936 0.1013 0.0882# 0.0529# 
RPS5 0.9936 0.3379 0.2808 0.2446 
SF3A1 0.9511 0.7558 0.7553 0.9936 
TAF11 0.2734 0.6273 0.0882* 0.2101 
YWHAZ 0.9511 0.8404 0.5448 0.6292 
1 General linear mixed model analysis of gene expression comparing high apoptosis vs. low 
apoptosis samples, high apoptosis vs. IVV samples, low apoptosis vs. IVV samples, and SCNT 
vs. IVV samples where the high and low apoptosis samples are both compared to IVV samples.  
False discovery rate (FDR) P-values are reported.  P-values deemed as significant (< 0.05) are 






































































Figure 2-1. Relationship between percent of PFF cells SR-FLICA positive and TUNEL 
positive.  Panel A shows the correlation between percent of cells that are SR-FLICA and 
TUNEL positive, indicating a close relationship between the two stains to detect 
apoptosis with an R2 of 0.69 and a p-value of 0.0008. The three replicates of each 
staurosporine treatment (0 µM, 0.08 µM, 0.4 µM, and 2 µM) are represented on the graph 
with a linear regression line.  Panel B indicates the average percent of cells from the 3 
replicates that SR-FLICA or TUNEL positive at each staurosporine concentration (0 µM, 









































































Figure 2-2. Embryo development from parthenogenetic activation following SR-FLICA 
treatment of oocytes compared to controls.  SR-FLICA treated oocytes (n = 4, total 237 
oocytes) compared to oocytes that had received no treatment (n = 4, total 227 oocytes).  
No significant difference was found at any of the developmental stages (24 hour 
cleavage, adjusted P = 0.99; Day 5 blastocysts, adjusted P = 0.99; Day 6 blastocysts, 
adjusted P = 0.95; Day 7 blastocysts, adjusted P = 0.99).  Error bars indicate the standard 






































Figure 2-3. The correlation between SR-FLICA score and the number of cells in day 3 
SCNT embryos (n = 156).  There is no clear correlation between number of cells and 
level of apoptosis (r2 = 0.01, P = 0.2).  Blue indicates embryos in the top 20% of SR-
FLICA scores and are considered high apoptosis.  Green indicates embryos in the bottom 
20% of SR-FLICA scores and are considered low apoptosis.  Black is the remaining 60% 










































































Figure 2-4.  SCNT blastocyst development following SR-FLICA sorting on day 3 of 
development.  Average blastocyst development rate (4 replicates) on day 5, 6, and 7 
following SR-FLICA staining and embryo sorting on day 3 of development with error 
bars indicating the standard error.  High apoptosis (n = 153) represents the embryos in the 
top 20% of SR-FLICA scores and low apoptosis (n = 153) represents the embryos in the 
bottom 20% of SR-FLICA scores.  No significant differences in development were found 
on any day of development (day 5 blastocysts, adjusted P = 0.49; day 6 blastocysts, 

































Figure 2-5.  Average number of cells in day 7 embryos sorted by apoptosis levels on day 
3.  Average number of cells of high (4 replicates, total n = 151) and low (4 replicates, 
total n = 150) apoptosis day 7 SCNT embryos sorted on day 3 of development with 
standard error bars.  All embryos had cells counted, regardless of their developmental 
stage on day 7.  There was no significant difference between high and low apoptosis 








































































Figure 2-6.  Connection between cell number and incidence of apoptosis.  Panel A shows 
the relationship between cell number and the incidence of apoptosis in day 6 PA 
blastocysts (3 replicates, total n = 132).  No correlation was found between the number of 
cells and relative level of apoptosis (r2 = 0.003, P = 0.5).  Blue and green indicate the top 
and bottom 20% of incidence of apoptosis, respectively.  Panel B depicts the average 
number of cells per day 6 PA blastocyst in high (3 replicates, total n = 23) and low (3 
replicates, total n = 24) incidence of apoptosis blastocysts.  Error bars represent the 
standard error.  No significant difference in the number of cells per embryo in high 






































































Figure 2-7.  Gene expression of apoptosis genes.  Log2 fold change comparing gene 
expression of apoptosis genes between in vivo produced blastocysts and SCNT 
blastocysts with high and low levels of apoptosis with standard error bars.  Fold change 
values have been normalized to the in vivo blastocysts.  Data represents 3 replicate 
cloning sessions (high n=13; low n=13) and 2 replicate in vivo blastocyst collections 
(n=11).  However, not every qPCR reaction worked, so number of samples analyzed per 
group for each gene can be found in Supplemental Table 1.  A generalized linear mixed 
model was fit to the data and analysis compared gene expression of high vs. low, high vs. 





























































































Figure 2-8.  Gene expression of epigenetic regulation genes.  Log2 fold change 
comparing gene expression of epigenetic regulation genes between in vivo produced 
blastocysts and SCNT blastocysts with high and low levels of apoptosis with standard 
error bars.  Fold change values have been normalized to the in vivo blastocysts.  Data 
represents 3 replicate cloning sessions (high n=13; low n=13) and 2 replicate in vivo 
blastocyst collections (n=11).  However, not every qPCR reaction worked, so number of 
samples analyzed per group for each gene can be found in Supplemental Table 1.  A 
generalized linear mixed model was fit to the data and analysis compared gene 
expression of high vs. low, high vs. IVV, low vs. IVV, and SCNT vs. IVV.  No statistical 



































































Figure 2-9.  Gene expression of imprinted genes. Log2 fold change comparing gene 
expression of imprinted genes between in vivo produced blastocysts and SCNT 
blastocysts with high and low levels of apoptosis with standard error bars.  Fold change 
values have been normalized to the in vivo blastocysts.  Data represents 3 replicate 
cloning sessions (high n=13; low n=13) and 2 replicate in vivo blastocyst collections 
(n=11).  However, not every qPCR reaction worked, so number of samples analyzed per 
group for each gene can be found in Supplemental Table 1.  A generalized linear mixed 
model was fit to the data and analysis compared gene expression of high vs. low, high vs. 





































Figure 2-10.  Gene expression of maternal effect genes.  Log2 fold change comparing 
gene expression of maternal effect genes between in vivo produced blastocysts and SCNT 
blastocysts with high and low levels of apoptosis with standard error bars.  Fold change 
values have been normalized to the in vivo blastocysts.  Data represents 3 replicate 
cloning sessions (high n=13; low n=13) and 2 replicate in vivo blastocyst collections 
(n=11).  However, not every qPCR reaction worked, so number of samples analyzed per 
group for each gene can be found in Supplemental Table 1.  A generalized linear mixed 
model was fit to the data and analysis compared gene expression of high vs. low, high vs. 
IVV, low vs. IVV, and SCNT vs. IVV.  No statistically significant differences were 



















































Signficant Difference in gene expression:* High v. IVV, # Low v. IVV,  SCNT v. IVV

 
Figure 2-11.  Gene expression of pluripotency genes. Log2 fold change comparing gene 
expression of pluripotency genes between in vivo produced blastocysts and SCNT 
blastocysts with high and low levels of apoptosis with standard error bars.  Fold change 
values have been normalized to the in vivo blastocysts.  Data represents 3 replicate 
cloning sessions (high n=13; low n=13) and 2 replicate in vivo blastocyst collections 
(n=11).  However, not every qPCR reaction worked, so number of samples analyzed per 
group for each gene can be found in Supplemental Table 1.  A generalized linear mixed 
model was fit to the data and analysis compared gene expression of high vs. low, high vs. 



















































Figure 2-12.  Gene expression of trophoblast differentiation and function genes.  Log2 
fold change comparing gene expression of trophoblast differentiation and function genes 
between in vivo produced blastocysts and SCNT blastocysts with high and low levels of 
apoptosis with standard error bars.  Fold change values have been normalized to the in 
vivo blastocysts.  Data represents 3 replicate cloning sessions (high n=13; low n=13) and 
2 replicate in vivo blastocyst collections (n=11).  However, not every qPCR reaction 
worked, so number of samples analyzed per group for each gene can be found in 
Supplemental Table 1.  A generalized linear mixed model was fit to the data and analysis 
compared gene expression of high vs. low, high vs. IVV, low vs. IVV, and SCNT vs. 
IVV.  No statistically significant differences were determined between any of the 



















































Figure 2-13.  Gene expression of housekeeping genes.  Log2 fold change comparing 
gene expression of housekeeping genes between in vivo produced blastocysts and SCNT 
blastocysts with high and low levels of apoptosis with standard error bars.  Fold change 
values have been normalized to the in vivo blastocysts.  Data represents 3 replicate 
cloning sessions (high n=13; low n=13) and 2 replicate in vivo blastocyst collections 
(n=11).  However, not every qPCR reaction worked, so number of samples analyzed per 
group for each gene can be found in Supplemental Table 1.  A generalized linear mixed 
model was fit to the data and analysis compared gene expression of high vs. low, high vs. 
IVV, low vs. IVV, and SCNT vs. IVV.  No statistically significant differences were 








Figure 2-14.  Unsupervised hierarchical clustering.  An unsupervised hierarchical 
clustering analysis of gene expression data using ΔΔCT values.  Hierarchical clustering 
produced using correlation metric with average linkage clustering using the Clustvis 
program.  Blue and red indicates ΔΔCT values.  On the sample tree, green indicates a low 




Figure 2-15.  Principal component analysis of gene expression.  A PCA of gene 
expression data using ΔΔCT values.  No scaling was applied to rows.  SVD with 
imputation is used to calculate principal components. X and Y axis show PC1 and 2 that 
explain 36.1% and 10.8% of the total variance, respectively.  Prediction ellipses are such 
that with 95% confidence, a new observation from the same group should fall within the 
ellipse.  Blue circles indicate high apoptosis samples.  Green triangles indicate low 











Supplemental Tables and Figures 
Supplementary Table 2-1. The number of samples 
analyzed per group for each gene analyzed in qPCR 
analysis. 
Category and Gene Low High In Vivo 
Apoptosis 
APAF1 13 13 11 
AIFM1 11 13 11 
ATM 13 13 11 
BAD 13 12 11 
BAX 13 13 11 
BCLX 13 13 11 
BID 10 13 11 
CDKN1A 13 13 9 
HSP70 8 7 10 
P53 12 11 11 
XIAP 11 9 11 
Epigenetic Regulation 
ASH2L 3 3 10 
DMAP1 11 12 11 
DNMT1A 11 10 11 
DNMT3A 11 13 11 
EHMT2 12 11 11 
EZH2 7 9 11 
HAT1 13 12 11 
HDAC1 11 12 11 
HDAC2 13 13 11 
HDAC3 13 13 11 
KAT2A 12 11 11 
KDM3A 12 13 11 
KDM4C 10 12 11 
MECP2 4 10 11 
SIRT1 13 13 11 
SUV39H1 8 12 11 
Imprinted Genes 
GNAS 13 13 11 
GRB10 12 13 10 
IGF2 12 9 9 
IGF2R 13 13 11 
IMPACT 9 7 11 
NECT 11 10 11 
NNAT 3 5 10 
RTL1 5 6 6 
SNRPN 7 6 11 
UBE3A 13 12 11 
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Category and Gene Low High In Vivo 
Maternal Effect 
BMP15 4 7 5 
GDF9 10 7 10 
MOS 9 8 8 
ZP2 6 12 10 
ZP3 4 10 8 
CMYC 9 8 11 
ID1 4 5 11 
ID3 9 7 8 
KLF4 12 13 11 
LIN28 13 13 11 
NANOG 12 10 11 
POU5F1 13 13 11 
SOX2 12 12 11 
Trophoblast Differentiation and Function 
DLX3 12 12 11 
ESRRB 13 13 11 
ETS2 11 13 11 
KRT8 13 13 11 
SFN 13 13 11 
TACSTD2 13 13 11 
TEAD4 13 13 11 
VIM 5 3 7 
Housekeeping 
ACTB 13 13 11 
EIF4a1 13 13 11 
HSP90 13 13 11 
RPS5 13 13 11 
SF3A1 13 13 11 
TAF11 10 13 11 
YWHAZ 13 13 11 
















AIFM1 Apoptosis Inducing Factor Mitochondria Associated 1 
APAF1 Apoptotic Peptidase Activating Factor 1 
ATM ATM Serine/Threonine Kinase 
BAD BCL2 Associated Agonist of Cell Death 
BAX BCL2 Associated X. Apoptosis Regulator 
BCL2 BCL2 Apoptosis Regulator 
BCLX BCL2 like 1 
BID BH3 Interacting Domain Death Agonist 
CASP3 Caspase 3 
CASP9 Caspase 9 
CDKN1A Cyclin Dependent Kinase Inhibitor 1A 
HSP70 Heat Shock Protein 70 
XIAP X-Linked Inhibitor of Apoptosis 
Epigenetic Regulation 
ASH2L ASH2 Like, Histone Lysine Methyltransferase Complex Subunit 
DMAP1 DNA Methyltransferase 1 Associated Protein 1 
DNMT1 DNA Methyltransferase 1 
DNMT3A DNA Methyltransferase 3A 
DNMT3B DNA Methyltransferase 3B 
EHMT2 Euchromatic Histone Lysine Methyltransferase 2 
EZH2 Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit 
HAT1 Histone Acetyltransferase 1 
HDAC1 Histone Deacetylase 1 
HDAC2 Histone Deacetylase 2 
HDAC3 Histone Deacetylase 3 
KAT2A Lysine Acetyltransferase 2A 
KDM3A Lysine Demethylase 3A 
KDM4C Lysine Demethylase 4C 
KDM5B Lysine Demethylase 5B 
MECP2 Methyl-CpG Binding Protein 2 
SIRT1 Sirtuin 1 
SUV39H1 Suppressor of Variegation 3-9 Homolog 1 
Imprinted Genes 
ASCL2 Achaete-Scute Family BHLH Transcription Factor 2 
DIRAS3 DIRAS Family GTPase 3 
GNAS GNAS Complex Locus 
GRB10 Growth Factor Receptor Bound Protein 10 





IGF2 Insulin Like Growth Factor 2 
IGF2R Insulin Like Growth Factor 2 Receptor 
IMPACT Impact RWD Domain Protein 
MEG3 Maternally Expressed 3 
NECD Notch Receptor Extracellular Domain 
NNAT Nauronatin 
PEG3 Paternally Expressed 3 
PEG10 Paternally Expressed 10 
RTL1 Retrotransposon Gag Like 1 
SNRPN Small Nuclear Ribonucleoprotein Polypeptide N 
UBE3A Ubiquitin Protein Ligase E3A 
Maternal Effect 
BMP15 Bone Morphogenetic Protein 15 
DAZL Deleted in Azoospermia Like 
DDX4 DEAD-Box Helicase 4 
FIGLA Folliculogenesis Specific BHLH Transcription Factor 
GDF9 Growth Differentiation Factor 9 
MOS MOS Proto-Oncogene, Serine/Threonine Kinase 
NLRP5 NLR Family Pyrin Domain Containing 5 
ZAR1 Zygote Arrest 1 
ZP2 Zona Pellucida Glycoprotein 2 
ZP3 Zone Pellucida Glycoprotein 3 
Pluripotency 
CMYC Cellular-myelocytomatosis proto-oncoprotein 
ID1 Inhibitor of DNA Binding 1 
ID3 Inhibitor of DNA Binding 3 
KLF4 Kruppel Like Factor 4 
LIN28 Lin-28 Homolog A 
NANOG Nanog Homeobox 
POU5F1 POU Class 5 Homeobox 1 
SOX2 SRY-Box 2 
ZIC1 Zic Family Member 1 
Trophoblast Differentiation and Function 
CDX2 Caudal Type Homeobox 2 
CYP17A1 Cytochrome P450 Family 17 Subfamily A Member 1 
DLX3 Distal-Less Homeobox 3 
ELF5 E74 Like ETS Transcription Factor 5 
ESRRB Estrogen Related Receptor Beta 
ETS2 ETS Proto-Oncogene 2, Transcription Factor 
HSD17B1 Hydroxysteroid 17-Beta Dehydrogenase 1 






TACSTD2 Tumor Associated Calcium Signal Transducer 2 
TEAD4 TEA Domain Transcription Factor 4 
VIM Vimentin 
Housekeeping 
ACTB Actin Beta 
EIF4A1 Eukaryotic translation Initiation Factor 4A1 
GAPDH Glyceraldehyde-3-Phospahete Dehydrogenase 
HSP90 Heat Shock Protein 90 
RPS5 Ribosomal Protein S5 
SF3A1 Splicing Factor 3a Subunit 1 
TAF11 TATA-Box Protein Associated Factor 11 














Supplemental Table 2-3. Gene symbol of genes analyzed with qPCR with accession number used to 
design forward and reverse primers and respective primer sequences. 
Gene Symbol Accession Number Primer Sequences 
ACTB XM_003124280.2 For:CCTGAACCCCAAAGCCAAC  
Rev:TACATGGCTGGGGTGTTGAA 
AIFM1 NM_001297632.N For:CATGGGAAAGATCCTCCCTGAA  
Rev:TAGCATTGGGCAGCACCTTA 
APAF1 XM_003481742.3 For:TGCCAGAACAAGCTCACAGTA  
Rev:GCGGTTGGGAAAATCACGTAA 
ASCL2 NM_001122991.1 For:TTTCCGGCCATCTCACTGTA  
Rev:TCCTTCGGCGGATACTTGAA 
ASH2L NM_001243568. For:TTTCCGGCCATCTCACTGTA  
Rev:TCCTTCGGCGGATACTTGAA 
ATM NM_001123080 For:TTAAGAGCTTGGGCTCTGGAA  
Rev:TGGTACAGCGAGATCACAC 
BAD XM_003122573.3 For:GCTCCGGAGGATGAGTGAC  
Rev:CTTCGGGCGAGGAAGTCC 
BAX XM_003127290.3 For:GCGCTTTTCTACTTTGCCAGTA  
Rev:GCCGATCTCGAAGGAAGTCC 
BCL2 XM_003121700.4 For:GCCCTGTGGATGACTGAGTAC  
Rev:GGCCCATACAGCTCCACAAA 
BCLX NM_214285.1 For:AGCGTAGACAAGGAGATGCA  
Rev:TTCAGGTAAGTGGCCATCCA 
BID NM_001030535.N For:TGCAGCTACTTCATGGAGGAC  
Rev:CTGGCAATGTCCCGAATGAC 
BMP15 NM_001005155. For:GGCCATTGGTTAATGGAGCAA  
Rev:GCTACCCGGTTTGGTCTCA 
CASP3 NM_214131.1 For:TCAGAGGGGACTGCTGTAGAA  
Rev:CGTCTCAATCCCACAGTCCAA 
CASP9 XM_003127618.3 For:ACTGTGAGGACCTGCTGAC  
Rev:ACAGCCAGGAATCTGCTTGTA 
CDKN1A XM_001929558.3 For:ACCTCCCAGGGCAGGAAA  
Rev:CGGCGTTTGGAGTGGTAGAA 
CDX2 NM_001278769.N For:CGCTACATCACCATTCGGAGAA  
Rev:TTCGCTCTGCGGTTCTGAAA 
CMYC NM_001005154.1 For:CGAACCCTTGGCTCTCCA  
Rev:GCTGCCTCTTTTCCACAGAAA 
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Gene Symbol Accession Number Primer Sequences 
CYP17A1 NM_214428.1 For:GGACACAGATGTCGTCGTCAA  
Rev:AAGCGCTCAGGCATGAACA 
DAZL XM_003358321.2 For:TTACATGCAGCCTCCAACCA  
Rev:CCTGAACTGGTGAACTTGGGTA 
DDX4 NM_001291682.N For:AGGAGGAGAAAGTGGTGACA  
Rev:AAGATGGAGTCCTCATCCTCA 
DIRAS3 NM_001044598.N For:CGAATTTGCCGCGAGGTT  
Rev:GACAGGTGCACAGGTTCTCT 
DLX3 XM_003131590.4 For:TACCGGCAATACGGAGCCTA  
Rev:CTTCAGCTTCCGGCTCTTCC 
DMAP1 NM_001243640. For:GACGGAGCCATGTTCTTCCA  
Rev:ACCTGCACCGTCTTGTTGAA 
DNMT1 NM_001032355. For:AAAGGCGCTCATAGGCTTCA  
Rev:ACGCTGAACAGTGGTGCAT 
DNMT3A NM_001097437. For:ATGACCTCTCCATCGTCAACC  
Rev:CAGGAGGCGGTAGAACTCA 
DNMT3B NM_001162404.1 For:AGCTGTACCCTGCCATTCC  
Rev:AAGTACCCTGTTGCGATTCCA 
EHMT2 NM_001101823. For:CGCATTGCCTTCTTCAGTTCA  
Rev:CAGAAGCGGTCACCATAGTCA 
EIF4A1 NM_001100196 For:AGGATCATGTCTGCGAGTCA  
Rev:CCTTCGGGCTCCATCC 
ELF5 NM_001243711.1 For:AGTGGCATCAAAAGCCAAGAC  
Rev:GCAGGTCTCGTACAAATTCCC 
ESRRB XM_001928051.6 For:CCTGCAAGGCCTTCTTCAA  
Rev:TCCGTTTGGTGATCTCACAC 
ETS2 XM_013991815.1 For:TGCCAACAGGCTTGGATTCA  
Rev:TTGCTGCATGGGGTCAACA 
EZH2 NM_001244309. For:GCTGCACACTGCAGAAAGATAC  
Rev:GTCGCAGGGCTGATAGTTGTA 
FIGLA XM_005662486.2 For:TCACCAGAGGGCGAAGTCTA  
Rev:TGATGCAGTTTCACTTCTGGGAA 
GAPDH NM_001206359.1 For:AGTGGACATTGTCGCCATCA  
Rev:CGTGGGTGGAATCATACTGGAA 
GDF9 NM_001001909. For:AACACTGTCCGGCTCTTCAC  
Rev:TCAACAGCAGTAACACGAT 
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Gene Symbol Accession Number Primer Sequences 
GNAS NM_214312.2 For:AAGGCAGAGGAGAAGAAGCA  
Rev:GATGGGTCCCCTCTTGGAA 
GRB10 NM_001134965.1 For:AAGCACGCGGATGAATATCCTA  
Rev:AGTGCTGCGTCCTGTGAA 
HAND1 NM_001014428.1 For:GCGAGAGCAAGCGGAAAA  
Rev:CCTGTGCGCCCTTTAATCC 
HAT1 XM_003483674.3 For:GTCTGGTGGCCATGGAGAA  
Rev:TCTCGAAAGCCTCTACATGTCA 
HDAC1 XM_013999116.1 For:CTCCATCCGCCCAGATAACA  
Rev:AACACCGGACAGTCCTCAC 

























































































































































































































Supplemental Figure 2-1.  SR-FLICA score histogram and values for groups sorted day 
3 of development.  Panel A is a histogram of distribution of SR-FLICA scores from day 3 
SCNT stained embryos (n = 156) that were subsequently fixed for cell count analysis.  
The top and bottom 20% of each replicate were classified as high (n = 30) and low (n = 
30) incidence of apoptosis.  Panel B then shows the average SR-FLICA score for each 
group with error bars representing the standard error of the mean.  A student’s t-test 
indicated a significant difference (P = <0.0001) in SR-FLICA value between the high and 

































































Supplemental Figure 2-2.  SR-FLICA score histogram and values for groups sorted day 
6 of development.   Panel A depicts a histogram of distribution of SR-FLICA scores from 
day 6 PA blastocysts (n = 132).  The top and bottom 20% of each replicate were 
classified as high (n = 26) and low (n = 26) incidence of apoptosis.  Panel B shows the 
average SR-FLICA score of these high and low apoptosis embryos with standard error 
bars.  The average SR-FLICA score is significantly different between high and low 












GENE EXPRESSION AND DNA METHYLATION PATTERNS OF HIGH AND LOW 




 Somatic cell nuclear transfer (SCNT) is extremely costly due to the inefficient 
nature of the technology, limiting its use in animal agriculture.  Increasing efficiency and 
decreasing cost by being able to select the embryos early in development that are most 
likely to succeed following transfer, would allow the technology to be more routinely 
utilized to enhance animal agriculture production.  We hypothesize that following SCNT, 
a majority of embryos undergo faulty epigenetic reprogramming, resulting in aberrant 
gene expression and incidentally increased levels of apoptosis.  Conversely, a fraction of 
the embryos undergo proper genome reprogramming, resulting in correct gene expression 
and low levels of apoptosis.  In this study, DNA methylation and gene expression 
patterns are analyzed in individual blastocyst-stage embryos through reduced-
representation bisulfite sequencing and RNA-seq to provide global patterns in high and 
low apoptosis SCNT blastocysts.  In vivo produced (IVV) blastocysts were collected and 
included as controls.  No differences in global DNA methylation patterns were found 
between the three groups: high apoptosis SCNT (HA), low apoptosis SCNT (LA), and 
IVV.  Comparing high apoptosis and low apoptosis SCNT blastocysts identified 4,346 
100 bp tiles that were differentially methylated and 413 genes that were differentially 
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expressed.  Hierarchical clustering of tiles which were found to be differentially 
methylated in at least one of the three analyses (HA v LA, HA v IVV, or LA v IVV) did 
not clearly separate samples by sample type.  Additionally, hierarchical clustering of 
differentially expressed genes, again where the genes were found to be differentially 
expressed in at least one of three analyses, did not separate the high apoptosis from low 
apoptosis samples.  Gene ontology analysis identified no significantly enriched terms or 
KEGG pathways from the list of genes with differentially methylated promoters, or from 
the list of differentially expressed genes themselves.  Together, these data support a 
stochastic nature of epigenetic reprogramming following SCNT and reinforce the 
necessity to identify embryos most likely to be successful due to proper epigenetic 
reprogramming in order to increase SCNT efficiency.   
 
Introduction 
 Nuclear reprogramming is the erasure and subsequent reestablishment of 
epigenetic marks on DNA that occurs following fertilization of an oocyte.  The nucleus 
begins to express gene products of developmental-specific genes following the directions 
provided by the oocyte cytoplasm as the donor-specific marks are erased [29].  The DNA 
of both the sperm and egg are highly methylated, and these marks must be removed and 
reset, with the exception of imprinted marks [59], before embryo development can 
properly occur.  The paternal genome undergoes an active demethylation though 
enzymatic removal of methylation marks that occurs rapidly following fertilization [57].  
On the other hand, demethylation of the maternal genome occurs passively through the 
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exclusion of DNMT1, the methyltransferase responsible for maintaining DNA 
methylation, from the nucleus [57] through the first several embryonic mitoses of early 
development.  After both the maternal and paternal genomes are demethylated, de novo 
methylation occurs.  A critical part of development is for epigenetic reprogramming at 
the time of fertilization to occur correctly and in a timely manner so proper embryo 
development can take place, including the maternal to zygotic transition when the 
embryo begins transcribing its own RNA and stops relying on maternal stores of RNA.   
 During SCNT, nuclear reprogramming is known to occur erroneously and is 
believed to be the cause of the low success rates associated with SCNT [7, 52, 59].  A 
differentiated somatic cell is utilized as the karyoplast donor in somatic cell nuclear 
transfer  The epigenetic marks of the donor cell DNA must be removed so that embryo 
development begins [59].  The somatic specific genes must be completely silenced and 
embryonic genes need to start being expressed in order for proper development of SCNT 
embryos to occur.  The reprogramming efficiency of the donor nucleus hinders the 
overall efficiency of SCNT, as evident by the fact that using an undifferentiated cell, a 
zygote, significantly increases the number of live births following SCNT in mice [43].  
SCNT embryos show overall increases in DNA methylation levels compared to in vitro 
produced embryos [52], obscuring the typical methylation patterns observed in the 
trophectoderm and inner cell mass cells [59].  Due to the overall increase in DNA 
methylation compared to IVF embryos, it was hypothesized that DNMT1, the enzyme 
responsible for maintaining DNA methylation, introduced through the donor cell, 
maintains DNA methylation when the DNA should be cleared of methylation marks [46].  
However, experimental data suggest that the donor cell goes through the de-methylation 
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process following SCNT, however not all genes are properly de-methylated [52].  These 
altered epigenetic marks are then responsible for altered gene expression observed in 
SCNT embryos. 
 Most genes are properly reprogrammed and expressed following SCNT, as 95% 
of genes show similar expression patterns between SCNT and in vitro fertilized (IVF) 
embryos [36].  However, this leaves 5% of genes that are misexpressed, which could 
have deleterious consequences on a developing embryo and fetus.  A noteworthy 
observation is that misexpressed genes seem to be random, with no distinct set of genes 
being consistently misexpressed across studies [36].  Additionally, most misexpressed 
genes are mildly changed in expression level, with less than 3% of genes showing more 
than a four-fold change in gene expression [36].  Previous studies have reported that in 
bovine SCNT embryos, some individual embryos contain gene expression patterns much 
closer to in vitro produced controls than other SCNT embryos [67] indicating that some 
embryos could be more competent as they are more similar to in vitro produced embryos.  
In addition, in vivo produced embryos had less variability in gene expression compared to 
SCNT and IVF embryos [67].  Together, these observations have contributed to the 
hypothesis that epigenetic reprogramming after SCNT happens in a random nature, 
leading to random differences in gene expression.   
 Altered DNA methylation and gene expression patterns have been shown to result 
in increased cell death through apoptosis [96].  Fibroblasts deficient in Dnmt1, which 
resulted in widespread DNA demethylation, showed a prevalent apoptotic phenotype 
mediated through p53 [96].  p53-dependent apoptosis has also been shown to result from 
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dysregulation of gene expression in cancer cell culture systems [97].  Studies have also 
indicated that disruption of the epigenetic makeup by treatment of various 
pharmacological methods results in apoptosis in somatic cell culture models [98, 99].  
Therefore, we propose that the stochastic defects in genome reprogramming which result 
from the process of SCNT directly relate to the incidence of apoptosis within each 
individual embryo. 
  In order to improve the overall efficiency of SCNT, we propose the use of a non-
toxic, non-invasive caspase activity reporter, SR-FLICA (Immunochemistry 
Technologies, Bloomington, MN), to detect the relative incidence of apoptosis in SCNT 
blastocysts as an indicator of the blastocyst(s) most likely to succeed following embryo 
transfer.  We hypothesize that following SCNT, a majority of embryos will undergo 
aberrant epigenetic reprogramming, resulting in altered gene expression which in turn 
leads to an increase in apoptosis.  Conversely, a portion of embryos will undergo proper 
epigenetic reprogramming, leading to appropriate gene expression and low levels of 
apoptosis.   
 The objective of this study is to characterize DNA methylation and gene 
expression patterns in day 6, porcine SCNT blastocysts exhibiting high and low incidence 
of apoptosis.  Using a whole genome approach to characterize patterns of both DNA 
methylation and mRNA expression of individual blastocysts, we hope to piece together a 
thorough picture of the individual blastocyst following SCNT to identify the 
characteristics of a blastocyst that would be most successful following embryo transfer.  
We propose the use of a modified single-cell reduced representation bisulfite sequencing 
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(RRBS) protocol [100] and RNA-sequencing utilizing DNA and mRNA collected from 
the same individual blastocyst.  RRBS is a high-throughput technique to analyze genome-
wide methylation [101].  The RRBS procedure provides a cost-effective alternative to 
deep sequencing the entire genome.  In experiments using mouse and human samples 
where approximately 10% of the genome was sequenced using RRBS, it was shown that 
a large proportion of the CpG-rich sites were able to be evaluated, including more than 
70% of gene promoters and more than 80% of CpG Islands [100].  However, traditional 
RRBS protocols require nanogram quantities of DNA, which are not available in 
individual blastocysts.  Therefore, modification of a single-cell RRBS protocol [100] is 
required for the analysis of such small amounts of DNA. 
 
Materials and Methods 
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise noted.  All procedures performed with animals were in agreement with 
principles of animal welfare as approved by the veterinary staff and Institutional Animal 
Care and Use Committee at Utah State University (IACUC protocol #2636). 
Oocyte source and in vitro maturation 
 Cumulus oocyte complexes for SCNT were purchased from Desoto Biosciences 
(Seymore, TN).  Oocyte maturation, manipulation, activation, and embryo culture were 
performed as described previously [88].  Briefly, oocytes with multiple layers of cumulus 
cells were collected by Desoto Biosciences, washed in maturation media, and allowed to 
mature for 40-44 hours at 39°C and 5.0% CO2.  During the 40-44 hour maturation period, 
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cumulus oocyte complexes were shipped to Utah State University in a portable incubator 
maintaining the temperature of 39°C.  Upon arrival, increased CO2 concentrations 
(compared to the commonly reported 5.0%) were used to account for the higher elevation 
of Utah State University.  Maturation media was provided by Desoto Biosciences.   
 
Donor Cell Preparation 
 Porcine fetal fibroblasts (PFF) cells served as donor cells for nuclear transfer.  
The PFF cells had been isolated and frozen previously.  For SCNT, the PFF cells were 
expanded and frozen for subsequent cloning using the same cell line at passage six.  PFF 
culture medium was prepared using Dulbecco’s Modified Eagle’s Medium (DMEM, 
Fisher Scientific) as the base supplemented with 15% fetal bovine serum (FBS, Atlanta 
Biologicals, Flowery Branch, GA), 25 µg/ml fibroblast growth factor (FGF2), and 40 
mg/ml gentamicin. PFF cells were seeded in a 4-well dish one week prior to SCNT and 
allowed to become confluent for several days for cell synchronization before cloning.  To 
prepare for donor cell injection, medium was removed from the well, fibroblast cells 
were rinsed with PBS, and 0.25% trypsin-EDTA (Fisher Scientific) was added for 3 
minutes.  The cells were then transferred into a 1.5 mL tube and 1 mL of PFF culture 
medium was added to inactivate the trypsin.  Cells were isolated by centrifugation at 400 
x g for 5 minutes.  Trypsin was removed and the cells were resuspended in manipulation 
medium consisting of 3.14 mM TL-Hepes, 40 µg/mL gentamicin, 30 mM NaCL and 




 Following oocyte maturation, oocytes were denuded of cumulus cells in medium 
that consisted of 100 mg Hyaluronidase, 6 g mannitol, 5 mL PVA-TL-Hepes stock [88], 
and 95 mL double distilled water.  Oocytes were placed in the hyaluronidase media at 39 
°C for 5 minutes then pipetted 40 times to remove the cumulus cells.  Oocytes were 
washed through manipulation medium containing a base of m199 supplemented with 
5.95 mM sodium bicarbonate, 3.14 mM HEPES, 30 mM NaCl, 0.3% BSA, and 0.04 
mg/ml gentamicin.  Oocytes with an extruded polar body were selected for SCNT.   
 Oocytes undergoing SCNT were enucleated in drops of enucleation media [88] 
under light mineral oil.  Enucleation took place using a beveled glass pipette to aspirate 
the first polar body and the metaphase II plate by removing a small amount of the 
cytoplasm adjacent to the polar body.  Following enucleation, the donor cell was injected 
into the perivitelline space.  Donor cell injection was performed by placing the donor 
cells into the droplet with the enucleated oocytes.  A single donor cell was picked up with 
the glass pipette and inserted through the same slit in the zona pellucida that was created 
during enucleation.  Donor cells were fused with oocytes at the same time of oocyte 
activation in activation media composed of 0.3 M mannitol, 1.0 mM CaCl2, 0.1 mM 
MgCl2, and 0.5 mM HEPES (pH 7.0-7.4).  Fusion and activation occurred with 2 direct 
current pulses of 1.2 kV/cm2 for 30 µsec.  Fusion of the donor cell was checked after 30 
minutes. 
 Embryos were cultured at 39°C and 6.2% CO2 in PZM3 medium [89] up to day 7 
of development.  PZM3 media was composed of 108 mM NaCl, 10 mM KCl, 0.35 mM 
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KH2PO4, 0.4 mM MgSO4, 25.07 mM NaHCO3, 0.2 mM sodium pyruvate, 2 mM calcium 
lactate, 1 mM L-Glutamine, 5 mM hypotaurine, 2% (v/v ) Basal Medium Eagle (BME) 
amino acids (Fisher Scientific), 1% (v/v), Minimum Essential Medium (MEM) amino 
acids (Fischer Scientific), 0.005% (w/v) gentamicin, and 0.3% (w/v) Fatty-acid-free 
BSA.  The pH was adjusted to 7.3-7.4.  SCNT blastocysts were collected from 3 replicate 
SCNT sessions with a minimum of 15 blastocysts for subsequent staining.   
 
SR-FLICA Staining 
 SR-FLICA (Immunochemistry Technologies) was resuspended as recommended 
by the manufacturer.  Briefly, 50 µL DMSO was added to one vial SR-FLICA. Embryos 
were stained in 500 µL PZM3 culture media with 2 µL reconstituted SR-FLICA for 2 
hours in the incubator.  Embryos were moved to a fresh 500 µL PZM3 and placed back in 
the incubator for 30 minutes.  Embryos were then washed in PZM3 and transferred to 
individual 10 µL PZM3 droplets under mineral oil for fluorescent microscopy. 
 
Microscopy and Image Analysis 
 Individual embryos were imaged at the 10X objective using the Zeiss Axio 
Obserer.Z1 (Carl Zeiss Microscopy; Thornwood, NY).  Fluorescent images of SR-FLICA 
(excitation 550-580 nm, emission 590-600 nm) stained embryos were captured with an 
Axiocam HRc (Carl Zeiss Microscopy) creating a black and white image and a red color 
was artificially added using Zen software (Carl Zeiss Microscopy; v. 2.0).  Images had a 
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1 second exposure time and light excitation intensity between embryos for accurate 
comparisons of incidence of apoptosis.  SR-FLICA excitation in each image was 
analyzed using Adobe Photoshop (v. 2017.1.1.20174025) to determine the average pixel 
intensity within the space of the zona pellucida of the embryo.  In blastocysts that were 
hatching, both the space inside the zona pellucida and the hatching extrusion was 
included in the analysis.  Average pixel intensity for each embryo was ranked, and the 
top and bottom 20% were considered high (n = 13) and low (n = 13) apoptosis, 
respectively.  Using microdroplets to minimize the amount of medium remaining, 
individual blastocysts were stored at -80°C until DNA and mRNA were isolated.  
 
In Vivo Embryo Collection 
 In vivo produced blastocysts were collected 5 days after natural breeding of the 
sow (2 sows, total n = 11 blastocysts collected).  Blastocysts were collected by flushing 
the isolated uterus with TL-Hepes [88].  Blastocysts were isolated and washed in TL-
Hepes.  Again using microdroplets to minimize the amount of medium remaining, 
individual blastocysts were then stored at -80°C until DNA and mRNA were isolated. 
 
DNA and RNA Isolation 
 DNA and total RNA were isolated from previously frozen individual blastocysts 
using the ZR-DUET DNA/RNA MiniPrep kit (Zymo Research; Irvine, CA) following 
manufacturer instructions except for two minor changes.  Rather than 400 µL of 
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DNA/RNA Lysis buffer being used as recommended, 200 µL was used instead.  
Additionally, the final RNA elution was performed using 20 µL DNase/RNase-free water 
from a single elution.  Collected DNA and RNA were stored at -80°C until library 
preparation was performed. 
 
RRBS Library Preparation and Sequencing 
 Reduced representation bisulfite sequencing libraries were prepared using the 
single-cell RRBS protocol developed by Guo et al. [100] with some modification.  The 
50 µL of eluted DNA was air dried to 5 µL to concentrate the DNA.  Samples were then 
digested with MspI using 9 U MspI (Thermo Fisher Scientific; New Jersey, USA), 1X 
Tango Buffer (Thermo Fisher Scientific), and 2280 fg unmethylated λ-DNA (dam-, dcm-; 
Thermo Fischer Scientific).  Nuclease-free water was added to bring the total reaction 
volume to 18 µL.  Tubes were mixed well by vortexing and centrifuged.  The reaction 
was then incubated at 37°C for 3 hours, then 80°C for 20 minutes to inactivate the MspI 
enzyme.  The tubes were placed on ice.  The samples then underwent the end-repair/dA-
tailing reaction.  Five U of Klenow fragment (exo-; Thermo Fischer Scientific), 1X Tango 
buffer, 40 µM dATP (New England Biolabs; Ipswich, MA), 4 µM dCTP (New England 
Biolabs), and 4 µM dGTP (New England Biolabs) were added to each reaction bringing 
the total reaction volume to 20 µL.  The reactions were then incubated at 37°C for 40 min 
and then 75°C for 15 minutes to inactivate the Klenow enzyme.   
 Next, the adapter ligation step was performed.  Reactions were mixed with 30 
Weiss U T4 DNA ligase (Thermo Fischer Scientific), 1X Tango buffer, 1mM ATP 
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(Thermo Fischer Scientific), and 1 µL of 1:20 diluted adapter (NEXTflex Bisulfite-Seq 
Barcodes; Bioo Scientific; Austin, TX, adapter sequence: 5'-
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCC
GATCTGATCGGAAGAGCACACGTCTGAACTCCAGTCACXXXXXXATCTCGTA
TGCCGTCTTCTGCTTG-3’ where XXXX indicates the Index sequence for each sample 
which can be found in Supplemental Table 3-1).  Nuclease-free water was added to bring 
the entire reaction volume to 25 µL.  Reactions were incubated at 16°C for 30 minutes 
then at 4°C overnight.  The enzyme was heat-inactivated at 65°C for 20 minutes.  All 25 
µL of the reaction were used to perform the bisulfite treatment using the MethylCode 
bisulfite conversion kit (Thermo Fischer Scientific) following manufacturer’s directions.  
Ten ng of tRNA was added to the supplied DNA binding buffer to serve a protective 
carrier.  DNA was eluted in 30 µL of elution buffer that had been pre-heated to 50°C.   
 Reactions then underwent the first-round of PCR enrichment.  To the DNA, 5 µL 
of 10X PCR Pfu Cx buffer (Agilent Technologies; Santa Clara, CA), 1 U Pfu Turbo Cx 
hotstart DNA polymerase (Agilent Technologies), 200 µM each dNTP mix (Takara Bio; 
Mountain View, CA), 300 nM each of QP1 and QP2 primer (QP1 5’- 
AATGATACGGCGACCACCGA-3’; QP2 5’-CAAGCAGAAGACGGCATACGA-3’), 
and 2.5 µL of 20X Evagreen (Biotium; Hayward, CA) were added.  Nuclease-free water 
was used to bring the total volume of the reaction to 50 µL.  PCR cycling conditions were 
as follows: 95°C for 2 min, 15-25 cycles of 95°C for 20 seconds, 65°C for 30 seconds, 
72°C for 1 minute, 72°C for 5 minutes, followed by a 4°C hold.  The number of 
amplification cycles ranged between 15 to 25 cycles because reactions were tracked using 
real-time PCR, and reactions were removed after 5 cycles of exponential increase.  PCR 
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reactions were purified twice via a 1:1-fold (sample volume to bead volume) Agencourt 
AMPure XP beads (Beckman Coulter; Atlanta, GA).  A second-round of PCR enrichment 
was performed using 25 µL of 2X Phusion HF PCR master mix (New England Biolabs), 
2.5 µL  of 20X Evagreen, 500 nM each of QP1 and QP2 primers bringing the total 
reaction volume to 50 µL.  PCR cycling conditions were as follows: 95°C for 2 min, 7 
cycles of 95°C for 20 seconds, 65°C for 30 seconds, 72°C for 1 minute, 72°C for 5 
minutes, followed by a 4°C hold.  Reactions were purified once using 1:1-fold (sample 
volume to bead volume) Agencourt AMPure XP beads and eluted in 20 µL of nuclease-
free water.  The samples were then purified once using 1:1.3-fold (sample volume to bead 
volume) Agencourt AMPure XP beads to remove primer-dimers present in the samples.  
DNA was eluted in 20 µL of nuclease-free water. Samples were analyzed for fragment 
size and the absence of primer-dimers to ensure successful sequencing using the 
TapeStation (Agilent Genomics; Santa Clara, CA) and sequenced on the NextSeq 
(Illumina; San Diego, CA) using high output 150 bp single-end reads.   
 
RRBS library analysis 
 At first, we performed quality check on the raw reads with FastQC 
(https://www.bioinformatics. babraham.ac.uk/projects/fastqc/) for all the 41 samples. 
Further read quality control was performed using Trim Galore 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) to remove the standard 
13 bp adapters (5’-AGATCGGAAGAGC-3’). Low-quality base calls were trimmed off 
the 3’ end of the reads before adapter removal.  Trim Galore also removed biased 
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methylation positions in the RRBS sequence.  The trimmed reads were then aligned using 
Bismark [102] against the bisulfite converted pig genome (Sus scrofa 11.1).  Context 
dependent (CpG/CHG/CHH) methylation was extracted using Bismark’s 
methylation_extractor from the mapped reads and methylation analysis was performed 
using MethylKit [103], an R package for DNA methylation analysis and annotation of 
high-throughput bisulfite sequencing. MethylKit analysis included basic statistics such as 
the coverage and percent methylation, sample correlation, sample clustering, PCA 
analysis, differential methylation at an individual base and region level (100bp), and 
visualization of methylation events including bar plots of hyper- and hypomethylation per 
chromosome, and annotation of differentially methylation regions.  Analysis was only 
performed on regions with at least 10X coverage in a minimum of 6 samples per group. 
DNA methylation level considered was the average of the 100bp tiles.  Differential 
methylation was determined between two groups if there was greater than 25% difference 
in methylation with an FDR less than 0.05, all calculated and determined by MethylKit.  
Differential methylation was performed on two groups at a time creating 3 different 
comparisons: High Apoptosis (n = 13) vs Low Apoptosis (n = 12), High Apoptosis (n = 
13) vs IVV (n = 11), and Low Apoptosis (n = 12) vs IVV (n = 11). To analyze the 
conversion rate of the bisulfite reaction, unmethylated λDNA was added to each sample.  
Each trimmed sample was then aligned to the λ genome and conversion rate was 
calculated. 
 
RNA-Seq Library Preparation and Sequencing 
 RNA sequencing libraries were prepared using the Ovation SoLo RNA-Seq 
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System (NuGen Technologies; San Carlos, CA) following the manufacturer’s protocol 
for total RNA Input.  10 µL of RNA was mixed with 1 µL DNase Buffer, 2.6 µL first 
strand primer mix, 1.7 µL  DTT solution, 0.7 µL nuclease-free water, and 2 µL HL-
dsDNase.  The reaction was then heated to 37°C for 10 minutes followed by 65°C for 5 
minutes.  The first strand cDNA synthesis was then performed by adding the 1 µL first 
strand buffer mix and 1 µL first strand enzyme mix to the reaction followed by heating to 
25°C for 5 minutes, 40°C for 30 minutes, and 70°C for 10 minutes.  The reaction next 
underwent cDNA processing by addition of 0.5 µL cDNA processing enzyme I and 0.5 
µL cDNA processing enzyme II.  Reactions were heated to 37°C for 30 minutes.  Two 
µL of cDNA processing reagent were added and the reactions were heated to 90°C for 20 
minutes.  Next, 2 µL of cDNA processing reagent II were added.  One µL cDNA 
processing reagent III and 1 µL cDNA processing enzyme III were added and reactions 
were heated to 37°C for 30 minutes followed by 70°C for 10 minutes.  Seven µL cDNA 
processing reagent IV and 1 µL cDNA processing enzyme IV were added and reactions 
were heated to 37°C for 30 minutes then 75°C for 20 minutes.  Second strand synthesis 
was performed by adding 3.5 µL second strand buffer mix, 3.5 µL second strand primer 
mix, and 1 µL second strand enzyme mix.  Reactions were then heated to 25°C for 15 
minutes, 37°C for 15 minutes, and 70°C for 10 minutes.  End repair was conducted by 
adding 1 µL of end repair enzyme mix I and 1 µL end repair enzyme mix II to each 
reaction followed by heating to 25°C for 30 minutes then 70°C for 10 minutes.  Reactions 
were stored at -20°C overnight. 
 Adapter ligation was performed by adding 3.25 µL of the barcoded adapter mix to 
each sample.  Additionally, 13 µL of ligation buffer mix, 2 µL of ligation enzyme mix, 
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and 1.75 µL of nuclease-free water were added to each sample reaction.  Reactions were 
heated to 25°C for 30 minutes then 70°C for 10 minutes.  Adapter ligation purification 
was performed using Agencourt beads and DNA resuspension buffer mix as follows.  35 
µL of nuclease-free water was added to each sample to bring the total volume to 100 µL.  
The beads were resuspended by mixing and 100 µL of beads were added to each sample.  
The sample-bead mixture was incubated at room temperature for 10 minutes then 
transferred to a magnet and allowed to sit for 5 minutes to clear the beads.  The binding 
buffer was removed and discarded.  The tubes were washed with 200 µL of 70% ethanol 
and allowed to stand for 30 seconds.  The ethanol was removed and the samples were 
washed one more time.  The beads were allowed to air dry for 10 minutes and the sample 
was resuspended in 30 µL of DNA resuspension buffer mix.  The beads were again 
collected by a magnet for 3 minutes and the eluate was removed and placed in a clean 
PCR tube.   
 Library amplification was optimized for qPCR following the recommended 
protocol provided in the SoLo RNA-seq system.  Three µL of DNA resuspension buffer 
mix was added to each sample.  Then, 2 µL amplification buffer mix, 1.9 µL 
amplification primer mix I, 0.1 µL amplification enzyme mix, 0.5 µL EvaGreen, and 2.5 
µL nuclease-free water was mixed with 3 µL of sample in a fresh set of tubes.  qPCR was 
performed using the following cycling parameters: 70°C for 10 minutes, 35 cycles of 
94°C for 30 seconds, 60°C for 30 seconds and 72°C for 1 minute, and then finally 72°C 
for 5 minutes.  The suggested cycle number for subsequent amplifications was 
determined from the exponential phase of amplification to be approximately 19 cycles.   
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 Libraries were then amplified for the first time by mixing 10 µL amplification 
buffer mix, 9.5 µL amplification primer mix I, 2 µL EvaGreen, and 0.5 µL of 
amplification enzyme mix to 30 µL of each sample.  Samples were amplified using qPCR 
to track each sample and the sample was removed after 4 cycles in the exponential phase 
of amplification. Cycling parameters were the same used for library amplification 
optimization.  Libraries were then purified using Agencourt beads by adding 40 µL of 
beads to the library amplification reaction product.  Purification was performed as 
previously explained.  The sample was eluted in 50 µL DNA resuspension buffer and 
bead purification was performed again.  Finally, the sample was eluted in 25 µL DNA 
resuspension buffer.   
 Libraries were quantified using the Qubit dsDNA HS Assay (Thermo Fischer 
Scientific).  The concentration of DNA for each sample came back lower than expected, 
so the library amplification I was repeated prior to InDA-C treatment to increase DNA in 
each sample.  Samples were amplified until 4 cycles of amplification occurred and then 
removed from the thermocycler.  The repeated amplification was effective at increasing 
concentration to an acceptable level. 
 InDA-C treatment was conducted by aliquoting 10 ng of each library into a new 
tube with nuclease-free water for a total volume of 8.5 µL.  Five µL amplification buffer 
mix, 10 µL InDa-C primer mix, 0.5 µL InDA-C enzyme mix, and 1 µL amplification 
enzyme mix was added to each sample and samples were heated to 37°C for 10 minutes, 
95°C for 2 minutes, 50°C for 1 minute, and 65°C for 10 minutes.  Five µL amplification 
buffer mix, 2.5 µL adaptor cleavage enzyme mix, and 17.5 µL nuclease-free water was 
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added to each sample and the reaction was heated to 55°C for 30 minutes followed by 
95°C for 5 minutes.   
 Libraries were then amplified for a second time by mixing 10 µL amplification 
buffer mix, 39.5 µL amplification primer mix II, and 0.5 µL amplification enzyme mix to 
each sample.  Amplification used the following thermocycling conditions: 95°C for 2 
minutes, 2 cycles of 95°C for 30 seconds and 60°C for 90 seconds, 6 cycles of 95°C for 
30 seconds and 65°C for 90 seconds, then 65°C for 5 minutes.  Libraries were purified 
twice with a 1:1 mixture of Agencourt beads and final libraries were eluted in 25 µL of 
DNA resuspension buffer mix.   
 Libraries were sequenced on the Illumina NextSeq using single-end 75 bp reads.   
 
RNA library analysis 
 RNA-seq libraries were aligned to the pig genome (Sus scrofa 11.1) using the 
Star-aligner.  Only reads that aligned uniquely to the genome were used in down-stream 
analysis.  Differential gene expression was determined if a gene had a fold-change greater 
than 1.5 and false discovery rate less than 0.05 using EdgeR.   
 Two samples (one low apoptosis and one IVV) were determined to be outliers 
based on principal component biplot analysis so were removed from the analysis.  
Additionally, many genes had very low read counts, so additional restrictions were added 
to the genes that were analyzed.  Genes were only analyzed if they had observed counts 
of 10 or more in at least 20% of all samples and a coefficient of variation between 0.7 
and 5.5.  The range for the coefficient of variation was determined empirically based on 
the distribution of the variation.  The range kept the genes from the mode to the max to 
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focus on the genes with more variation and drop those with very little variation, those less 
than the mode.  Of the original 25,880 genes included in the sequencing reads that had 
aligned to the genome, 7,915 were kept in the analysis.   
 A generalized linear mixed model accounting for collection day and sample type 
using the lme4 package [104] was fit to the data to determine differential expression.  The 
glmer.nb function for negative binomial distribution of read count data was used.  The 
data was normalized using the log of the total read counts within each sample.  The 
model did not converge for 1 of the 7,915 genes tested.   
 
Gene Ontology Analysis 
  Gene ontology analysis of genes that were differentially methylated and 
differentially expressed between groups was analyzed using DAVID EASE (version 6.8; 
[105, 106]).  Official gene symbols were uploaded to form a gene list.  The list was 
submitted and the annotations were used for all species.  Sus scrofa was used as the 
background.  Gene ontology analysis of biological process, cellular component, and 
molecular function was analyzed in addition to KEGG pathways.  Terms or pathways 
considered significantly enriched had a false discovery rate corrected p-value less than 







RRBS sequencing  
 RRBS libraries were sequenced producing between 5.09 and 39.39 million reads 
(Table 3-1).  The high apoptosis blastocysts (HA), low apoptosis blastocysts (LA), and in 
vivo (IVV) produced blastocysts averaged 28.31 ± 3.92 million, 24.21 ± 6.62 million, and 
27.41 ± 5.92 million total reads, respectively (Table 3-1).  Of these raw reads, 5.35 ± 1.96 
million, 4.57 ± 1.84 million, and 8.63 ± 3.89 million reads aligned to the bisulfite 
converted genome in the HA, LA, and IVV samples, representing an average percent 
alignment of  18.4% ± 5.5, 18.9% ± 6.0, and 30.5% ± 11.7, respectively (Table 3-1).  
Together, this provided 69.52 million, 54.88 million, and 93.9 million aligned reads for 
the HA, LAs, and IVV samples, respectively (Table 3-1).  While these mapping 
efficiencies may seem low, they are appropriate according to previously published RRBS 
protocols [100]. 
 During RRBS library preparation, unmethylated lambda-DNA was added to each 
sample to serve as a control for bisulfite conversion efficiency.  Because every cytosine 
of the lambda-DNA is unmethylated, they should all be turned to uracil in the conversion 
process, and then sequenced as thymine. The conversion efficiency ranged from 96.4% to 
98.6% (Table 3-2).  The HA, LA, and IVV samples had a conversion efficiency of 97.9% 
± 0.4, 97.9% ± 0.5, and 97.9% ± 0.7, respectively (Table 3-2). 
 Differential methylation was determined on 100 base pair, consecutive tile 
fragments throughout sequenced regions.  Due to limitations in the MethylKit program, 
only two groups could be compared at a time, resulting in three different pairwise 
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analyses: HA vs LA, HA vs IVV, and LA vs IVV.  A tile was considered to be 
differentially methylated if the difference in methylation was greater than 25% and FDR 
corrected p-value less than 0.05.  Between the three analyses, a total of 224,786 unique 
tiles were analyzed.  In each analysis, approximately 32.9%, 44.9%, 8.8%, and 11.6% of 
tiles were located within intergenic regions, introns, exons, and promoters, respectively 
(Figure 3-1A).  A majority (90%) of differentially methylated tiles were found in 
intergenic regions of the genome (Figure 3-1B).  Approximately 6% of the tiles were 
located in introns and 2% located in exons (Figure 3-1B).  Only 1% of the differentially 
methylated tiles were located in promoter regions of the genome (Figure 3-1B).   
 
Global methylation patterns 
 Global methylation patterns were analyzed by evaluating average percent 
methylation across all tiles analyzed.  HA blastocysts (n=13) had an average tile 
methylation of 17.25% ± 3.5 (Figure 3-2).  LA blastocyst (n=12) had an average tile 
methylation of 16.47% ± 2.4 (Figure 3-2).  Finally, average tile methylation of IVV 
blastocysts (n=11) was 15.0% ± 5.7 (Figure 3.2).  A one-way ANOVA showed no 
statistical difference in variance of percent methylation of tiles (P = 0.4). 
 Global methylation patterns were also evaluated by depicting the percent of tiles 
methylated at varying levels of methylation from 0-20%, 20-40%, 40-60%, 60-80%, and 
80-100% methylated (Figure 3-3).  Each sample was plotted separately to visually show 
the unique nature of each sample.  A majority of tiles in each sample had low levels of 
methylation, between 0-20% and a very small fraction of tiles were highly methylated 
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(80-100%) (Figure 3-3).  The individual breakdown of the fraction of tiles that were 
methylated at each level was unique for each sample, even within HA, LA, and IVV 
groups.  LA samples visually had the least amount of variability, while IVV had the most 
(Figure 3-3).   
 
Tile Methylation Patterns 
 Differential methylation of tiles was determined in the HA vs LA, HA vs IVV, 
and LA vs IVV samples if tiles were greater than 25% differentially methylated with an 
FDR corrected p-value less than 0.05.  In the HA (n = 13) vs LA (n = 12) comparison, 
1627 tiles were hypomethylated, meaning lower methylation levels in the HA compared 
to the LA, while 2719 tiles were hypermethylated, meaning higher methylation levels in 
the HA compared to the LA (Figure 3-4).  In the HA vs IVV (n = 11) comparison, 649 
tiles were hypomethylated while 8494 tiles were hypermethylated (Figure 3-4).  Finally, 
in the LA vs IVV analysis, 451 tiles were hypomethylated while 3764 were 
hypermethylated (Figure 3-4).   
 When all three of the analyses were brought together, overlap of differentially 
methylated tiles was present.  The HA vs LA analysis, HA vs IVV analysis, and LA vs 
IVV analysis contained 2,222, 6,663, and 2,745 tiles, respectively, that were uniquely 
differentially methylated (Figure 3-5).  The HA vs LA and HA vs IVV analyses shared 
1,337 differentially methylated tiles (Figure 3-5).  The HA vs LA and LA vs IVV 
analyses shared 590 differentially methylated tiles (Figure 3-5).  The HA vs IVV and LA 
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vs IVV analyses had 659 differentially methylated tiles in common (Figure 3-5).  And 
finally, 15 tiles were differentially methylated in all three analyses.   
 Principal component analyses (PCA) of a random subset of all tiles analyzed and 
only those differentially methylated provided insight to overall trends in methylation 
patterns (Figure 3-6).  Due to limitations in the ClustVis program, only a 2 MB file can 
be analyzed in the PCA analysis.  Fig. 3-6A shows the PCA of a random subset of all 
tiles analyzed.  Principal component (PC) 1 and PC 2 explain 11.6% and 6.2% of the 
variance, respectively (Figure 3-6A).  Interestingly, when all tiles are considered, the 
samples are all centered and overlap.  The LA samples are the most tightly clustered, but 
both the HA and IVV samples sit on top of this cluster (Figure 3-6A).  When only 
differentially methylated tiles are analyzed, PC1 and PC2 explain 16.1% and 6.1% of the 
variance, respectively (Figure 3-6B).  Again it is interesting that the HA, LA, and IVV 
samples overlap on a central point (Figure 3-6B).  But unlike the co-localized nature of 
the PCA when all tiles were included, the differentially methylated tiles within each 
group radiate away from each other from the centralized overlapping area (Figure 3-6B). 
 Hierarchical clustering of 1197 tiles (again a random subset was used because 
ClustVis only allows for clustering up to 1200 rows) of all tiles analyzed, shows very 
little clustering by sample type (Figure 3-7).  Additionally, a heat map of the percent 
methylation for each sample indicates no clear pattern by sample type.  Rather, noticeable 
differences in patterning of the heat map are at an individual blastocyst level (Figure 3-7).  
Conversely, when only a random subset of 1200 differentially methylated tiles are 
included in the hierarchical clustering and heat map analysis, samples do generally 
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separate by type, but still no distinct clusters are evident (Figure 3-8).  And while not 
overly distinct, some heat map patterns can be identified by group rather than only by 
sample, as before (Figure 3-8).   
 
RRBS Gene Ontology Analysis 
 Differentially methylated tiles were associated with the nearest transcription start 
site, which ranged from 9,565,509 base pairs downstream to 19,920,929 base pairs 
upstream.  On average, the tiles were 15,974 base pairs upstream of the transcription start 
site.  A histogram shows the number of tiles found within 500,000 base pairs up or 
downstream of the transcription start site (Supplemental Figure 3-1).  The genes of the 
nearest transcription start site for the differentially methylated tiles were used for gene 
ontology analysis. 
 When all genes associated with differentially methylated tiles were used in gene 
ontology analyses, many gene ontology terms were found to be significantly enriched.  In 
the HA vs LA analysis, the top ten biological process gene ontology terms found to be 
enriched (Table 3-3) include cellular response to chemical stimulus (FDR = 5.3x10-11), 
positive regulation of response to stimulus (FDR = 8.4x10-11), programmed cell death 
(FDR = 2.3x10-10), developmental process involved in reproduction (FDR = 2.6x10-10), 
cell death (FDR = 2.7x10-10), regulation of apoptotic process (FDR = 2.8x10-10), single 
organism reproductive process (FDR = 2.9x10-10), reproduction (FDR = 3.0x10-10), 
regulation of cell death (FDR = 3.2x10-10), and regulation of programmed cell death 
(FDR = 3.2x10-10).  However, when limited to genes only with a differentially methylated 
129 
tile within 5,000 base pairs up or downstream of the TSS, no biological process gene 
ontology terms were significantly enriched in the high vs low analysis (Table 3-4).   
 Similar findings are true in the HA vs IVV and LA vs IVV analysis for biological 
process gene ontology terms. In the HA vs IVV analysis with all genes included (Table 3-
3), the top ten gene ontology terms that were found to be significantly enriched included 
cellular response to chemical stimulus (FDR = 6.1x10-17), positive regulation of 
metabolic process (FDR = 1.8x10-15), oxidation-reduction process (FDR = 2.4x10-14), 
response to organic substance (FDR = 2.7x10-14), regulation of molecular function (FDR 
= 2.7x10-14), positive regulation of response to stimulus (FDR = 2.8x10-14), positive 
regulation of cellular metabolic process (FDR = 2.1x10-13), positive regulation of cell 
communication (FDR = 2.3x10-13), cellular response to organic substance (FDR = 
2.7x10-13), and positive regulation of signaling (FDR = 3.7x10-13). In the LA vs IVV 
analysis, the top ten gene ontology terms (Table 3-3) that were found to be significantly 
enriched included cellular response to chemical stimulus (FDR = 4.9x10-12), cellular 
response to organic substance (FDR = 9.3x10-10), response to organic substance (FDR = 
2.2x10-9), positive regulation of metabolic process (FDR = 2.8x10-9), positive regulation 
of response to stimulus (FDR = 6.6x10-9), positive regulation of biosynthetic process 
(FDR = 1.0x10-8), cellular response to endogenous stimulus (FDR = 1.1x10-8), positive 
regulation of signal transduction (FDR = 1.4x10-8), reproductive structure development 
(FDR = 1.4x10-8), and positive regulation of cell communication (FDR = 1.5x10-8). 
Again, when gene ontology analysis is limited to the genes with a differentially 
methylated tile within 5,000 bp up or downstream of the TSS, no terms were significantly 
enriched for biological processes in the HA vs IVV or LA vs IVV analyses (Table 3-4). 
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 Similar patterns hold true for gene ontology analysis for terms associated with 
cellular components.  When including all genes, regardless of distance from the 
differentially methylated tile to the TSS, many terms were found to be significantly 
enriched.  In the HA vs LA analysis, the top ten significantly enriched cellular component 
terms (Table 3-5) included extracellular region (FDR = 4.2x10-5), cytosol (FDR =  
2.3x10-4), membrane-bounded vesicle (FDR = 4.7x10-4), membrane region (FDR = 
1.9x10-3), extracellular region part (FDR = 2.0x10-3), membrane microdomain (FDR = 
2.0x10-3), membrane raft (FDR = 2.0x10-3), troponin complex (FDR = 5.2x10-3), pigment 
granule (FDR = 1.2x10-2), and melanosome (FDR = 1.2x10-2). The top ten significantly 
enriched cellular component terms (Table 3-5) for the high vs IVV analysis included 
extracellular region (FDR = 6.7x10-10), membrane-bounded vesicle (FDR = 2.7x10-8), 
extracellular region part (FDR = 4.2x10-8), extracellular exosome (FDR = 2.2x10-6), 
extracellular organelle (FDR = 2.5x10-6), extracellular vesicle (FDR = 2.9x10-6), cytosol 
(FDR = 2.9x10-5), endoplasmic reticulum part (FDR = 1.6x10-3), plasma membrane 
region (FDR = 3.1x10-3), and lipid particle (FDR = 4.2x10-3).  Many terms were also 
identified as significantly enriched in the LA vs IVV cellular component gene ontology 
analysis (Table 3-5).  The top ten included extracellular region (FDR = 2.0x10-6), 
membrane-bounded vesicle (FDR = 1.6x10-5), extracellular region part (FDR = 9.4x10-5), 
extracellular organelle (FDR = 2.3x10-4), extracellular exosome (FDR = 2.5x10-4), 
extracellular vesicle (FDR = 2.7x10-4), cytosol (FDR = 2.7x10-3), extracellular space 
(FDR = 2.8x10-2), mitochondrion (FDR = 3.2x10-2), and cell projection cytoplasm (FDR 
= 3.4x10-2).  Again, when limited to the genes with a differentially methylated tile within 
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5,000 bp of the TSS, no cellular component gene ontology terms were significantly 
enriched in any of the analyses (Table 3-6).   
 In the HA vs LA gene ontology analysis for terms associated with molecular 
function (Table 3-7) identified from all genes with an associated differentially methylated 
tile, the significantly enriched terms included receptor binding (FDR = 7.1x10-4), protein 
dimerization activity (FDR = 1.9x10-3), hormone activity (FDR = 6.8x10-3), identical 
protein binding (FDR = 8.8x10-3), glycoprotein binding (FDR = 9.0x10-3), growth factor 
activity (FDR = 2.6x10-2), and sulfur compound binding (FDR = 4.0x10-2).  The top ten 
molecular function gene ontology terms (Table 3-7) significantly enriched in the HA vs 
IVV analysis for all genes with an associated differentially methylated tile included 
hormone activity (FDR = 4.0x10-8), receptor binding (FDR = 5.7x10-6), protein 
dimerization activity (FDR = 2.1x10-5), identical protein binding (FDR = 3.3x10-4), 
glycoprotein binding (FDR = 1.1x10-3), growth factor activity (FDR = 2.3x10-3), cofactor 
binding (FDR = 2.6x10-3), coenzyme binding (FDR = 2.9x10-3), G-protein coupled 
peptide receptor activity (FDR = 4.4x10-3), and peptide receptor activity (FDR =  
6.0x10-3).  Only three molecular function gene ontology terms were significantly 
enriched in the LA vs IVV analysis of all genes associated with differentially methylated 
tiles (Table 3-7).  These terms included receptor binding (FDR = 1.2x10-2), hormone 
activity (FDR = 1.4x10-2), and growth factor binding (FDR = 2.2x10-2).  Again, when 
gene ontology analysis is limited only to the genes with a significantly differentially 
methylated tile within 5,000 bp, no significant molecular function terms are enriched in 
the analysis (Table 3-8). 
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 Similar to the gene ontology analyses, significantly enriched KEGG pathways 
were also identified in all genes and those genes with a differentially methylated tile 
within 5,000 bp of the TSS.  Again, all genes resulted in a large number of enriched 
KEGG pathways (Table 3-9) while those with a TSS within 5,000 bp of a differentially 
methylated tile had no enriched pathways (Table 3-10).  The top ten significantly 
enriched KEGG pathways in the HA vs LA analysis (Table 3-9) included TGF-beta 
signaling pathway (FDR = 8.1x10-4), insulin signaling pathway (FDR = 1.1x10-3), 
inflammatory bowel disease (FDR = 1.4x10-3), Jak-STAT signaling pathway (FDR = 
1.9x10-3), metabolic pathways (FDR = 2.2x10-3), FoxO signaling pathway (FDR = 
2.3x10-3), HIF-1 signaling pathway (FDR = 2.7x10-3), Leishmaniasis (FDR = 3.1x10-3), 
carbon metabolism (FDR = 3.2x10-3) and hepatitis C (FDR = 3.3x10-3).  In the HA vs 
IVV analysis, the top ten significantly enriched KEGG pathways (Table 3-9) included 
TGF-beta signaling pathway (FDR = 8.6x10-6), hepatitis C (FDR = 1.4x10-5), prolactin 
signaling pathway (FDR = 1.5x10-5), FoxO signaling pathway (FDR = 3.0x10-5), AMPK 
signaling pathway (FDR = 1.1x10-4), insulin signaling pathway (FDR = 2.6x10-4), Chagas 
disease (American trypanosomiasis) (FDR = 4.1x10-4), PPAR signaling pathway (FDR = 
4.3x10-4), signaling pathways regulating pluripotency of stem cells (FDR = 4.8x10-4), and 
hippo signaling pathway (FDR = 5.1x10-4).  The top ten significantly enriched KEGG 
pathways in LA vs IVV analysis (Table 3-9) included pertussis (FDR = 9.8x10-4), 
tuberculosis (FDR = 1.3x10-3), hepatitis C (FDR = 1.5x10-3), TGF-beta signaling 
pathway (FDR = 1.8x10-3), Hippo signaling pathway (FDR = 2.1x10-3), metabolic 
pathways (FDR = 5.1x10-3), osteoclast differentiation (FDR = 1.1x10-2), insulin signaling 
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pathway (FDR = 1.5x10-2), PPAR signaling pathway (FDR = 1.6x10-2), and Chagas 
disease (American trypanosomiasis) (FDR = 1.9x10-2). 
 
RNA sequencing 
 RNA-seq libraries were sequenced to an average of 6.33 ± 1.25 million, 7.09 ± 
0.66 million, and 11.16 ± 4.5 million reads for the HA, LA, and IVV group, respectively 
(Table 3-11).  Of these total reads, 4.56 ± 1.01 million (71.6% ± 4.3), 4.77 ± 0.85 million 
(66.7% ± 8.8), and 9.31 ± 4.43 (80.2% ± 10.2) million reads aligned on averaged in the 
HA, LA and IVV group, respectively (Table 3-11).  Sequencing resulted in a total of 
59.25 million, 59.53 million, and 93.04 million aligned reads analyzed for the HA, LA, 
and IVV groups, respectively (Table 3-11).  
 
Differentially Expressed Genes 
 Genes were considered to be differentially expressed between sample types if 
they had a fold change greater than 1.5 and FDR corrected p-value less than 0.05.  For 
easier comparison to the RRBS data, analyses were again performed with two groups at a 
time, resulting in three separate analyses of HA (n = 13) vs LA (n = 12), HA vs IVV (n = 
10), and LA vs IVV.  In the HA vs LA analysis, 18 genes had increased expression in the 
high apoptosis group compared to the low apoptosis, while 395 genes had decreased 
expression in the high group compared to the low apoptosis group (Figure 3-9).  In the 
HA vs IVV analysis, 709 genes had increased expression while 885 had decreased 
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expression (Figure 3-9).  Lastly, in the LA vs IVV analysis, 1,761 genes had increased 
expression while 777 had decreased expression (Figure 3-9). 
 Some of the genes determined to be differentially expressed in each analysis were 
also found to be differentially expressed in one or both of the other analyses.  In the HA 
vs LA analysis, 128 genes were uniquely differentially expressed (Figure 3-10).  The HA 
vs IVV analysis and the LA vs IVV analysis contained 219 and 1,022 uniquely 
differentially expressed genes, respectively (Figure 3-10). The HA vs LA and HA vs IVV 
analyses had 34 genes commonly differentially expressed while the HA vs LA and LA vs 
IVV analyses had 175 commonly differentially expressed genes (Figure 3-10).  The HA 
vs IVV and LA vs IVV analyses had 1,265 genes commonly differentially expressed 
(Figure 3-10).  All three analyses found 76 common differentially expressed genes. 
(Figure 3-10). 
 PCA was performed on a random subset of all genes analyzed as well as on only 
differentially expressed genes (Figure 3-11).  PCA of all genes indicated that PC 1 and 
PC2 explained 51.1% and 25.5% of the variation, respectively (Figure 3-11A).  In this 
analysis, each sample type overlaps.  In the PCA of only differentially expressed genes, 
PC1 and PC2 explain 62.5% and 24.3% of the variation, respectively (Figure 3-11B).  In 
this analysis, the high apoptosis and IVV samples overlap, while the low apoptosis 
samples show a slightly different patter but still overlap with the high apoptosis and IVV 
samples (Figure 3-11B).   
 Hierarchical clustering and a heat map analysis was performed on a random 
subset of all genes analyzed (Figure 3-12).  In the hierarchical clustering analysis, all of 
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the IVV samples cluster together, with the HA and LA sample scattered without 
clustering (Figure 3-12).  When only differentially expressed genes are analyzed, all of 
the IVV samples cluster separately from the cloned samples in the hierarchical clustering 
analysis (Figure 3-13).  The cloned samples, while not as scattered as when all genes 
were included, still do not separate into HA and LA groups (Figure 3-13).   
 
RNA-Seq Gene Ontology Analysis 
 Gene ontology analysis was performed on genes that were differentially expressed 
in each analysis.  In the HA vs LA and HA vs IVV analyses, gene ontology analysis 
found no biological process terms that were significantly enriched (Table 3-12).  The LA 
vs IVV analysis resulted in 9 biological process terms that were significantly enriched 
(Table 3-12), including biological adhesion (FDR = 0.003), cell adhesion (FDR = 
0.0069), taxis (FDR = 0.019), chemotaxis (FDR = 0.02), response to external stimulus 
(FDR = 0.021), ion transport (FDR = 0.023), regulation of cell proliferation (FDR = 
0.024), positive regulation of immune system process (FDR = 0.028), and regulation of 
response to stress (FDR = 0.038).  
 Gene ontology analysis of cellular component (Table 3-13) terms identified 3 
significantly enriched terms from the HA vs LA analysis including intrinsic component 
of plasma membrane (FDR = 0.009), integral component of plasma membrane (FDR = 
0.0099), and extracellular space (FDR = 0.02). In the HA vs IVV analysis, no 
significantly enriched terms were identified from the cellular component gene ontology 
analysis (Table 3-13).  And six cellular component gene ontology terms (Table 3-13) 
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were significantly enriched in the LA vs IVV analysis including extracellular region 
(FDR = 0.000055), intrinsic component of plasma membrane (FDR = 0.0033), 
extracellular space (FDR = 0.0037), integral component of plasma membrane (FDR = 
0.0038), extracellular region part (FDR = 0.0083), and extracellular matrix (FDR = 0.02).   
 Gene ontology analysis of molecular function terms resulted in no significantly 
enriched terms in the HA vs LA and HA vs IVV analyses (Table 3-14).  The top ten 
significantly enriched molecular function gene ontology terms (Table 3-14) in the LA vs 
IVV analysis included cation transmembrane transporter activity (FDR = 0.022), 
secondary active transmembrane transporter activity (FDR = 0.034), ligand-gated ion 
channel activity (FDR = 0.037), ligand-gated channel activity (FDR = 0.037), calcium 
ion binding (FDR = 0.039), active transmembrane transporter activity (FDR = 0.04), 
channel activity (FDR = 0.041), passive transmembrane transporter activity (FDR = 
0.041), peptidase regulator activity (FDR = 0.046), and peptidase inhibitor activity (FDR 
= 0.048). 
 Gene ontology analysis also analyzed for KEGG pathways that were significantly 
enriched in each analysis (Table 3-15).  No KEGG pathways were identified as 
significantly enriched in the HA vs LA and HA vs IVV analyses (Table 3-15).  Only one 
KEGG pathway was significantly enriched in the LA vs IVV analysis (Table 3-15): 





Combined differential methylation and gene expression 
 To piece together DNA methylation and RNA expression data, genes from each 
analysis were identified that had a differentially methylated tile within 5,000 bp and were 
differentially expressed.  In the HA vs LA analysis, 4 genes met this criteria: ADGRF1, 
CCND2, SPATA17, and TMEM86B (Table 3-16).  The difference in percent methylation 
and gene expression fold change can be found in Table 3-16.  In the HA vs IVV analysis, 
12 genes met this criteria: ACTC1, AUTS2, GIP, LPL, MYOZ1, TDRKH, TMEM126A, 
TRA2B, TSSK2, NSSSCG00000015664, ENSSSCG00000032383, and 
ENSSSCG00000013387. (Table 3-17).  In the LA vs IVV analysis, 8 genes matched the 
criteria: C2, COL5A2, LGALS2, MYOZ1, PRXL2B, RSAD2, TNNT3, and TSSK2.  
 Using these genes, which were found to be differentially expressed and with a 
differentially methylated tile within 5,000 bp in at least one comparison, correlation 
between RPKM values and tile percent methylation was calculated (Figure 3-14).  Of the 
22 genes, 5 genes showed significant correlation between RPKM value and percent 
methylation and 3 genes trended towards significance:  ACTC1 (p = 0.002), AUTS2 (p = 
0.04), GIP (p = 0.04), TDRKH (p = 0.02), and ENSSSCG00000032383 (p = 0.03) were 
significantly correlated while ADGRF1 (p = 0.08), MYOZ1 (p = 0.07), and TRA2B (p = 
0.06) trended towards significance.  However, contrary to expectation, ACTC1, MYOZ1, 
TDRKH, and ENSSSCG00000032383 all showed a positive correlation between RPKM 





 For the first time, both DNA methylation and gene expression from individual 
blastocysts with high and low incidence of apoptosis were compared to in vivo produced 
blastocysts.  This study provided deeper insight into the epigenetic reprograming of 
individual embryos following SCNT.  Additionally, a large number of biological 
replicates were included which provided a deeper understanding of the stochastic DNA 
methylation and gene expression patterns in each individual embryo.  The global 
perspective used in this study yielded vast amounts of data.   
 While the high apoptosis SCNT and low apoptosis SCNT blastocysts were 
selected to tease apart differences between them, they are extremely similar as they are 
cloned porcine blastocysts.  In order to reach the blastocyst stage of development, the 
embryos had to overcome nuclear reprogramming, the maternal to zygotic transition, 
embryonic genome activation, and multiple rounds of mitosis.  Many cloned embryos 
stall development and fail to reach the blastocyst stage due to altered gene expression and 
epigenetic reprogramming [107].  Therefore by isolating and analyzing only blastocysts, 
these embryos have shown a level of competence to have successfully continued 
development.  Because of this milestone, it was expected that differences in DNA 
methylation and gene expression would be limited when comparing the high apoptosis to 
low apoptosis SCNT embryos.  However, any differences that were identified could be 
incredibly important to be able to identify the most competent of cloned blastocysts.   
 Rather than a targeted approach, RRBS provides a global perspective of DNA 
methylation patterns while maximizing returns by sequencing areas of the genome that 
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are rich in CpG content.  However, this broadens the scope of the analyzed genome to 
areas outside of the traditionally analyzed CpG islands located in promoter regions of 
genes of interest.  From our sequencing efforts, we did successfully enrich for promoter 
regions.  Nearly 12% of all tiles analyzed fell within a promoter regions, which is 
significantly enriched when less than 1% of the genome comprises promoter regions.  
However, only 1% of the differentially methylated regions were located in the promotor 
regions of genes and 90-92% occurred in intergenic regions of the genome.  This is rather 
interesting as it appears that the cloned embryos are more successful at conserving 
methylation patterns of the promoter regions which would be critical for the development 
and success of the embryo.  However, limited differential methylation of promoters 
makes it very difficult to find cause and effect relationships between DNA methylation 
and RNA expression as DNA methylation of gene promoters are the traditional drivers of 
gene expression.  Due to the connection between DNA methylation driving gene 
expression patterns, there is a desire to make direct links between DNA methylation level 
and gene expression patterns.  However, because we did not use a targeted approach, it is 
difficult to identify any direct correlations between DNA methylation level and gene 
expression patterns. Additionally, differential methylation was determined on a 100 bp 
tile rather than overall methylation levels of promoter regions.  Rather, a majority of the 
analysis occurred on a genome wide as well as 100 bp tile scale, rather than a gene 
promoter scale. 
 Global DNA methylation patterns showed similar overall methylation levels to 
previously reported RRBS studies of in vivo blastocysts in cattle [108] but provided no 
statistically significant differences in percent methylation across all tiles analyzed 
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between high apoptosis (HA) SCNT blastocysts, low apoptosis (LA) SCNT blastocysts 
and in vivo produced (IVV) blastocyst.  Previous studies have reported differential 
demethylation of the inner cell mass and trophectoderm in cloned bovine blastocysts 
[109], and assuming that porcine SCNT blastocyst show similar differences in 
methylation patterns it could be possible that global dysregulation of DNA methylation is 
being obscured by analyzing the whole embryo.  Unexpectedly, the IVV samples had the 
largest amount of variation between samples at global percent methylation, which is also 
apparent when looking at the fraction of tiles that contained various levels of methylation.  
This inconsistency could be the result of developmental variation noted in the IVV 
blastocysts where one collection was clearly more developed from the second collection. 
From visual assessment, the high apoptosis samples had more variability in methylation 
patterns based on fraction of tiles methylated at varying methylation levels compared to 
the low apoptosis samples, which were fairly consistent from sample to sample.  
Increased variation in the high apoptosis global methylation profiles could indicate more 
variable and inappropriate DNA reprogramming following SCNT and indicate the 
embryos were less competent.  
 Analyzing DNA methylation patterns at a 100 base pair tile resolution, more tiles 
were hypermethylated than hypomethylated in all three of the analyses; high apoptosis vs 
low apoptosis, high apoptosis vs IVV, and low apoptosis vs IVV.  Previous research 
supports these findings as cloned embryos have been shown to generally de-methylate 
but do not do so completely, thereby increased methylation levels in cloned embryos 
would be expected and would explain why more regions were hypermethylated [52].  
Comparing the high apoptosis samples to the low apoptosis samples, the percent of tiles 
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that were hypomethylated and hypermethylated was closer to equal, however more tiles 
were still hypermethylated indicating no distinct pattern of reprogramming but rather 
some level of failure to both de-methylate and re-methylate certain regions adding 
evidence to the hypothesis of random reprogramming following SCNT as no distinct 
methylation pattern emerged in the cloned embryos.  The trend from more regions of 
hypermethylation across analyses supports the global methylation findings that suggested 
slightly higher levels of methylation in the cloned samples compared to the IVV samples, 
although these differences were not significant.  The high apoptosis vs IVV analysis 
found the most tiles to be differentially methylated greater than 25 percent, perhaps 
indicating a greater difference in overall methylation patterns comparing the high 
apoptosis embryos to the IVV embryos while the low apoptosis embryos may be more 
similar to the IVV embryos.  This similarity of the low apoptosis and IVV samples is 
supported by the Venn diagram breakdown of differentially methylated tiles where more 
than double the number of tiles were uniquely differentially methylated in the HA v IVV 
analysis compared to the LA v IVV and HA v LA analyses.  Only 15 of the tiles were 
found to be differentially methylated in all 3 analyses indicating distinct methylation 
patterns between the groups and again supporting a random nature of reprogramming.  
DNA methylation at a 100 bp tile level indicates that low apoptosis blastocysts are more 
similar to IVV blastocysts and could therefore be more successful than the high apoptosis 
blastocysts.   
 PCA of methylation tells a different story.  PCA on a global scale where all tiles 
were included shows similarities between all 3 groups as the samples overlap on a central 
point, indicating similar overall methylation patterns which would be expected as all the 
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embryos have successfully reached the blastocyst stage of development which would 
require some level of competence.  In the PCA analysis representing all tiles, the three 
sample types all overlap on one central location.  The overall similarity in global 
methylation is supported by the non-descript heat map of percent methylation of all tiles 
where very little variance in percent methylation is seen between samples. This is 
supported by the PCA of only differentially methylated tiles that still have an overlapping 
section of all three groups.  While these three groups then radiate out and away from each 
other, which is expected as these tiles have previously been identified as different, the 
three still group together indicating some similarity in methylation, even in the tiles that 
are different.  The heat map of differentially methylated tiles also shows small changes in 
methylation level across samples.  This data continues to support the concept that 
methylation had to be “normal” at some level in order to reach the blastocyst stage of 
development.  
 When differentially methylated tiles were associated with the nearest transcription 
start site for gene ontology analysis, a remarkably large number of biological process, 
cellular component, and molecular function gene ontology terms were found to be 
significantly enriched in each analysis.  In the high vs low apoptosis analysis, the top ten 
enriched biological process terms included terms associated with apoptosis, reproduction, 
and response to stimulus.  Just as interesting, the high apoptosis vs IVV analysis provided 
terms related to metabolic process, cell communication, and response to stimulus while 
the low apoptosis vs IVV analysis provided terms associated with response to stimulus, 
cell communication, and the metabolic process.  Gene ontology terms found to be 
significantly enriched in the high vs low apoptosis for the molecular function analysis 
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included terms such as receptor binding, growth factor activity, hormone activity, and 
protein dimerization.  Similar terms were identified in the high apoptosis vs IVV and low 
apoptosis vs IVV analysis.  All of these pathways were interesting as they are integral 
components of successful embryo development and could provide direction of future 
studies to identify specific gene promoters of importance for embryo competency.  
 When analyzing KEGG pathways that were significantly enriched in the high 
apoptosis vs low apoptosis embryos, the most significantly enriched pathway was the 
TGF-beta signaling pathway, an important signaling cascade in embryo development 
(reviewed in [110]. Interestingly, terms associated with immune response, such as 
inflammatory bowel disease, Hepatitis C, and Tuberculosis were found in all three 
analyses.  The fact that genes associated with immune response altered in cloned 
blastocysts with high and low apoptosis compared to IVV blastocysts adds to the need to 
better understand the immune response to cloned embryos, as it has been previously 
reported that cloned pregnancies are lost as a result of immune-mediated rejection of the 
fetus [111]. 
While these gene ontology findings provided exciting terms of significance, it is 
crucial to note that the average distance of the differentially methylated tiles to the 
transcription start site was nearly 16,000 base pairs away which brings into question the 
biological significance of the findings.  While scientific understanding of DNA 
methylation regulation of gene expression continues to grow, traditional thinking is that 
DNA methylation of promoter regions of genes regulates gene expression and most 
promoters will be located 2,000-3,000 base pairs upstream of the transcription start site.  
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Therefore, in an effort to limit the analysis to tiles that are more likely to be relevant to 
gene expression control, differentially methylated tiles were limited to those within 5,000 
base pairs of the transcription start site.  With the new restricted list of genes for gene 
ontology analysis, no gene ontology terms or KEGG pathways were found to be 
enriched, indicating a random nature of DNA reprogramming in cloned embryos as no 
pattern of reprogramming at sites near transcription start sites which could be directly 
responsible for gene expression was evident. Although, it is also possible that by 
restricting the gene list, the number of genes analyzed was significantly reduced and the 
power to call terms significantly enriched was lost, which is why no terms were 
determined to be significantly enriched in these analyses.  The limiting of the gene list in 
combination with an overall randomness of nuclear reprogramming in cloned embryos 
would make identifying altered pathways extremely difficult with a large number of 
samples.   
Nuclear reprogramming abnormalities are also present through gene expression in 
the high apoptosis, low apoptosis, and IVV blastocysts, where gene expression changes 
varied depending on the analysis, unlike the methylation data where across all three 
analyses more tiles were hypermethylated.  In the high vs low apoptosis analysis, 
significantly more genes had decreased expression compared to increased expression 
which does not fit with the methylation data where more genes were hypermethylated 
compared to hypomethylated.  While not anticipated, this data is not alarming due to the 
many controls of gene expression outside of DNA methylation alone, including histone 
methylation, chromatin structure, and RNA interference [112].  Another interesting 
observation is that the low apoptosis vs IVV gene expression analysis yielded the most 
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genes that were significantly differentially expressed while the high apoptosis vs IVV 
comparison resulted in the most differentially methylated tiles.   
When analyzing the overlap of the genes that were found to be differentially 
expressed in each comparison, only 128 genes were uniquely differentially expressed in 
the high vs low apoptosis SCNT samples.  As expected, most of the differential gene 
expression was associated with differences in gene expression patterns between cloned 
embryos and IVV embryos which was expected as numerous reports have found large 
numbers of gene expression abnormalities when comparing cloned embryos to IVF or 
IVV [36].  The conclusion that IVV embryos share a gene expression profile which is 
different from cloned embryos is evident in the hierarchical clustering where the IVV 
samples cluster separately from cloned samples when all genes and only differentially 
expressed genes are analyzed, yet the high apoptosis and low apoptosis samples scatter 
together as a cloned group rather than separating based on incidence of apoptosis.  The 
hierarchical clustering was performed on genes that were found to be differentially 
expressed in at least one analysis, so a majority of the genes included in the analysis were 
not found to be differentially expressed in the high vs low analysis which explains why 
the high and low groups are not separating form each other.  Taken together, the two 
hierarchical clustering analyses of gene expression indicate that the high and low 
apoptosis samples share gene expression profiles and cannot be separated on gene 
expression alone.   
Gene ontology analysis of differentially expressed genes found only significantly 
enriched gene ontology terms for cellular component terms from the high and low 
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apoptosis analysis.  Even then, only three terms were significantly enriched, two of which 
involved the plasma membrane.  Oddly, the high apoptosis vs IVV differentially 
expressed genes resulted in no gene ontology terms or KEGG pathways that were 
significantly enriched while the low apoptosis vs IVV differentially expressed genes 
resulted in numerous significantly enriched terms and pathways in each gene ontology 
category.  The low apoptosis vs IVV analysis did result in nearly five times the number 
of uniquely differentially expressed genes that did not appear in the other two analyses, 
which could simply be providing the statistical power in gene ontology analysis to drive 
such different results compared to the high apoptosis vs IVV gene ontology analysis.  
While other studies have reported gene ontology differences in cloned and IVF 
blastocysts [113], a review of misexpressed genes in cloned embryos failed to identify 
consistently misexpressed genes supporting the hypothesis of the random nature of 
epigenetic reprogramming following SCNT [36].  As a result of using a small number of 
samples and a large degree of variation among the samples, there could be an increased 
probability of false positives.  However, by increasing the sample size in our study, we 
reduced the probability of false positives by having an increased representation of the 
variation present in cloned embryos.  Because most RNA-seq studies use a relatively 
small number of samples, typically three to four, it could be that by analyzing so many 
samples in our study the random epigenetic reprogramming was observed within one 
study and obscured any gene ontology results that could have been present in a subset of 
the samples.   
In an attempt to blend together the DNA methylation data with the gene 
expression data, genes from each analysis were identified that were differentially 
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expressed with a fold change of at least 1.5 and had a differentially methylated tile at 
least 25% differentially methylated within 5,000 base pairs of the gene transcription start 
site.  These criteria identified a total of 22 total genes from the three analyses.  
Correlation of RPKM values and percent tile methylation was determined for each gene 
and 5 genes had a statistically significant correlation while 3 genes trended on 
significance.  Because increased levels of methylation decrease gene expression levels, a 
negative correlation is expected between percent methylation and RPKM values.  In half 
of the significantly correlated genes, a positive correlation was present.  Previous studies 
have found a complicated association between DNA methylation and gene expression 
depending on the genomic context of the methylation and gene expression levels [114], 
where findings outside the traditional concept of increased methylation results in 
decreased gene expression where found.  For instance, genes that had high levels of gene 
expression resulted in a negative correlation between gene expression levels and DNA 
methylation [114].  Additionally, cancer cells have shown instances where CpG islands 
were aberrantly hypermethylated and the corresponding gene did not show decreased 
expression levels, as would be expected [115]. Even in the genes with the appropriate 
negative correlation, low r2 values indicate that there was not a strong fit for the linear 
regression.  Taken together these findings are not surprising as a majority of these genes 
had a single 100 bp tile that was differentially methylated within 5,000 base pairs up or 
downstream of the transcription start site.  A typical gene promoter would be larger than 
100 base pairs.  So at best, this one tile would be significantly differentially methylated 
tile and fall within the promoter region, but the rest of the promoter region was not found 
to be differentially methylated, so gene expression patterns would most likely not be 
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completely explained by a singular tile.  To better understand the link between DNA 
methylation and gene expression patterns in these embryos, a different approach that 
focused on the promoter region rather than a genome wide approach could be pursued.   
The hypothesis of this study centered on the concept that certain SCNT embryos 
undergo proper genome reprogramming, resulting in proper gene expression patterns, 
leading to low levels of apoptosis.  Apoptosis could then serve as a useful biomarker of 
embryo competency early in development in order to increase the efficiency of the 
technology by being able to select the most successful embryos and minimizing cost of 
maintaining excessive recipient animals that either will not get pregnant or would lose the 
pregnancy.  However, based on the presented findings, there were relatively few 
differences in the high apoptosis SCNT blastocysts compared to the low apoptosis SCNT 
blastocysts in terms of DNA methylation and gene expression profiles.  While there were 
regions that were identified to be significantly differentially methylated as well as genes 
which were differentially expressed in the high apoptosis compared to low apoptosis 
samples, no clear patterns emerged.  In the methylation data, the low apoptosis samples 
were less variable than the high apoptosis samples in the PCA, yet the opposite is true of 
the gene expression data.  In the methylation data, hierarchical clustering of differentially 
methylated tiles separated the high apoptosis from the low apoptosis samples, but this is 
not true of the differentially expressed genes.  So while there may be some more distinct 
patterns of methylation in the high and low apoptosis embryos, there does not appear to 
be a distinct pattern of gene expression between the groups.  Finally, gene ontology 
analysis of both genes with a differentially methylated tile within 5,000 base pairs as well 
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as gene ontology analysis of differentially expressed genes resulted in no gene ontology 
terms or KEGG pathways that were enriched.   
In conclusion, global methylation patterns were similar between the HA, LA, and 
IVV samples.  This methylation pattern contradicts previously published reports that have 
shown vast differences in global and gene promoter DNA methylation [62, 109].  
However, different techniques to detect methylation were used.  While we did report 
difference in DNA methylation, the differences were not as abundant as expected 
indicating that more epigenetic regulatory mechanisms could be involved than DNA 
methylation alone.  More differences were found in gene expression, especially when 
comparing the cloned blastocysts to the IVV blastocysts, but very few gene ontology 
pathways were identified as different in the comparisons [109].  Taken together, these 
data support the concept of stochastic epigenetic reprogramming following SCNT.  Our 
results suggest that each embryo undergoes a unique reprogramming process, resulting in 
no clear patterns of DNA methylation and consequently no distinct patterns of RNA 
expression which is why so few differences between the high and low apoptosis embryos 
were discovered.   
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Table 3-1. RRBS sequencing data. 




High    
1 29.34 5.22 17.8 
2 28.48 5.36 18.8 
3 27.96 4.39 15.7 
4 31.34 6.44 20.5 
5 34.12 8.64 25.3 
6 26.24 7.29 27.8 
7 28.59 4.64 16.2 
8 19.66 1.77 9.0 
9 21.88 2.35 10.8 
10 29.57 3.85 13.0 
11 32.31 7.15 22.1 
12 29.67 6.12 20.6 
13 28.90 6.30 21.8 
Total 368.06 69.52   
Average 28.31 5.35 18.4 
Standard Deviation 3.92 1.96 5.5 
Low 
   
1 25.13 6.51 25.9 
3 23.69 6.50 27.4 
4 27.58 4.94 17.9 
5 25.89 4.33 16.7 
6 24.62 7.07 28.7 
7 20.75 2.90 14.0 
8 29.97 4.42 14.8 
9 24.16 5.09 21.1 
10 30.84 5.48 17.8 
11 5.09 0.83 16.4 
12 27.60 2.21 8.0 
13 25.21 4.60 18.2 
Total 290.53 54.88   
Average 24.21 4.57 18.9 
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Standard Deviation 6.62 1.84 6 
In Vivo 
   
1 20.42 1.33 6.5 
2 39.39 10.98 27.9 
3 20.05 2.56 12.8 
4 27.88 9.32 33.4 
5 27.14 9.34 34.4 
6 28.35 7.11 25.1 
7 23.32 9.75 41.8 
8 26.02 10.13 38.9 
9 30.23 12.05 39.9 
10 23.47 7.68 32.7 
11 35.23 14.65 41.6 
Total 301.50 94.90   
Average 27.41 8.63 30.5 
Standard Deviation 5.92 3.89 11.7 
















Table 3-2. Bisulfite conversion efficiency 
determined by exogenous un-methylated 
lambda-DNA. 
















Standard Deviation 0.4 
Low   
Low 1 98.0 
Low 3 97.2 
Low 4 98.3 
Low 5 98.1 
Low 6 98.1 
Low 7 98.2 
Low 8 97.5 
Low 9 98.1 
Low 10 98.2 
Low 11 97.7 
Low 12 96.9 
Low 13 98.5 
Average 97.9 
Standard Deviation 0.5 
In Vivo 
 
IVV 1 97.3 
IVV 2 97.7 
IVV 3 96.4 
IVV 4 98.4 
IVV 5 98.1 
IVV 6 96.9 
IVV 7 98.4 
IVV 8 98.4 
IVV 9 98.6 
IVV 10 97.8 
IVV 11 98.5 
Average 97.9 
Standard Deviation 0.7 
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Table 3-3. The top ten biological process gene ontology terms from genes with 
associated differentially methylated tiles any distance from transcription start 
site in each analysis. 
Term Count1 FDR2 
High vs. Low    
cellular response to chemical stimulus 221 5.3E-11* 
positive regulation of response to stimulus 183 8.4E-11* 
programmed cell death 166 2.3E-10* 
developmental process involved in reproduction 90 2.6E-10* 
cell death 173 2.7E-10* 
regulation of apoptotic process 144 2.8E-10* 
single organism reproductive process 125 2.9E-10* 
reproduction 130 3.0E-10* 
regulation of cell death 150 3.2E-10* 
regulation of programmed cell death 144 3.2E-10* 
High vs. IVV 
 
cellular response to chemical stimulus 294 6.1E-17* 
positive regulation of metabolic process 342 1.8E-15* 
oxidation-reduction process 109 2.4E-14* 
response to organic substance 283 2.7E-14* 
regulation of molecular function 267 2.7E-14* 
positive regulation of response to stimulus 236 2.8E-14* 
positive regulation of cellular metabolic process 316 2.1E-13* 
positive regulation of cell communication 196 2.3E-13* 
cellular response to organic substance 237 2.7E-13* 
positive regulation of signaling 196 3.7E-13* 
Low vs. IVV   
cellular response to chemical stimulus 219 4.9E-12* 
cellular response to organic substance 178 9.3E-10* 
response to organic substance 208 2.2E-09* 
positive regulation of metabolic process 247 2.8E-09* 
positive regulation of response to stimulus 171 6.6E-09* 
positive regulation of biosynthetic process 154 1.0E-08* 
cellular response to endogenous stimulus 109 1.1E-08* 
positive regulation of signal transduction 135 1.4E-08* 
reproductive structure development 61 1.4E-08* 
positive regulation of cell communication 142 1.5E-08* 
1 Count indicates the number of genes represented in each gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR 









Table 3-4. The top ten biological process gene ontology terms from genes 
with associated differentially methylated tiles within 5,000 base pairs up or 
downstream of the transcription start site in each analysis 
Term Count1 FDR2 
High vs. Low     
skeletal muscle contraction 2 9.2E-01 
cytoplasmic pattern recognition receptor 
signaling pathway 
2 9.2E-01 
cellular response to cytokine stimulus 6 9.2E-01 
immune response-regulating signaling pathway 4 9.3E-01 
response to virus 5 9.3E-01 
immune effector process 7 9.3E-01 
response to biotic stimulus 8 9.3E-01 
regulation of cell death 11 9.3E-01 
homeostatic process 12 9.3E-01 
response to oxygen-containing compound 9 9.3E-01 
High vs. IVV 
positive regulation of cytokine production 11 1.1E-01 
positive regulation of immune system process 16 1.2E-01 
cytokine production 14 1.4E-01 
regulation of immune response 14 1.5E-01 
positive regulation of immune response 13 1.6E-01 
lymphocyte mediated immunity 8 2.1E-01 
immune effector process 16 2.1E-01 
negative regulation of viral process 6 2.1E-01 
adaptive immune response based on somatic 
recombination of immune receptors built from 
immunoglobulin superfamily domains 
8 2.2E-01 
cellular response to type I interferon 4 2.3E-01 
Low vs. IVV 
monocarboxylic acid metabolic process 7 6.8E-01 
single organism reproductive process 11 6.9E-01 
oxidation-reduction process 8 6.9E-01 
glycerolipid biosynthetic process 4 7.0E-01 
multicellular organismal reproductive process 8 7.1E-01 
T cell differentiation 5 7.1E-01 
oxoacid metabolic process 9 7.1E-01 
carboxylic acid metabolic process 9 7.2E-01 
multicellular organism reproduction 8 7.2E-01 
multi-organism reproductive process 9 7.2E-01 
1 Count indicates the number of genes represented in each gene ontology 
term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR 





Table 3-5. The top ten cellular component gene ontology terms 
from genes with associated differentially methylated tiles any 
distance from transcription start site in each analysis 
Term Count1 FDR2 
High vs. Low  
extracellular region 365 4.2E-05* 
cytosol 149 2.3E-04* 
membrane-bounded vesicle 277 4.7E-04* 
membrane region 37 1.9E-03* 
extracellular region part 316 2.0E-03* 
membrane microdomain 32 2.0E-03* 
membrane raft 32 2.0E-03* 
troponin complex 7 5.2E-03* 
pigment granule 15 1.2E-02* 
melanosome 15 1.2E-02* 
High vs. IVV 
extracellular region 495 6.7E-10* 
membrane-bounded vesicle 380 2.7E-08* 
extracellular region part 437 4.2E-08* 
extracellular exosome 313 2.2E-06* 
extracellular organelle 314 2.5E-06* 
extracellular vesicle 314 2.9E-06* 
cytosol 189 2.9E-05* 
endoplasmic reticulum part 91 1.6E-03* 
plasma membrane region 83 3.1E-03* 
lipid particle 17 4.2E-03* 
Low vs. IVV 
extracellular region 364 2.0E-06* 
membrane-bounded vesicle 280 1.6E-05* 
extracellular region part 318 9.4E-05* 
extracellular organelle 232 2.3E-04* 
extracellular exosome 231 2.5E-04* 
extracellular vesicle 232 2.7E-04* 
cytosol 138 2.7E-03* 
extracellular space 123 2.8E-02* 
mitochondrion 158 3.2E-02* 
cell projection cytoplasm 10 3.4E-02* 
1 Count indicates the number of genes represented in each 
gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered 






Table 3-6. The top ten cellular component gene ontology terms from 
genes with associated differentially methylated tiles within 5,000 base 
pairs up or downstream of the transcription start site in each analysis. 
Term Count1 FDR2 
High vs. Low  
extracellular region 29 7.0E-01 
cytosol 11 9.3E-01 
peroxisome 3 9.5E-01 
microbody 3 9.5E-01 
extracellular organelle 17 9.6E-01 
membrane-bounded vesicle 21 9.8E-01 
extracellular vesicle 17 9.8E-01 
mitochondrion 13 9.9E-01 
extracellular exosome 17 1.0E+00 
High vs. IVV 
membrane-bounded vesicle 41 1.7E-01 
extracellular organelle 34 1.8E-01 
extracellular vesicle 34 2.3E-01 
extracellular exosome 34 3.0E-01 
extracellular region 46 4.3E-01 
axon 7 4.7E-01 
extracellular region part 41 4.9E-01 
cytosol 20 5.2E-01 
nuclear outer membrane-endoplasmic 
reticulum membrane network 
10 7.3E-01 
anchored component of membrane 3 7.4E-01 
Low vs. IVV 
extracellular organelle 22 3.9E-01 
acrosomal vesicle 4 4.4E-01 
extracellular vesicle 22 4.4E-01 
extracellular exosome 22 4.8E-01 
membrane-bounded vesicle 26 5.2E-01 
lipid particle 4 5.7E-01 
extrinsic component of plasma membrane 4 5.7E-01 
sperm part 4 6.1E-01 
mitochondrial part 9 6.8E-01 
extracellular region part 26 7.0E-01 
1 Count indicates the number of genes represented in each gene 
ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  






Table 3-7. The top ten molecular function gene ontology terms from genes with associated differentially 
methylated tiles any distance from transcription start site in each analysis. 
Term Count1 FDR2 
High vs. Low  
receptor binding 84 7.1E-04* 
protein dimerization activity 28 1.9E-03* 
hormone activity 21 6.8E-03* 
identical protein binding 27 8.8E-03* 
glycoprotein binding 18 9.0E-03* 
growth factor activity 16 2.6E-02* 
sulfur compound binding 27 4.0E-02* 
cofactor binding 38 5.1E-02 
cytokine receptor binding 32 7.4E-02 
cytokine activity 30 1.0E-01 
High vs. IVV 
hormone activity 33 4.0E-08* 
receptor binding 108 5.7E-06* 
protein dimerization activity 36 2.1E-05* 
identical protein binding 35 3.3E-04* 
glycoprotein binding 22 1.1E-03* 
growth factor activity 20 2.3E-03* 
cofactor binding 50 2.6E-03* 
coenzyme binding 38 2.9E-03* 
G-protein coupled peptide receptor activity 31 4.4E-03* 
peptide receptor activity 31 6.0E-03* 
Low vs. IVV 
receptor binding 74 1.2E-02* 
hormone activity 20 1.4E-02* 
growth factor binding 11 2.2E-02* 
steroid binding 16 5.8E-02 
cofactor binding 37 5.8E-02 
protein dimerization activity 22 1.3E-01 
G-protein coupled peptide receptor activity 22 1.5E-01 
insulin-like growth factor binding 6 1.5E-01 
transforming growth factor beta receptor, cytoplasmic mediator activity 5 1.5E-01 
peptide receptor activity 22 1.7E-01 
1 Count indicates the number of genes represented in each gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR corrections performed using 










Table 3-8. The top ten molecular function gene ontology terms from genes with associated 
differentially methylated tiles within 5,000 base pairs up or downstream of the transcription start site 
in each analysis. 
Term Count1 FDR2 
High vs. Low  
cysteine-type endopeptidase inhibitor activity 4 7.3E-01 
peptidase inhibitor activity 4 9.1E-01 
core promoter proximal region DNA binding 5 9.2E-01 
transcriptional repressor activity, RNA polymerase II core promoter 
proximal region sequence-specific binding 
3 9.4E-01 
core promoter proximal region sequence-specific DNA binding 5 9.4E-01 
insulin-like growth factor binding 2 9.4E-01 
hormone activity 3 9.4E-01 
endopeptidase regulator activity 4 9.5E-01 
RNA polymerase II core promoter proximal region sequence-specific 
DNA binding 
5 9.6E-01 
endopeptidase inhibitor activity 4 9.8E-01 
High vs. IVV 
insulin-like growth factor binding 3 5.7E-01 
transcription factor activity, RNA polymerase II core promoter proximal 
region sequence-specific binding 
8 5.8E-01 
core promoter proximal region DNA binding 8 6.0E-01 
core promoter proximal region sequence-specific DNA binding 8 6.3E-01 
regulatory region nucleic acid binding 14 6.7E-01 
regulatory region DNA binding 14 6.7E-01 
cysteine-type endopeptidase inhibitor activity involved in apoptotic 
process 
3 6.8E-01 
sequence-specific double-stranded DNA binding 11 6.9E-01 
RNA polymerase II transcription factor activity, sequence-specific DNA 
binding 
11 6.9E-01 
transcription regulatory region DNA binding 14 7.0E-01 
Low vs. IVV 
ribonucleotide binding 19 1.5E-01 
purine nucleotide binding 19 1.6E-01 
purine ribonucleotide binding 19 1.7E-01 
nucleoside phosphate binding 22 1.8E-01 
nucleotide binding 22 1.8E-01 
nucleoside binding 19 1.8E-01 
ribonucleoside binding 19 2.1E-01 
purine ribonucleoside binding 19 2.5E-01 
purine nucleoside binding 19 2.5E-01 
ATP binding 15 2.9E-01 
1 Count indicates the number of genes represented in each gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR corrections performed 




Table 3-9. The top KEGG pathway terms from genes with associated differentially 
methylated tiles any distance from transcription start site in each analysis. 
Term Count1 FDR2 
High vs. Low  
TGF-beta signaling pathway 24 8.1E-04* 
Insulin signaling pathway 33 1.1E-03* 
Inflammatory bowel disease (IBD) 21 1.4E-03* 
Jak-STAT signaling pathway 33 1.9E-03* 
Metabolic pathways 170 2.2E-03* 
FoxO signaling pathway 32 2.3E-03* 
HIF-1 signaling pathway 26 2.7E-03* 
Leishmaniasis 19 3.1E-03* 
Carbon metabolism 26 3.2E-03* 
Hepatitis C 30 3.3E-03* 
High vs. IVV 
TGF-beta signaling pathway 32 8.6E-06* 
Hepatitis C 43 1.4E-05* 
Prolactin signaling pathway 28 1.5E-05* 
FoxO signaling pathway 43 3.0E-05* 
AMPK signaling pathway 38 1.1E-04* 
Insulin signaling pathway 40 2.6E-04* 
Chagas disease (American trypanosomiasis) 34 4.1E-04* 
PPAR signaling pathway 25 4.3E-04* 
Signaling pathways regulating pluripotency of stem 
cells 
39 4.8E-04* 
Hippo signaling pathway 40 5.1E-04* 
Low vs. IVV 
Pertussis 23 9.8E-04* 
Tuberculosis 39 1.3E-03* 
Hepatitis C 31 1.5E-03* 
TGF-beta signaling pathway 22 1.8E-03* 
Hippo signaling pathway 32 2.1E-03* 
Metabolic pathways 161 5.1E-03* 
Osteoclast differentiation 29 1.1E-02* 
Insulin signaling pathway 28 1.5E-02* 
PPAR signaling pathway 18 1.6E-02* 
Chagas disease (American trypanosomiasis) 24 1.9E-02* 
1 Count indicates the number of genes represented in each gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR 






Table 3-10. The KEGG pathways identified from genes with associated 
differentially methylated tiles within 5,000 base pairs up or downstream of the 
transcription start site in each analysis. 
Term Count1 FDR2 
High vs. Low  
cAMP signaling pathway 6 5.9E-01 
Hepatitis B 5 6.5E-01 
RIG-I-like receptor signaling pathway 4 8.3E-01 
Amphetamine addiction 3 9.4E-01 
HTLV-I infection 5 9.5E-01 
High vs. IVV 
Hepatitis C 7 7.9E-01 
RIG-I-like receptor signaling pathway 4 9.2E-01 
AMPK signaling pathway 5 9.2E-01 
Alzheimer's disease 6 9.3E-01 
Prolactin signaling pathway 4 9.5E-01 
Hepatitis B 6 9.8E-01 
Regulation of autophagy 3 9.9E-01 
Low vs. IVV 
Osteoclast differentiation 4 9.3E-01 
Endocytosis 5 9.4E-01 
Insulin signaling pathway 4 9.7E-01 
Neurotrophin signaling pathway 4 9.8E-01 
Alzheimer's disease 5 1.0E+00 
1 Count indicates the number of genes represented in each gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR 










Table 3-11.  RNA sequencing data. 
 Total Reads1 Number of Aligned Reads1 Percent Aligned 
High    
1 2.67 1.68 62.9 
2 5.54 4.24 76.6 
3 6.84 5.08 74.3 
4 7.13 5.05 70.8 
5 7.55 5.74 76.0 
6 6.64 4.99 75.2 
7 6.15 4.19 68.2 
8 6.87 4.90 71.4 
9 6.10 3.98 65.3 
10 6.49 4.41 67.9 
11 5.97 4.38 73.5 
12 7.50 5.49 73.2 
13 6.80 5.12 75.2 
Total 82.25 59.25  
Average 6.33 4.56 71.6 
Standard Deviation 1.25 1.01 4.3 
Low    
1 6.63 4.88 73.6 
3 7.53 5.36 69.8 
4 7.18 4.82 64.8 
5 7.20 4.74 65.8 
6 8.17 5.73 70.1 
7 6.45 4.07 63.1 
8 7.48 4.50 60.1 
9 7.05 5.33 75.6 
10 7.93 5.28 66.6 
11 6.33 4.21 66.5 
12 7.50 5.49 73.2 
13 6.80 5.12 75.2 
Total 86.25 59.53  
Average 7.09 4.77 66.7 
Standard Deviation 0.66 0.85 8.8 
In Vivo    
1 5.66 3.57 63.1 
2 6.65 5.11 76.9 
3 5.27 3.24 61.5 
4 6.97 5.54 79.6 
5 14.63 12.27 83.8 
6 17.32 15.24 88.0 
7 13.24 11.63 87.9 
8 12.94 11.23 86.8 
9 14.38 12.72 88.5 
11 14.57 12.49 85.8 
Total 111.63 93.04  
Average 11.16 9.31 80.2 
Standard Deviation 4.50 4.43 10.2 




Table 3-12. The top ten biological process gene ontology terms from genes 
differentially expressed in each analysis. 
Term Count1 FDR2 
High vs. Low   
biological adhesion 21 2.0E-01 
positive regulation of response to stimulus 26 2.2E-01 
cell adhesion 21 2.3E-01 
circulatory system development 18 2.5E-01 
cardiovascular system development 18 2.5E-01 
vasculature development 13 2.8E-01 
regulation of angiogenesis 7 5.4E-01 
cell-substrate adhesion 8 5.8E-01 
positive regulation of signal transduction 19 6.1E-01 
regulation of vasculature development 7 6.6E-01 
High vs. IVV   
negative regulation of response to external 
stimulus 
17 1.7E-01 
regulation of response to stress 45 1.9E-01 
regulation of response to external stimulus 33 2.2E-01 
negative regulation of reproductive process 9 2.4E-01 
negative regulation of defense response 12 2.7E-01 
negative regulation of inflammatory response 10 3.5E-01 
regulation of defense response 24 5.2E-01 
multi-organism reproductive process 29 5.2E-01 
epithelial cell proliferation 17 5.2E-01 
wound healing 17 5.2E-01 
Low vs. IVV    
biological adhesion 93 3.0E-03* 
cell adhesion 90 6.9E-03* 
taxis 46 1.9E-02* 
chemotaxis 46 2.0E-02* 
response to external stimulus 121 2.1E-02* 
ion transport 77 2.3E-02* 
regulation of cell proliferation 90 2.4E-02* 
positive regulation of immune system process 56 2.8E-02* 
regulation of response to stress 75 3.8E-02* 
regulation of programmed cell death 84 5.4E-02 
1 Count indicates the number of genes represented in each gene ontology 
term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR 





Table 3-13. The top ten cellular component gene ontology terms from 
genes differentially expressed in each analysis. 
Term Count1 FDR2 
High vs. Low 
intrinsic component of plasma membrane 25 9.0E-03* 
integral component of plasma membrane 25 9.9E-03* 
extracellular space 23 2.0E-02* 
extracellular region part 42 1.0E-01 
extracellular matrix 10 1.8E-01 
extracellular region 44 2.3E-01 
cell surface 11 4.9E-01 
collagen trimer 4 5.0E-01 
membrane region 6 6.2E-01 
external side of plasma membrane 5 8.2E-01 
High vs. IVV 
extracellular region 135 1.9E-01 
extracellular region part 116 7.0E-01 
extracellular matrix 20 8.2E-01 
proteinaceous extracellular matrix 15 8.6E-01 
extracellular space 47 8.8E-01 
lytic vacuole 17 9.4E-01 
neuron projection terminus 4 9.4E-01 
lipid particle 5 9.5E-01 
nuclear speck 7 9.5E-01 
extracellular organelle 78 9.5E-01 
Low vs. IVV 
extracellular region 259 5.5E-05* 
intrinsic component of plasma membrane 102 3.3E-03* 
extracellular space 96 3.7E-03* 
integral component of plasma membrane 98 3.8E-03* 
extracellular region part 219 8.3E-03* 
extracellular matrix 38 2.0E-02* 
extracellular organelle 152 1.2E-01 
cell surface 48 1.2E-01 
lipid particle 10 1.3E-01 
extracellular vesicle 152 1.3E-01 
1 Count indicates the number of genes represented in each gene 
ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  






Table 3-14. The top ten molecular function gene ontology terms from genes 
differentially expressed. 
Term Count1 FDR2 
High vs. Low 
potassium channel activity 5 5.3E-01 
cation channel activity 8 5.5E-01 
purinergic nucleotide receptor activity 3 5.5E-01 
nucleotide receptor activity 3 5.5E-01 
inorganic cation transmembrane transporter activity 10 5.6E-01 
gated channel activity 8 5.7E-01 
molecular transducer activity 29 5.7E-01 
receptor activity 29 5.7E-01 
receptor binding 12 6.0E-01 
purinergic receptor activity 3 6.2E-01 
High vs. IVV 
carboxylic ester hydrolase activity 9 5.9E-01 
growth factor binding 5 5.9E-01 
channel activity 21 6.0E-01 
passive transmembrane transporter activity 21 6.0E-01 
endopeptidase regulator activity 11 6.0E-01 
integrin binding 5 6.1E-01 
calcium-activated potassium channel activity 4 6.2E-01 
protein complex binding 15 6.2E-01 
metal ion transmembrane transporter activity 19 6.3E-01 
peptidase inhibitor activity 11 6.3E-01 
Low vs. IVV 
cation transmembrane transporter activity 53 2.2E-02* 
secondary active transmembrane transporter activity 27 3.4E-02* 
ligand-gated ion channel activity 18 3.7E-02* 
ligand-gated channel activity 18 3.7E-02* 
calcium ion binding 55 3.9E-02* 
active transmembrane transporter activity 36 4.0E-02* 
channel activity 41 4.1E-02* 
passive transmembrane transporter activity 41 4.1E-02* 
peptidase regulator activity 23 4.6E-02* 
peptidase inhibitor activity 21 4.8E-02* 
1 Count indicates the number of genes represented in each gene ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  FDR 







Table 3-15. The top ten KEGG pathway terms from genes differentially 
expressed in each analysis. 
Term Count1 FDR2 
High vs. Low 
Cell adhesion molecules (CAMs) 6 6.0E-01 
Hippo signaling pathway 6 7.9E-01 
High vs. IVV 
Protein processing in endoplasmic reticulum 14 4.3E-01 
Protein digestion and absorption 9 4.3E-01 
MAPK signaling pathway 16 6.0E-01 
Regulation of actin cytoskeleton 14 6.5E-01 
PPAR signaling pathway 7 6.6E-01 
Insulin resistance 9 7.2E-01 
Lysosome 9 7.4E-01 
Vasopressin-regulated water reabsorption 5 7.7E-01 
Transcriptional misregulation in cancer 10 7.9E-01 
PI3K-Akt signaling pathway 17 8.0E-01 
Low vs. IVV 
Neuroactive ligand-receptor interaction 36 3.7E-03* 
Type I diabetes mellitus 10 8.6E-02 
Histidine metabolism 7 1.0E-01 
Cell adhesion molecules (CAMs) 19 1.7E-01 
Complement and coagulation cascades 12 2.0E-01 
Cholinergic synapse 15 2.9E-01 
Protein digestion and absorption 12 2.9E-01 
PI3K-Akt signaling pathway 31 3.2E-01 
Graft-versus-host disease 7 3.4E-01 
PPAR signaling pathway 10 3.6E-01 
1 Count indicates the number of genes represented in each gene 
ontology term. 
2 FDR-corrected p-values less than 0.05 were considered significant.  








Table 3-16.  Genes with differentially expressed with a differentially methylated tile within 5,000 bp 
in the HA vs LA blastocysts. 
 Methylation Gene Expression 





FDR3 FC4 FDR4 
ADGRF1 
7 41842401 -4985 36.29 3.00E-21 0.01 1.40E-02 
(ENSSSCG00000001726) 
CCND2 
5 66113001 1476 27.06 2.20E-08 0.03 3.10E-02 
(ENSSSCG00000038694) 
SPATA17 
10 7797201 -218 -31.3 1.30E-15 0.03 3.00E-02 
(ENSSSCG00000029778) 
TMEM86B 
6 59428101 -2016 31.14 5.80E-05 0.03 2.90E-02 
(ENSSSCG00000003302) 
1 Chr and start refers to the chromosome location of the tile that was differentially methylated.   
2 Distance to TSS is the distance to the gene’s transcription start site, where a negative number is 
the number of bases before the transcription start site and a positive number is the number of bases 
after the transcription start site.   
3 Diff in Methyl is the difference in percent methylation of the tile comparing high to low apoptosis 
samples with the associated FDR corrected P-value.  
4 Fold change is the fold change gene expression level based on RPKM values comparing high to 











Table 3-17.  Genes with differentially expressed with a differentially methylated tile within 5,000 bp 
in the HA vs IVV blastocysts. 
 Methylation Gene Expression 





FDR3 FC4 FDR4 
ACTC1 
(ENSSSCG00000004803) 
1 136276901 -4119 -31.00 2.3E-53 0.37 8.3E-08 
AUTS2 
(ENSSSCG00000007727) 
3 13563601 -1739 26.30 7.7E-14 5.08 2.2E-02 
GIP 
(ENSSSCG00000026330) 
12 25162201 3971 26.86 1.2E-20 3.00 5.0E-03 
LPL 
(ENSSSCG00000040631) 
14 4106601 1789 26.31 4.4E-34 4.06 4.3E-02 
MYOZ1 
(ENSSSCG00000010304) 
14 76455201 -2256 40.30 1.7E-39 3.79 1.9E-02 
TDRKH 
(ENSSSCG00000027770) 
4 97418501 2563 32.60 5.8E-116 4.45 3.5E-08 
TMEM126A 
(ENSSSCG00000025187) 
9 19572001 -4199 32.35 2.0E-104 0.47 2.1E-07 
TRA2B 
(ENSSSCG00000030225) 




886 33.38 6.6E-15 
7.51 1.1E-02 3086 44.24 2.0E-46 
3186 29.86 2.1E-16 
(ENSSSCG00000015664) 9 67932501 -793 28.04 6.5E-36 3.86 6.9E-04 
(ENSSSCG00000032383) 2 150558101 -3182 26.90 3.7E-19 4.24 8.4E-03 
(ENSSSCG00000013387) 2 44250801 -1749 26.64 3.2E-12 4.68 1.0E-02 
1 Chr and start refers to the chromosome location of the tile that was differentially methylated.   
2 Distance to TSS is the distance to the gene’s transcription start site, where a negative number is the 
number of bases before the transcription start site and a positive number is the number of bases after 
the transcription start site.   
3 Diff in Methyl is the difference in percent methylation of the tile comparing high to low apoptosis 
samples with the associated FDR corrected P-value.  
4 Fold change is the fold change gene expression level based on RPKM values comparing high to low 







Table 3-18.  Genes with differentially expressed with a differentially methylated tile within 5,000 bp 
in the LA vs IVV blastocysts. 
 Methylation Gene Expression 





FDR3 FC4 FDR4 
C2 
(ENSSSCG00000001422) 
7 24024901 4313 27.90 4.4E-08 2.73 9.5E-05 
COL5A2 
(ENSSSCG00000016035) 
15 93758701 -12 -26.71 1.3E-09 3.64 2.5E-02 
LGALS2 
(ENSSSCG00000021728) 
5 10234001 -3672 36.75 1.2E-20 17.01 1.4E-04 
MYOZ1 
(ENSSSCG00000010304) 
14 76455201 -2256 35.54 1.2E-16 6.82 2.9E-04 
PRXL2B 
(ENSSSCG00000026554) 
6 64434101 1809 35.27 1.1E-10 7.04 4.0E-02 
RSAD2 
(ENSSSCG00000008648) 
3 1.29E+08 3810 29.48 6.5E-16 2.06 1.3E-02 
TNNT3 
(ENSSSCG00000031903) 
2 1306601 4295 25.54 4.9E-07 10.87 6.5E-04 
TSSK2 
(ENSSSCG00000010113) 14 50943901 886 25.22 3.1E-08 6.18 2.0E-02 
1 Chr and start refers to the chromosome location of the tile that was differentially methylated.   
2 Distance to TSS is the distance to the gene’s transcription start site, where a negative number is 
the number of bases before the transcription start site and a positive number is the number of bases 
after the transcription start site.   
3 Diff in Methyl is the difference in percent methylation of the tile comparing high to low apoptosis 
samples with the associated FDR corrected P-value.  
4 Fold change is the fold change gene expression level based on RPKM values comparing high to 
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Figure 3-1. Annotation of tiles.  Panel A indicates the percent of all tiles analyzed that 
fell within promoters (black), exons (pink), introns (green), intergenic regions (blue), and 
regions that were not annotated (grey).  Panel B only includes the tiles that were 





























Figure 3-2. Global methylation patterns of average percent methylation of all tiles 





























































































































Figure 3-3. Fraction of tiles methylated at varying levels of methylation.  The fraction of 
tiles in each sample that are methylated from 0-20% (red), 20-40% (orange), 40-60% 
(yellow), 60-80% (green), and 80-100% (blue).  Samples are grouped by sample type; 





















































Figure 3-4. The number of differentially methylated tiles in each analysis.  The number 
of tiles at least 25% differentially methylated in the high (n = 13) vs low (n = 12), high vs 
IVV (n = 11), and low vs IVV analyses shown in red, blue, and yellow, respectively.  
Hypomethylated tiles refer to tiles with lower methylation levels in the first group of the 
analysis compared to the second group.  Conversely, hypermethylated tiles refers to tiles 












Figure 3-5. Venn diagram depicting similarities and differences in differentially 
methylated tiles from each analysis.  Values in the uniquely blue, green, and orange 
segments indicate tiles that were uniquely differentially methylated in the high vs low, 
low vs IVV, and high vs IVV analysis, respectively.  Overlapping segments represent the 












   
 
Figure 3-6. Principal component analyses of gene expression analysis. Panel A includes 
all tiles analyzed while panel B includes only differentially methylated tiles.  High 
apoptosis, low apoptosis, and in vivo embryos are plotted in blue circles, green triangles, 
and grey squares, respectively.  No unit variance scaling is applied to rows.  SVD with 
imputation is used to calculate principal components.  X and Y axis show principal 
component 1 and 2, respectively.  Prediction ellipses are such that with a probability of 











Figure 3-7. Heat map and clustering analysis of a representative sub-set of all tiles 
analyzed for DNA methylation patterns.  Rows (1197 tiles) had no unit variance scaling 
applied.  Columns (N = 36) are clustered using correlation distance and average linkage.  
High apoptosis are represented in hierarchical clustering by blue, low apoptosis by green, 








Figure 3-8. Heat map and clustering analysis of a representative sub-set of the 
differentially methylated tiles identified as differentially methylated in at least one of the 
analysis; high vs low, high vs IVV, or low vs IVV.  Rows (1200 genes) had no unit 
variance scaling applied.  Columns (N = 36) are clustered using correlation distance and 
average linkage.  High apoptosis are represented in hierarchical clustering by blue, low 
apoptosis by green, and in vivo by grey.  Red, yellow, and blue in the heat map indicates 





































Figure 3-9. The number of differentially expressed genes in each analysis.  The number 
of genes differentially expressed with a fold-change greater than 1.5 and FDR-corrected 
p-value less than 0.05 comparing high apoptosis (n = 13) to low apoptosis (n = 12) 
samples, high apoptosis to in vivo embryos (n = 10), and low apoptosis to in vivo 
embryos indicated by red, blue, and yellow bars, respectively.  Genes with increased 
expression showed increased RPKM counts in the first sample type compared to the 
second sample type of the comparison, while genes with decreased counts showed 









Figure 3-10. Venn diagram depicting similarities and differences in differentially 
expressed genes from each analysis.  Values in the uniquely blue, green, and orange 
segments indicate genes that were uniquely differentially expressed in the high vs low, 
low vs IVV, and high vs IVV analysis, respectively.  Overlapping segments represent the 














    
Figure 3-11. Principal component analyses of gene expression analysis. Panel A includes 
all genes analyzed while panel B includes only differentially expressed genes.  High 
apoptosis, low apoptosis, and in vivo embryos are plotted in blue circles, green triangles, 
and grey squares, respectively.  No unit variance scaling is applied to rows.  SVD with 
imputation is used to calculate principal components.  X and Y axis show principal 
component 1 and 2, respectively.  Prediction ellipses are such that with a probability of 


















Figure 3-12. Heat map and clustering analysis of a representative sub-set of all genes 
analyzed for gene expression patterns.  Rows (1192 genes) had unit variance scaling 
applied.  Columns (N = 35) are clustered using correlation distance and average linkage.  
High apoptosis are represented in hierarchical clustering by blue, low apoptosis by green, 
and in vivo by grey.  Red, yellow, blue in the heat map indicates ln(x+1) transformed 










Figure 3-13. Heat map and clustering analysis of a representative sub-set of the 
differentially expressed genes identified as differentially expressed in at least one of the 
analysis; high vs low, high vs IVV, or low vs IVV.  Rows (1198 genes) had no unit 
variance scaling applied.  Columns (N = 35) are clustered using correlation distance and 
average linkage.  High apoptosis are represented in hierarchical clustering by blue, low 
apoptosis by green, and in vivo by grey.  Red, yellow, and blue in the heat map indicates 


































































































































































































































































































































































































Figure 3-14. Correlation between RPKM values and percent methylation of genes found 
to be differentially expressed with at least one differentially methylated tile within 5,000 
bp of the transcription start site in at least one of the comparisons: high vs low, high vs 
IVV, or low vs IVV. Blue dots are high apoptosis samples.  Green dots are low apoptosis 
samples.  And black dots are IVV samples.  Linear regression lines are shown with 






Supplemental Tables and Figures 
Supplemental Table 3-1. RRBS library 






Sample Adapter Index 
L1 17 GTAGAG 
L2 28 CAAAAG 
L3 31 CACGAT 
L4 34 CATGGC 
L5 37 CGGAAT 
L6 40 CTCAGA 
L7 43 TACAGC 
L8 17 GTAGAG 
L9 28 CAAAAG 
L10 31 CACGAT 
L11 34 CATGGC 
L12 37 CGGAAT 
L13 40 CTCAGA 
H1 24 GGTAGC 
H2 29 CAACTA 
H3 32 CACTCA 
H4 35 CATTTT 
H5 38 CTAGCT 
H6 41 GCGCTA 
H7 44 TATAAT 
H8 24 GGTAGC 
H9 29 CAACTA 
H10 32 CACTCA 
H11 35 CATTTT 
H12 38 CTAGCT 
H13 41 GCGCTA 
IVV1 26 ATGAGC 
IVV2 30 CACCGG 
IVV3 33 CAGGCG 
IVV4 36 CCAACA 
IVV5 39 CTATAC 
IVV6 42 TAATCG 
IVV7 26 ATGAGC 
IVV8 30 CACCGG 
IVV9 33 CAGGCG 
IVV10 36 CCAACA 
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Supplemental Figure 3-1. Histogram of distance to transcription start site of tiles 
differentially methylated in each analysis.  The farthest downstream tile was 9,565,509 
base pairs from the TSS while the farthest upstream tile was 19,920,929 base pairs 











ACTIVE CASPASE ACTIVITY AS AN INDICATOR OF EMBRYO QUALITY IN 
BOVINE SCNT BLASTOCYSTS 
 
Abstract 
 Somatic cell nuclear transfer (SCNT) remains highly inefficient and therefore 
expensive due to the number of embryos that must be transferred in order to achieve a 
live and surviving offspring.  Increasing the efficiency of the technology by being able to 
select the embryos most likely to succeed following transfer would allow for the 
increased use of the technology in the animal agriculture industry.  We hypothesize that 
incidence of apoptosis in blastocysts could serve as a useful biomarker of those embryos 
which will be most successful following transfer due to their proper epigenetic 
reprogramming resulting in appropriate gene expression and low levels of apoptosis.  
Conversely, the blastocysts likely to fail following embryo transfer will have increased 
incidence of apoptosis as a result of aberrant epigenetic reprogramming and gene 
expression.  SR-FLICA, a non-toxic, non-invasive caspase activity reporter to measure 
the incidence of apoptosis could serve as the necessary biomarker to identify the most 
competent embryos.  In this study, the correlation between cell number and incidence of 
apoptosis and gene expression patterns based on incidence of apoptosis were evaluated in 
day 7 bovine SCNT blastocysts.  Additionally, day 7 blastocysts were transferred to 
recipient females for evaluation of pregnancy establishment and pregnancy associated 
glycoprotein (PAG) concentration as they relate to SR-FLICA staining intensity.  A 
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significant correlation was identified between incidence of apoptosis and average cell 
number per blastocysts.  Only one of twenty genes analyzed, KLF4, was differentially 
expressed in blastocysts with high versus low incidence of apoptosis.  But no genes 
showed a correlation between FLICA score and log2 fold change gene expression.  
Finally, while SR-FLICA did not hinder pregnancy rates, apoptosis score was not an 
indicative measure for pregnancy establishment or PAG concentration on day 29 to 33 of 
gestation.  In conclusion, SR-FLICA was not toxic to embryos, but neither did it provide 
an accurate prediction of embryo success following transfer when the entire embryo was 
analyzed for incidence of apoptosis.   
 
Introduction 
 Somatic cell nuclear transfer (SCNT) is extremely inefficient at producing live 
and surviving offspring.  While SCNT was first successful in mammals in 1997 with the 
birth of Dolly, the cloned sheep, the first successful use of the technology set the stage for 
inefficiency.  In the creation of Dolly, only 29 of 247 embryos (11.7%) survived to the 
morula or blastocyst stage and these 29 surviving embryos were transferred to 13 total 
recipients with only 1 live birth, representing a 7.7% success rate when calculated as 
percent of live births per recipient (Wilmut et al. 1997).  However, when considering the 
success on a per blastocyst basis, only one of 29 blastocysts resulted in a live birth, 
representing a success rate of 3.4% (Wilmut et al. 1997).  Furthermore, when calculating 
the success rate as the number of live births to the total number of embryos cultured, an 
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even lower success rate is evident with only 0.4% of embryos developing into a living 
offspring (Wilmut et al. 1997). 
 Twenty years following the birth of Dolly, success rates have not increased, 
despite ongoing research in the field to improve the technology.  In a more recent study 
of bovine SCNT, 303 embryos were started in culture of which only 229 (75.6%) began 
embryo development by cleaving into a 2-cell embryo (Wang et al. 2011).  By day 7 of 
development, only 82 (27.1%) had developed into blastocyst stage embryos (Wang et al. 
2011).  Of these, 77 blastocysts were transferred individually and 30, 6, and 4 
pregnancies remained at day 40, 90, and 240 of gestation, respectively (Wang et al. 
2011).  From there, 3 calves were born and only 2 survived to 60-days of age (Wang et 
al. 2011).  A reported success rate of 2.6% represents the number of surviving offspring 
from the total number of transferred blastocysts; however, again factoring in the number 
of embryos that did not even make it to the blastocyst stage of development, the overall 
success rate is even lower where only 0.6% of the created embryos resulted in live and 
surviving offspring.  This study also tested the use of treatment on both donor cells and 
early embryos with 0.01 µM 5-aza-2’-Deoxycytidine and 0.05 µM trichostatin A, 
chemicals that aid in the nuclear reprogramming of the donor cell by partial erasure of 
pre-existing epigenetic marks, and the percent of calves born was significantly increased 
from 3.9% to 20.7% (Wang et al. 2011).  The percent of surviving calves was also 
increased from 2.6% to 13.4%, however the results were not significant (Wang et al. 
2011).  Even with these improvements though, the overall efficiency of the technology 
leaves plenty of room for improvement.  
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 Taken together, these data indicate the continued need to increase SCNT 
efficiency in order to lower costs and make the technology a reality for production 
agriculture.  Current research to increase the efficiency of SCNT focuses on improving 
the nuclear reprogramming of SCNT embryos during early development.  Scientists 
understand that SCNT embryos undergo faulty epigenetic reprogramming (Giraldo et al. 
2009), resulting in aberrant gene expression (Somers et al. 2006).  Altered gene 
expression seems to be random in cloned embryos, with no distinct list of differentially 
expressed genes consistently identified between cloned and control embryos across 
studies, and most differences in gene expression appear to be smaller differences, with 
less than 3% of differentially expressed genes showing more than a four-fold change in 
gene expression compared to in vitro produced embryos (Oback 2008).  Additionally, a 
wide range of gene expression patterns in SCNT embryos suggests that some individual 
SCNT embryos are more similar to in vitro produced embryos than other SCNT embryos 
(Smith et al. 2007).  These findings indicate that within a pool of SCNT embryos, certain 
embryos may be predisposed to have a better chance of surviving to term and providing 
surviving offspring, and this phenomenon could be capitalized on to improve cloning 
efficiency if the high quality embryos could be identified somehow before embryo 
transfer.  
 Following embryo transfer, altered DNA methylation and gene expression 
continue in the fetuses that proceed through development and are often accompanied by 
characteristic abnormalities.  Abnormalities of bovine SCNT pregnancies include 
abnormal placental development, fetal overgrowth or large offspring syndrome, enlarged 
umbilical cord, cardiac enlargement, fatty liver disease, and renal lesions [reviewed in 
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(Chavatte-Palmer et al. 2012)].  Associated with placental developmental abnormalities, 
bovine SCNT pregnancies are also associated with increased maternal circulating 
pregnancy associated glycoproteins (PAGs) concentrations on day 62 of gestation 
(Constant et al. 2011). PAGs are a family of proteins produced by binucleated giant cells 
of the placenta.  PAGs serve as a pregnancy marker in cattle because they are exclusively 
produced in the placenta and are then transferred to the maternal circulation.  Maternal 
circulating PAG concentration on day 31 of gestation indicates the probability of late 
embryonic loss, where cows likely to lose the pregnancy between day 31 and 59 of 
gestation had decreased circulating levels of PAGs (Pohler et al. 2016).  If increased 
caspase activity on day 7 of development indicated increased abnormalities in the 
developing embryo, high caspase activity could be an early biomarker of future placental 
abnormalities and increased PAG concentrations.  Conversely, a blastocyst with low 
caspase activity could serve as a biomarker of normal placental development and normal 
PAG concentration.   
 Most current methods to assess embryo quality rely on visual assessment of the 
embryos during development. One indicator of superior embryo quality is the time 
required to cleave from one cell into two cells where faster cleavage indicates embryos 
more likely to develop to the blastocyst stage of development (Isom et al. 2012).  Current 
non-invasive methods to evaluate blastocyst quality rely on morphological assessment, 
which is known to be subjective (Rocha et al. 2016).  A more quantitative method of 
morphological assessment is the number of cells in a blastocyst, as increased cell 
numbers are correlated with increased embryo quality (Matsuura et al. 2010).  More 
invasive methods of analysis include analysis of the integrity of blastomere membranes, 
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analysis of embryo metabolism, measurement of cellular respiration, and electron-
microscopy analysis- all of which can either damage or kill the embryo or are cost 
prohibitive (Rocha et al. 2016).  Because there is no optimized embryo quality metric for 
selecting SCNT embryos, strategies are typically taken to simply enhance the probability 
of a live birth.  These include performing a large number of transfers if only one 
blastocyst is transferred to each surrogate, such as in cattle where multiple offspring 
could be a complication during pregnancy and parturition, or by transferring a large 
number of blastocysts to each surrogate, such as in pigs where multiple pregnancies are 
not a problem in the litter bearing species.  By developing a non-invasive assay to select 
the high quality blastocysts, the efficiency of SCNT could be improved by not wasting 
resources in order to hedge bets that a successful pregnancy will develop. 
 A novel indicator of embryo quality could be through the detection of apoptosis.  
Apoptosis has been detected in embryos of numerous species including pigs (Hao et al. 
2003), cattle (Fahrudin et al. 2002), and humans (Hardy et al. 1989).  Apoptosis appears 
to be a normal part of embryo development, as apoptosis has been detected in in vivo 
produced embryos (El-Shershaby and Hinchliffe 1974).  Additionally, bovine SCNT 
embryos show earlier and increased levels of apoptosis compared to in vitro produced 
controls and the apoptosis continued as development continued in SCNT embryos (Park 
et al. 2004).  We hypothesize that apoptosis can be detected non-invasively through 
staining to quantify active caspase molecules to identify the blastocysts most likely to 
develop to term.  We believe that the blastocysts with low caspase activity will have 
undergone proper nuclear reprogramming leading to proper gene expression and low 
levels of apoptosis.  Conversely, the blastocysts that have undergone altered nuclear 
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reprogramming resulting in aberrant gene expression will show increased levels of 
caspase activity and will fail following embryo transfer.  
 In this experiment, the ability of SR-FLICA (a non-toxic, non-invasive caspase 
activity reporter; Immunochemistry Technologies, Bloomington, MN) to successfully 
predict the day 7 bovine SCNT embryos which will establish pregnancies was validated.  
Additionally, the non-toxic nature of SR-FLICA on live embryos was confirmed through 
embryo transfers following staining and the resulting pregnancies.  Pregnancy status will 
be diagnosed by ultrasound between day 29 and 33 of gestation.  A blood sample was 
collected to analyze the connection between early apoptosis and circulating PAG 
concentrations.  Embryo quality metrics was also evaluated by staining day 7 blastocysts 
with SR-FLICA then determining embryo cell number and gene expression patterns.   
 
Materials and Methods 
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) 
unless otherwise noted.  All procedures performed with animals were in agreement with 
principles of animal welfare as approved by the veterinary staff and Institutional Animal 
Care and Use Committee at Utah State University (IACUC protocol #2303). 
 
Oocyte Collection and Maturation 
Bovine ovaries were collected from a local abattoir and transported to the 
laboratory in 0.9% saline solution.  Oocytes were aspirated using a vacuum system from 
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follicles with a 3-8 mm diameter.  Only oocytes with compact cumulus-oocyte complexes 
(COCs) were saved.  Once isolated, COCs were cultured in TCM199 maturation medium 
with Earle’s salts, L-glutamine, and sodium bicarbonate (Hyclone, Logan, Utah) 
supplemented with 10% fetal bovine serum (FBS), 0.05 mg/ml bovine follicle stimulating 
hormone (Sioux Biochemicals, Sioux city, IA), 5 mg/ml bovine luteinizing hormone 
(Sioux Biochemicals), 100 U/ml penicillin, and 100 mg/ml streptomycin at 39 °C with 
5% CO2 for 22 to 24 hr.  
 
Somatic cell nuclear transfer embryo production 
Primary somatic cell cultures were created using well-established procedures 
(Aston et al. 2009). From frozen stocks, thawed cells, passage 4-5, were grown to 80-
100% confluence for use as nuclear donors.  Eight hours prior to cloning, 20 µg/mL α-
amanatin was added to donor cell culture.  SCNT was performed as previously reported 
(Aston et al. 2009).  Briefly, oocytes with a first polar body were isolated and used for 
SCNT.  Fusion of the donor occurred first through electrical stimulation of one DC pulse 
of 2.2 kV/cm for 25 µS in mannitol fusion medium (Wells et al. 1999).  After fusion, 
embryos were placed in SOFaa medium with 3% FBS for 1.5 hours to allow for 
activation.  Next, chemical activation by treatment with 5 µM ionomycin for 5 minutes 
followed by a 4 hour treatment of 10 µg/ml cycloheximide.  Following activation, 
embryos were cultured under mineral oil in 50 µL drops of SOFaa (Holm et al. 1999) 
with 3% FBS on a single layer of bovine cumulus cells. The embryos were cultured at 
39˚C at 100% humidity with 5% CO2.  Every other day beginning the day after 
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activation, 25 µL of the SOFaa medium was replaced with fresh medium.  Embryos used 
in cell count and gene expression experiments used the same cell line throughout the 
experiment, unlike the transfer experiments which used multiple cell lines.   
 
SR-FLICA and Hoechst 33342 Staining 
 SR-FLICA was resuspended as recommended by the manufacturer.  Briefly, 50 
µL DMSO was added to one vial SR-FLICA. Embryos were stained in 500 µL SOFaa 
culture media with 2 µL reconstituted SR-FLICA for 2 hours in the incubator.  Embryos 
were moved to a fresh 500 µL SOFaa and placed back in the incubator for 30 minutes.  
Embryos used for cell count analysis were then stained with Hoechst 33342 to visualize 
nuclei in order to count number of cells, but all other embryos were only stained with SR-
FLICA. Embryos were stained in 1 mg/ml of Hoechst 33342 for 10 minutes in the 
incubator.  Embryos were then washed in SOFaa and transferred to individual 10 µL 
SOFaa droplets under mineral oil for fluorescent microscopy. 
 
Microscopy and Image Analysis 
 Individual embryos were imaged at the 10X objective using the Zeiss Axio 
Observer.Z1 (Carl Zeiss Microscopy; Thornwood, NY).  Fluorescent images of SR-
FLICA (excitation 550-580 nm, emission 590-600 nm) stained embryos were captured 
with an axiocam HRc (Carl Zeiss Microscopy) creating a black and white image and 
color was artificially added using Zen software (Carl Zeiss Microscopy; v. 2.0) where  
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SR-FLICA was assigned a red color.  SR-FLICA images had a 1 second exposure time 
and light excitation intensity remained constant between embryos for accurate 
comparisons of incidence of apoptosis.  SR-FLICA staining intensity was analyzed using 
Adobe Photoshop (v. 2017.1.1.20174025) to determine the average pixel intensity within 
the space of the zona pellucida of the embryo.  In blastocysts that were hatching, both the 
space inside the zona pellucida and the hatching extrusion was included in the analysis.    
 
Cell Counts 
Day 7 SCNT blastocysts were stained with SR-FLICA and Hoechst 33342.    
Embryos were analyzed for levels of apoptosis using SR-FLICA staining and subsequent 
analysis.  Blastocysts were then mounted onto slides for counting of nuclei.  In 3 
replicates, day 7 SCNT embryos (n = 26) were fixed following SR-FLICA imaging and 
cell numbers were counted to determine if there was a correlation between incidence of 
apoptosis and cell number on day 7 of development.  Additionally, embryos were 
classified as high (n = 7) or low (n = 6) incidence of apoptosis and average cell number 
was compared between groups using a student’s t-test for statistical analysis.  Both 
correlation analysis and t-test were performed using GraphPad Prism (version 8.0.1; 




Gene Expression Analysis 
Following 4 cloning sessions, embryos developed to day 7.  Blastocysts were 
stained with SR-FLICA and average red pixel intensity was calculated.  Blastocysts were 
stored at -80°C until RNA extraction could be performed.  RNA extraction and cDNA 
conversion was performed on individual blastocysts as reported previously in individual 
oocytes (Cox et al. 2015).  Briefly, RNA was isolated using the Quick RNA Micro Prep 
kit (Zymo Research; Irvine, CA) following manufacturer instructions except the final 
elution was performed using 20 µL DNase/RNase-free water.  RNA was converted to 
cDNA using the GoScript Reverse Transcriptase System (Promega; Madison, WI) again 
with minor modifications to the manufacturer’s protocol.  8 µL of RNA was combined 
with 1 µL of oligo primers and 1 µL of random primers and water was then left out of the 
reverse transcription reaction mix; otherwise the reaction was performed as per the 
manufacturer’s protocol.   
 Gene expression analysis was performed through qPCR using the Fluidigm 
(South San Francisco, CA) 96.96 Dynamic Array™ IFC for gene expression and 48.48 
Dynamic Array™ IFC for gene expression.  The 96.96 platform follows standard PCR 
chemistry in nanoliter-scale reactions to evaluate 96 genes for each of 96 samples using 
the 96.96 Dynamic Array integrated fluidic circuit (IFC) chip.  Similarly, the 48.48 
platform allows for the evaluation of 48 genes for each of 48 samples.  Gene categories 
evaluated include apoptosis (BAX, BID, and TP53), epigenetic regulation (ASH2L, 
DNMT3A, DNMT3B, HDAC1, HDAC2, HDAC3, and KDM3A), imprinted genes (GNAS, 
GRB10, IGF2R, and UBE3A), pluripotency (KLF4, LIN28, POU5F1, and SOX2), 
trophoblast differentiation and function (ETS2), and housekeeping (EIF4A1, GAPDH, 
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HSP90, TAF11, and YWHAZ).  A small number of apoptosis genes were selected as 
previous studies in bovine blastocysts found that genes related to apoptosis were not 
reliable markers of apoptosis as their expression levels did not change with the induction 
of apoptosis (Vandaele et al. 2008).  Fluidigm Corporation’s DeltaGene assay design 
service designed custom primers based on NCBI’s reference sequence for cattle.  Gene 
names and PCR primer sequence for each gene symbol can be found on Supplementary 
Table 4-5 and 4-6, respectively.   
 To perform quantitative PCR gene expression analysis using the Biomark system, 
Fludigm’s protocol (PN 68000130) was followed.  Specific target amplification was 
performed to each sample before qPCR by creating a 200 nM primer mix by pooling 1 
µL of each combined forward and reverse primer set (20 µM each).  The specific target 
amplification is performed by combining 1.25 µL of the pooled primer mix, 2.5 µL of 
TaqMan PreAmp Master Mix (Applied Biosystems; Foster City, CA) and 1.25 µL of 
cDNA.  The polymerase is activated at 95°C for 10 minutes and then the reaction is 
amplified for 14 cycles of 95°C for 15 seconds then 60°C for 4 minutes.  The reaction is 
then treated with Exonuclease I (ExoI; New England Biolabs; Ipswich, MA) to remove 
any primers that were not integrated in the specific target amplification.  The ExoI 
treatment added 1.4 µL of water, 0.2 µL of ExoI reaction buffer, and 0.4 µL ExoI enzyme 
to each specific target amplification reaction.  The reactions were incubated at 37°C for 
30 minutes to allow for complete digestion of the non-integrated primers.  Then, 
reactions were inactivated at 80°C for 15 minutes.  Following ExoI treatment, each 
reaction was diluted 5-fold to a total volume of 25 µL.  Reactions were stored at -20°C 
until further gene expression analysis was performed.   
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 Next, individual sample and primer solutions were prepared for qPCR.  Two 
microliters of the diluted specific target amplification were combined with 2.5 µL of  2X 
TaqMan Gene Expression Master Mix (Applied Biosystems), 0.25 µL of 20x DNA 
binding dye sample loading reagent (Fluidigm), and 0.25 µL of 20X EvaGreen DNA 
Binding Dye (Biotium; Hayward, CA). Samples were run in duplicate on one chip and 
individually on a second chip for technical replication. Primer mixes were made by 
combining 2.25 µL of each primer (20 µM) with 2.5 µL of 2x Assay loading reagent 
(Fluidigm) and 0.25 µL water.  Primers were ran in duplicate for technical replication on 
both chips.  The IFC chip was primed prior to loading samples and primers using the 
Prime Script (136X) of the HX IFC controller.  Once priming was complete, 5 µL of each 
primer mix and 5 µL of each sample mix were pipetted into their correct inlets on the 
chip.  The chip was again inserted into the IFC controller and the samples and primers 
were loaded into the chip using the Load Mix Script (136X) so that the samples and 
primers were moved into the reaction chambers.  After the chip was loaded, the chip was 
placed in the BioMark thermal cycler for quantitative PCR where cycles consisted of 5 
minutes of enzyme activation at 95°C, followed by 35 cycles of 95°C for 15 seconds then 
60°C for 60 seconds for denaturation and extension, and finished with a three minute 
final extension cycle at 60°C.  Following PCR amplification, a melt curve analysis was 
performed to assess the quality of each product.  Each gene was run in duplicate on the 
chip yielding two reactions of each sample and primer.   
 Analysis of qPCR data was performed using the Fluidigm Real-Time PCR 
Analysis Software (v 4.3.1).  Using a positive control sample as reference and a 
combined pool of all housekeeping genes as normalizer samples and assays, respectively, 
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ΔΔCT values were calculated.  While 24 different primers were run on the Fluidigm chip, 
4 primers (BAX, DNMT3B, SOX2, and ETS2) did not work in the positive control sample 
and were therefore not analyzed.  Twenty genes were analyzed for correlation between 
apoptosis score and gene expression, as well as, difference in expression between high 
and low apoptosis embryos.  Statistical analysis was performed in Graphpad Prism 
through correlation analysis and student’s t-test to analyze log2 fold change values for 
each group type.  Student’s t-test was performed on the averaged log 2-fold change 
values from the six technical replicates.  Samples where at least 3 of the 6 technical 
replicates did not work were not included in downstream analyses.  Because not all 
reactions worked properly, the number of samples analyzed in the correlation analysis 
and for each group of the high vs low analysis has been provided in Supplementary Table 
4-3 and 4-4, respectively.  All p-values were corrected for  false discovery rate (FDR) as 
described by Benjamini and Hochberg (Benjamini and Hochberg 1995).  
Principal component analysis and hierarchical clustering was analyzed through an 
unsupervised hierarchical clustering created through the ClustVis program using ΔΔCT 
values from the 6 technical replicates (Metsalu and Vilo 2015).  ΔΔCT values for each 
sample and gene analyzed were uploaded into the program.  No unit variance scaling was 
applied to each gene and singular value decomposition with imputation was used to 
calculate principal components.  Imputation was used for missing value estimations.  





 Embryo transfers were performed after 4 cloning sessions with a total of 98 
transferred blastocysts.  Because this study took advantage of a cloning system in place to 
produce cloned bulls for a client, multiple cell lines were used (n = 5).  In addition, some 
embryos were created from donor cells treated with α-amanatin (n = 72) and some were 
not (n = 26) – this was a side experiment to analyze the effectiveness of the treatment to 
increase cloning success, results of which will not be discussed here.  To ensure that the 
SR-FLICA was not having a negative impact on embryonic development, some embryos 
were stained and analyzed (n = 64) and some were left as controls (n = 34).  All factors 
were included in statistical analysis, as discussed below.  The cell line, α-amanatin 
treatment, SR-FLICA staining, apoptosis score, and pregnancy diagnosis for each 
transferred embryo can be found in Supplemental Table 4-8.   
 Cows were synchronized for embryo transfer.  Nine days prior to SCNT, EAZI-
BREED CIDRs (Zoetis Animal Health; Parsippany, NJ) were placed vaginally in the 
cows and remained in place for 7 days.  Concurrent to CIDR placement, an injection of 
25 mg Lutalyse® (Zoetis Animal Health) was administered IM. Seven days later, the 
CIDRs were removed and heat detection patches were placed on the tail head of the 
cattle.  Two days after, on the day of SCNT, GnRH was administered through 100 mcg of 
Cystorelin® (Boehringer Ingelheim International Gmbh; Germany) IM and estrous 
behavior was detected by checking of the heat detection patch.  Embryo transfers were 
performed a week later on day 7 of embryonic development.  
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 On day 7 of development, a subset of blastocysts were stained with SR-FLICA 
and analyzed as described above.  All blastocysts were then loaded individually into 
0.25cc artificial insemination straws and transported to the farm in a portable incubator 
maintained at 39°C.  Cows were administered an epidural by veterinarians to minimize 
rectal movement.  Ovaries were palpated by a veterinarian to identify which ovary had a 
corpus luteum and check the size of the corpus luteum to ensure adequate tissue 
prevalence for proper progesterone levels.  A pipette containing the blastocysts was then 
passed through the vagina and cervix; the blastocyst was deposited into the uterine horn 
on the same side as the corpus luteum.   
 Establishment of pregnancy was diagnosed by the same veterinarian on day 29 to 
33 of gestation through ultrasound.  At that time, a blood sample was collected in a 
vacutainer tube through venipuncture.  The blood sample was allowed to clot at room 
temperature for at least 1 hour.  Serum was isolated through centrifugation at 3,000 x g 
for 20 min at 4°C.  Serum was collected and stored at -20°C until PAG concentration was 
measured.   
 Pregnancies from high and low apoptosis blastocysts (n = 11 each) were 
monitored throughout gestation and pregnancy survival was plotted.  At the time of 







 PAG analysis was generously provided by the Pohler lab at Texas A&M 
University.  PAG concentration was determined using previously reported methods 
(Pohler et al. 2016).  Briefly, a commercially available test from Idexx Laboratories Inc. 
(Westbrook, ME) was used.  In addition to the test samples, a standard curve, a sample 
from a known pregnant cow at day 60 of gestation, and a sample from a non-pregnant 
cow was included on the plate.  Manufacturer protocol was followed.   
 
Statistical Analysis of Embryo Transfer Data 
For statistical analysis of embryo transfer, many factors were included in the 
analysis, although the primary factor of interest focused on SR-FLICA staining compared 
to controls and SR-FLICA scores.  Random factors included cloning session, cell line, 
embryo transfer technician, α-amanatin treatment well (nested in cloning session), and 
SR-FLICA staining well (nested in α-amanatin treatment well).  Fixed factors included 
whether donor cells received α-amanatin treatment and if the embryos were stained with 
SR-FLICA. A binary response model using PROC GLIMMIX in SAS was fit to analyze 
if SR-FLICA staining had an effect on pregnancy outcome.  The same model was then 
used which also accounted for apoptosis score in an ANCOVA model to determine if SR-
FLICA score was predictive of pregnancy outcome.  To determine if SR-FLICA staining 
effected PAG concentration, a Gaussian response model was fit in SAS again using 
PROC GLIMMIX.  Finally, a Gaussian model using PROC GLIMMIX in SAS with an 
206 
ANCOVA model to account for SR-FLICA score was used to determine if SR-FLICA 




 While bovine SCNT blastocysts did show active caspase activity through SR-
FLICA staining (Fig. 4-1), staining patterns were different than previously observed in 
porcine SCNT blastocysts (Supplemental Fig. 4-1).  In the bovine blastocysts, even those 
embryos with high levels of apoptosis showed splotchy areas of red (Fig. 4-1, panel A 
and B), indicating active caspase activity.  The bovine blastocysts that were classified as 
low apoptosis had such low levels of active caspase activity, that the fluorescent image 
appears to be empty as no red is evident (Fig. 4-1, panel C).  In contrast, porcine high 
apoptosis blastocysts have been uniformly red throughout the entire embryo.  
Additionally, even the low apoptosis embryos show some level of active caspase activity.  
 
Cell counts 
 Developmental rates from the three cloning sessions used in cell count analysis is 
found in Supplemental Table 4-1.  On average from the three cloning sessions, blastocyst 
development was 21% of the cleaved embryos. In day 7 bovine SCNT blastocysts (3 
replicates, total n = 26 blastocysts), Fig. 4-2 shows that there was a significant negative 
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correlation between SR-FLICA score and number of cells per blastocyst (P = 0.01).  
However, the fit of a linear regression line did not have a tight fit (r2 = 0.25).   
 Embryos were sorted by incidence of apoptosis and the top and bottom 25% were 
considered high and low apoptosis, respectively.  When the average number of cells in 
high (3 replicates, total n = 7) apoptosis and low (3 replicates, total n = 6) apoptosis 
blastocysts was compared with a Student’s t-test (Fig. 4-3), the low apoptosis blastocysts 
had significantly more cells compared to high apoptosis embryos (P = 0.005) by 23.17 ± 
6.5 cells.  High apoptosis blastocysts had 25.17 ± 3.06 cells while low apoptosis 
blastocysts had 48.33 ± 5.76 cells.  For reference, in vivo produced bovine blastocysts 
typically contain over 100 cells (Enright et al. 2000; Hosoe et al. 2017). 
 
Gene expression analysis 
 Development rates from the four cloning sessions used in the gene expression 
analysis are located in Supplemental Table 4-2.  On average, blastocyst development was 
13.9% of cleaved embryos from the four replicates.   
 Twenty genes were analyzed for the correlation between SR-FLICA score and 
log2 fold change of gene expression.  No genes showed significant correlation between 
incidence of apoptosis and gene expression levels (Fig. 4-4).  Additionally, linear 
regression fit was extremely low, noted by the low r2 values (Fig. 4-4).  The number of 
samples included in the analysis and statistical summary can be found in Supplemental 
Table 4-3. 
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 When the top and bottom 20% of incidence of apoptosis, high and low apoptosis, 
respectively, are compared by gene for gene expression levels, only 1 of twenty genes 
was found to be significantly differentially expressed (Fig. 4-5).  KLF4, a pluripotency 
gene, had significantly increased expression in low apoptosis blastocysts compared to 
high apoptosis blastocysts (FDR corrected P = 0.03).  The other 19 genes analyzed 
showed no difference in gene expression between high and low apoptosis blastocysts. 
 This similar pattern of gene expression in high and low apoptosis blastocysts is 
supported by principal component analysis (PCA, Fig. 4-6) and unsupervised hierarchical 
clustering (Fig. 4-7).  PCA shows overlapping prediction ellipses for high apoptosis and 
low apoptosis blastocysts.  Additionally, the middle apoptosis blastocysts representing 
the middle 60% of incidence of apoptosis overlap with the high and low apoptosis 
blastocysts.  Similar findings are reported in the hierarchical clustering and heat map 
where samples do not segregate based on level of apoptosis and no distinct patterns 
emerge in the heat map based on level of apoptosis.   
 
Embryo Transfers 
Embryo development from cloning sessions used for embryo transfer can be 
found in Supplemental Table 4-7.  On average, 23.3% of the cleaved embryos developed 
to the blastocyst stage.  Statistical analyses accounting for the complicated experimental 
design were performed as described in the methods section.  To address whether SR-
FLICA staining affected pregnancy outcome, a binary response model was fit using 
PROC GLIMMIX in SAS.  There was no evidence of significant staining effect on 
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pregnancy rate (P = 0.544). Pregnancy rate of SR-FLICA stained and unstained embryos 
is shown in Fig. 4-8.  Additionally, the average SR-FLICA score of embryos which 
resulted in a not-pregnant (n = 27) and pregnant (n = 9) recipient is presented in Fig. 4-9.  
A student’s t-test indicated no significant difference (P = 0.23) in average SR-FLICA 
score of embryos resulting in pregnant and not-pregnant recipients.   
 A second model was fit using a binary response model using PROC GLIMMIX in 
SAS, which also accounted for apoptosis score in an ANCOVA model to determine if 
SR-FLICA score was predictive of pregnancy outcome.  This model found a negative but 
non-significant (P = 0.2143) effect of SR-FLICA score (effect estimate -0.01869) on the 
probability of pregnancy.  High apoptosis blastocysts had a non-significant decrease in 
probability of pregnancy (Fig. 4-10) compared to low apoptosis embryos. 
To verify that PAG concentration was predictive of pregnancy, a logistic 
regression model was fit.  There was a clear significant relationship (P = 0.0001) 
indicating a clear relationship between PAG concentration and pregnancy. 
 To determine if SR-FLICA staining affected PAG concentration, a Gaussian 
response model using PROC GLIMMEX in SAS was fit to the study design.  However, 
because so many transfers resulted in no pregnancy being established, the data had a 
zero-inflated mixture distribution because no PAG could be detected in most cases.  No 
transformation could make these data normally distributed, so a two-part model was 
fitted.  The first part of the model was a generalized linear mixed model to predict the 
probability of detecting any PAG level (but only for the observations where a protein 
level amount was reported, even if it was zero).  None of the study design factors were 
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found to be significant predictors in this model.  All random effects in the model had zero 
effect.  The random effects were then dropped from the model.  The remaining fixed 
effects (α-amanitin treatment and SR-FLICA staining) did not have significant effect on 
PAG concentration, P = 0.13 and P = 0.65, respectively.  The second part of the model 
was a generalized linear mixed model for the PAG concentration detected (but only for 
the observations where a non-zero amount was detected).  The data here were 
approximately normally distributed, so no transformation was performed.  In this model, 
it seemed that PAG concentration may have been lowered in the presence of α-amanitin 
treatment, but the difference only trended towards significant (P = 0.09).  Again, the 
random effects in the second part of the model were essentially zero.  Therefore, the 
random effects were dropped resulting in a significant effect of α-amanitin treatment on 
PAG concentration (P = 0.0247).  Together, it appears that there may be some evidence 
that the presence of the treatment results in a significant decrease in the detected PAG 
concentration, with an estimated magnitude difference of 0.299 ng/ml. 
 Finally, a Gaussian model using PROC GLIMMIX in SAS with an ANCOVA 
model to account for SR-FLICA score was used to determine if SR-FLICA score was 
predictive of PAG concentration.  Again, a two-part model was needed due to the PAG 
concentration having a zero-inflated mixture distribution.  In the first part of the model, to 
predict the probability of any non-zero protein detection, there was no significant effect 
found due to the α-amanitin treatment or SR-FLICA score.  Because the random effects 
were found to have zero effect, they were again dropped from the model.  A simple 
ANCOVA model was fit and resulted in a negative but not significant effect of SR-
FLICA score on the probability of PAG detection (effect estimate -0.01647, P = 0.1344).  
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In the second part of the model, for the amount of protein detected among observations 
with non-zero protein level detection, the data were roughly normally distributed so no 
transformation was necessary.  The random effects again were all essentially zero and the 
effects of α-amanitin and SR-FLICA staining on PAG concentrations were non-
significant, (P = 0.17 and P = 0.75, respectively).  Using a simple ANCOVA model for 
the amount of non-zero PAG detected, there was no SR-FLICA score effect (P = 0.8285). 
 Correlation between SR-FLICA score and PAG concentration was analyzed (3 
replicates, total n = 42), disregarding other factors (Fig. 4-11).  No significant correlation 
(P = 0.27) was present and a linear regression line showed poor fit (r2 = 0.03).  High and 
low apoptosis embryos showed no difference in average PAG concentration (Fig. 4-12, P 
= 0.96). 
 A survival plot (Fig. 4-13) indicates the pregnancy survival rate of high and low 
apoptosis blastocysts throughout gestation.  While there was a numerical increase in 
pregnancies established in the low apoptosis group (3 pregnancies established) compared 
to the high apoptosis group (1 pregnancy established), by the end of gestation, only 1 
pregnancy remained in each group.   
 Pregnancy rate by cloning session and cell line are shown in Supplemental Figs. 
4-2 and 4-3, respectively.  However, no statistical analysis was performed on these 
factors.  Rather they served as random effects in the statistical models to analyze effect of 





Scientists recognize the need for a way to identify the most competent cloned 
embryos early in development in order to increase the efficiency of SCNT.  We proposed 
the use of SR-FLICA, a non-toxic and non-invasive caspase activity reporter, to isolate 
those blastocysts that would be most successful following embryo transfer.  While our 
analyses did not produce a method to statistically increase the probability of a cloned 
pregnancy on day 30 of gestation, incidence of apoptosis did serve as an indicator of cell 
number and gene expression of KLF4.  Follow up studies could provide a significant 
increase in overall SCNT efficiency following embryo transfer. 
While the initial aim of the study was to assess apoptosis as a predictor of 
pregnancy establishment using porcine blastocysts, a change was made to use bovine 
blastocysts instead.  Due to challenges with estrus synchronization in pigs, embryo 
transfers were not successful in our relatively small research herd.  Additionally, the time 
requirements to analyze hundreds of blastocysts to transfer multiple embryos per 
recipient was not practical when there is no consequence to transferring large number of 
embryos into a pig.  From there, the most competent embryos will develop while those 
that are not will die off.  Conversely, there is increased risk to a cloned bovine pregnancy 
with more than one developing clone.  Therefore, there is a greater importance in being 
able to select the best embryos when only one embryo will be transferred to each 
recipient.  Therefore, it was decided to perform transfer experiments using the bovine 
rather than porcine model. 
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From previous work assessing apoptosis in porcine SCNT blastocysts, clear 
differences in active caspase activity were apparent compared to the bovine SCNT 
blastocysts.  Porcine blastocysts had overall increased levels of active caspases in both 
the high and low incidence of apoptosis blastocysts compared to their bovine 
counterparts.  This increase in caspase activity could be the result of different culture 
systems as the oocytes are matured and embryos are developed in different species-
specific media.  Previous work analyzing apoptosis in in vivo and in vitro produced 
porcine and bovine blastocysts found an increased level of damaged cells (measured as 
the percent of cells with membrane damage, DNA strand breaks, and fragmented nuclei), 
and found increased damage in bovine blastocysts compared to porcine blastocysts 
(Pomar et al. 2005).  However, different culture systems were used in this study 
compared to our study, which could have resulted in culture systems having differing 
effects on the embryos.  Our bovine system could be a better match to the in vivo 
environment compared to the porcine embryo system, so the bovine blastocysts had 
lower caspase activity compared to the porcine blastocysts.  
Previous unpublished work in our lab has found no significant difference in cell 
number per blastocyst based on caspase activity in porcine parthenogenetic blastocysts.  
Therefore, it was unexpected that a significant correlation was found in bovine SCNT 
blastocysts between incidence of apoptosis and average cell number per blastocysts.  It 
was even more surprising that there was a statistical difference in high and low apoptosis 
bovine SCNT blastocysts average cell number per blastocysts, especially considering that 
far fewer blastocysts were analyzed in the bovine system compared to the porcine system.  
However, these findings do match our original hypothesis that blastocysts with higher 
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caspase activity would be lower quality than those with lower caspase activity. A 
possibility is that these different findings in the porcine and bovine embryos are a result 
of comparing parthenogenetic porcine blastocysts and bovine SCNT blastocysts, or the 
difference could be the result of different culture systems.  Additionally, other studies 
have reported a significant but marginal negative correlation between cell number and 
apoptotic index (Knijn et al. 2003).  The cell count data points to incidence of apoptosis 
being a novel, noninvasive indicator of embryo quality, as lower apoptosis embryos had 
significantly higher number of cells, a known indication of embryo quality (Matsuura et 
al. 2010).   
 Unfortunately, the differences in high and low apoptosis bovine SCNT blastocysts 
are essentially limited to cell number.  Gene expression data found no correlation 
between incidence of apoptosis and relative gene expression.  Additionally, only one of 
twenty genes had significantly different gene expression in high apoptosis compared to 
low apoptosis blastocysts.  While it is interesting that the one differentially expressed 
gene, KLF4, is a gene associated with pluripotency and has increased expression level in 
the low apoptosis embryos compared to the high apoptosis embryos, it is the only one of 
three pluripotency genes that was found to be differentially expressed.  KLF4 is one of 
the four reprogramming factors used in induced pluripotent stem cells (Takahashi and 
Yamanaka 2006).  SCNT blastocysts have lower expression of KLF4 compared to IVF 
blastocysts (Zhou et al. 2013).  While we found increased KLF4 expression in low 
caspase activity blastocysts, previous reports have found that normally developing bovine 
SCNT conceptuses had decreased KLF4 expression compared to abnormal conceptuses 
(Degrelle et al. 2012).  However, other studies have reported increased porcine SCNT 
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embryo development with treatment of vitamin C was associated with increased KLF4 
expression (Huang et al. 2011). 
Overall gene expression profiles across all genes analyzed was not different 
between the high apoptosis and low apoptosis blastocysts, as evident in the PCA and 
hierarchical clustering analysis. In both the PCA and hierarchical clustering analysis, 
there was no clear division of the high and low apoptosis blastocysts.  This data 
contradicts our initial hypothesis that blastocysts with low apoptosis would have 
undergone proper genome reprogramming and have different gene expression compared 
to the high apoptosis blastocysts, as incidence of apoptosis does not appear to have a 
connection to gene expression patterns.   
 The most anticipated portion of these experiments was the results of the embryo 
transfers to validate the use of SR-FLICA as a non-toxic, non-invasive caspase activity 
reporter to select the blastocysts most likely to be successful following SCNT and 
embryo transfer.  While other methods have been commonly used to detect apoptosis in 
embryos (Hardy 1999; Hao et al. 2003), they all require the termination of embryo 
development.  Therefore, the first and perhaps most critical question to answer was if SR-
FLICA staining would hinder the development of blastocysts following transfer.  To our 
best knowledge, this is the first report of using SR-FLICA on viable embryos that were 
not terminated in development at the blastocyst stage.  Fortunately, no significant 
difference in pregnancy rate was obtained from blastocysts that were stained with SR-
FLICA compared to those that were not.  With no evidence that SR-FLICA hinders early 
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embryonic development of pregnancy establishment, active caspase activity could serve 
as a useful biomarker on embryos in future studies. 
 There was also no evidence that SR-FLICA score calculated from the whole 
embryo served as a useful biomarker of pregnancy establishment.  Increased power 
through more SR-FLICA stained embryo transfers could possibly lead to a significant 
finding down the road.  Because of the necessity to also validate the non-toxic nature of 
SR-FLICA, only a portion of the embryos were stained and provided an apoptosis score.  
And of course because these are cloned embryos, very few of these embryos then resulted 
in pregnancy establishment.  So increasing the number of transfers could provide data 
that could find a statistically significant predictive nature of apoptosis score.  Additional 
studies utilizing in vitro produced embryos for transfer could also provide insight through 
more pregnancies established to better understand if apoptosis score has a significant 
effect on pregnancy establishment.   
 However, assuming that increasing observations leads to the same conclusions, 
more questions are raised.  Perhaps the most intriguing question is how blastocysts with 
high levels of active caspase activity are able to continue to develop and establish 
pregnancies just as efficiently as those with low caspase activity?  Previous unpublished 
work in our lab verified the ability of staining with SR-FLICA to identify apoptotic cells 
by also staining the cells with the more commonly used TUNEL stain, which identified 
DNA strand breaks.  Additionally, studies that have used both FLICA and TUNEL to 
detect apoptosis have shown similar detection of percent of cells that are apoptotic 
(Bedner et al. 2000; Wang et al. 2017).  Therefore, the detection of active caspase 
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activity by SR-FLICA does not appear to be in question.  Because apoptosis had 
traditionally been evaluated through methods which involve destroying or killing the 
embryos through fixation, little is known about downstream development.  However, SR-
FLICA provides the opportunity to evaluate live blastocysts and track future development 
in the same embryo without the need to destroy or halt its development.  Therefore, 
future studies are needed to evaluate how these embryos are coping with high levels of 
caspase activity without being destroyed through programmed cell death.   
Another possibility is that SR-FLICA treatment results in a downstream reduction 
in apoptosis.  SR-FLICA covalently binds to the cleavage site of active caspases, making 
the proteins ineffective at carrying out the apoptosis cascade in the cells.  Our staining 
protocol was to expose embryos to 12 µM SR-FLICA (SR-VAD-FMK) for 2 hours.  
Studies using similar fluorescent stains at 10 µM of FAM-VAD-FMK for 3 hours 
reported only a 24% reduction in apoptotic cells (Amstad et al. 2001).  Another study 
indicated that a 24 hour treatment of 10 µM FAM-VAD-FMK showed approximately 
50% of the cells still died from apoptosis induction (Smolewski et al. 2001).  Because our 
treatment was a low concentration and only 2 hours, we do not believe that the SR-
FLICA treatment would have had a lasting effect.  Any stimulus which was causing the 
increase in apoptosis would have still been present so more caspases would have 
continued to be activated, even if some caspases were inhibited by our treatment.   The 
final aim of this study was to determine if there was a relationship between incidence of 
apoptosis on day 7 and PAG concentration between day 29 and 33 of gestation.  Because 
PAGs are produced by the placenta and SCNT bovine pregnancies are riddled with 
placental abnormalities (Chavatte-Palmer et al. 2012), we hypothesized that increased 
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incidence of apoptosis would result in more abnormalities in the SCNT pregnancy, 
including the placenta, and therefore increased PAG concentrations.  However, no 
relationship was found between apoptosis score and PAG concentration.  In conclusion, 
apoptosis score was not useful in determining pregnancy establishment or PAG 
concentration, which is indicative in bovine pregnancies of late embryonic loss (Pohler et 
al. 2016).   
 All of these data were produced by analyzing active caspase activity through SR-
FLICA staining and subsequent analysis at a whole embryo level.  The apoptosis score 
represents the mean red pixel intensity of the whole embryo by analyzing the area inside 
the zone pellucida.  Certain areas could possibly be more critical measures of embryo 
competency.  For instance, a blastocyst with increased incidence of apoptosis in the inner 
cell mass but not the trophoblast could result in a lower mean red pixel intensity, or SR-
FLICA score, compared to a blastocyst with a moderate incidence of apoptosis 
throughout the inner cell mass and the trophoblast.  But if the incidence of apoptosis in 
the inner cell mass is the most critical region for embryo development, perhaps the first 
blastocyst should have a higher incidence of apoptosis compared to the second blastocyst.  
In studies using mouse blastocysts, the ICM is less resistant compared to the trophoblast 
and therefore incurs increased levels of apoptosis which can deplete the ICM of the 
required stem cells for future development resulting in compromised development 
(Pampfer 2000).  A similar increased incidence of apoptosis in the ICM compared to the 
trophoblast has been reported in bovine blastocysts (Fabian et al. 2005).  Therefore, 
future studies should evaluate embryos by morphological section to tease apart some of 
the more complex possibilities.   
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 In conclusion, while there was a significant difference in cell number between day 
7 bovine SCNT blastocysts with high and low incidence of apoptosis, no major 
differences were found in gene expression patterns, pregnancy establishment, or 
subsequent PAG concentrations.  Embryo competency was not hindered as a result of 
SR-FLICA staining, so SR-FLICA could still serve as a useful tool for embryo quality 
assessment prior to embryo transfer.  Future work should focus on apoptosis in distinct 
morphological regions including the inner cell mass and trophoblast to determine if more 
incidence of apoptosis in each region could be indicative of success following transfer 
while whole embryo apoptosis was not.   
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Fig.4-1. Bovine SCNT blastocysts with SR-FLICA staining.  Bovine SCNT blastocysts 
which were classified as high incidence of apoptosis by SR-FLICA staining are shown in 
panel A and B.  Low incidence of apoptosis have such low levels of floresence that the 
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Fig. 4-2. Correlation between SR-FLICA score and cell number in day 7 bovine SCNT 
blastocysts.  The relationship between cell number and the incidence of apoptosis in day 
7 SCNT blastocysts (3 replicates, total n = 26) with a linear regression line.  Significant 
correlation was found between the number of cells and relative level of apoptosis (r2 = 
0.25, P = 0.01).  Blue and green indicate the top and bottom 20% of incidence of 






























Fig. 4-3. Cell counts in day 7 blastocysts. Average number of cells of high (3 replicates, 
total n = 7) and low (3 replicates, total n = 6) apoptosis day 7 SCNT embryos with 
standard error bars.  There was a significant difference between high and low apoptosis 





















































































































































































































































































































Fig. 4-4. Correlation between incidence of apoptosis measured by SR-FLICA score and 
log2 fold change value.  Correlation for 20 genes expressed in day 7 bovine SCNT 
blastocysts.  Error bars represent the standard error.  Linear regression line is shown 
along with the fit of the line indicated by the r2 value.  Data represents 4 replicate cloning 
session with a total of 40 embryos analyzed.  However, not every qPCR reaction worked, 
so number of samples analyzed per group for each gene can be found in Supplemental 
Table 4-3.  Statistical significance of the correlation is designated by the FDR corrected P 
value for each gene.  No significant correlation was found between FLICA score and 










































































































Fig. 4-5. Gene expression in high and low apoptosis blastocysts.  Log2 fold change 
comparing gene expression of genes between SCNT blastocysts with high and low levels 
of apoptosis with standard error bars.  Data represents 4 replicate cloning session (high 
n=9; low n=9).  However, not every qPCR reaction worked, so number of samples 
analyzed per group for each gene can be found in Supplemental Table 4-4.  A student’s t-
test was used to determine significantly different expression.  P-values were adjusted for 




Fig. 4-6. Principal component analysis of ΔΔCT gene expression.  Analyzed in 
blastocysts with the top 20% of apoptosis [high apoptosis (n = 9), blue circles], the 
bottom 20% of apoptosis [low apoptosis (n = 9), green squares], and the central 60% of 
apoptosis [middle embryos (n = 22), grey triangles] from 4 cloning sessions.  No unit 
variance scaling was applied to each gene and singular value decomposition (SVD) with 
imputation was used to calculate principal components.  X shows principal component 1 
while Y shows principal component 2.  PC1 and PC2 explain 22.5% and 13.7% of the 
total variance, respectively.  Ellipses indicate the probability a new observation from the 




Fig. 4-7. Unsupervised clustering and heatmap analysis of ΔΔCT values of gene 
expression.  Analyzed in blastocysts with the top 20% of apoptosis [high apoptosis (n = 
9), blue], the bottom 20% of apoptosis [low apoptosis (n = 9), green], and the central 60% 
of apoptosis [middle embryos (n = 22), grey] from 4 cloning sessions.  Red, yellow, and 
blue of the heatmap indicates ΔΔCT values.  Unit variance scaling was applied.  
Imputation was used for missing value estimation.  Samples were clustered using 


































Fig. 4-8. Pregnancy rates from SR-FLICA stained and control blastocysts.  Pregnancy 
rate between day 29 and 33 of gestation resulting from blastocysts that had be stained 
with SR-FLICA (total n = 64) and controls which had not be stained (total n = 34) from 4 
embryo transfer sessions.  Error bars represent the standard error.  No significant 
difference in pregnancy rate resulted from embryos being exposed to SR-FLICA staining 




































Fig. 4-9.  Average SR-FLICA scores from embryos that failed to establish pregnancy and 
embryos that established pregnancy.  Average FLICA score of embryos that resulted in a 
cow being not pregnant (total n = 27) and pregnant (total n = 9) between day 29 and 33 of 
gestation from 4 transfer sessions.  Error bars represent the standard error.  No significant 
difference was found in FLICA score between the embryos that produced a pregnancy 







































Fig. 4-10. Probability of pregnancy from high and low apoptosis blastocysts.  Probability 
of pregnancy on day 29 to 33 of gestation resulting from day 7 blastocysts over 4 embryo 
transfer sessions with the top and bottom 20% of FLICA scores, high (total n = 11) and 
low apoptosis (total n = 11), respectively.  Error bars represent the standard error.  No 




































Fig. 4-11. Correlation between SR-FLICA score and PAG concentration.  Correlation 
between FLICA score of day 7 blastocysts and PAG concentration between day 29 and 
33 of gestation (total n = 42) from 3 embryo transfer sessions.  Linear regression line is 
shown (r2 = 0.03).  No significant correlation was found between FLICA score and PAG 
correlation (P = 0.27).  Green points indicate low apoptosis embryos from each transfer 





































Fig. 4-12. Average PAG concentration from high and low apoptosis blastocysts.  
Average PAG concentration on day 29 to 33 of gestation from day 7 blastocysts with 
high (total n = 8) and low (total n = 7) levels of apoptosis from 3 embryo transfer 
sessions with standard error bars.  There was no significant difference in PAG 


























Fig. 4-13.  Survival plot of high and low apoptosis blastocysts.  Survival of pregnancies 
from high apoptosis (n = 11) and low apoptosis (n = 11) blastocysts.  High apoptosis 
blastocysts are indicated in blue circles and low apoptosis blastocysts are indicated in 
green squares.  One low apoptosis pregnancy remains on day 236 of gestation and is 















Supplemental Tables and Figures 
 
Table S4-1. Developmental rates of SCNT embryos used in cell counts 
Cloning 
Session 























































Table S4-2. Developmental rates of SCNT embryos used in gene expression analysis 
Cloning 
Session 




























































Table S4-3. Summary statistics of apoptosis and gene expression 
correlation data 
 
No. of Samples R squared P-value FDR 
ASH2L 29 0.0070 0.6655 0.937 
BID 28 0.0020 0.8226 0.937 
DNMT3A 37 0.1625 0.0134 0.134 
EIF4A1 40 0.0266 0.3147 0.629 
GAPDH 36 0.0159 0.4637 0.843 
GNAS 39 0.0470 0.1848 0.629 
GRB10 27 0.0432 0.2980 0.629 
HDAC1 38 0.0286 0.3099 0.629 
HDAC2 25 0.2553 0.0100 0.134 
HDAC3 28 0.0013 0.8570 0.937 
HSP90AA1 40 0.0017 0.8007 0.937 
IGF2R 26 0.0003 0.9366 0.937 
KDM3A 32 0.0479 0.2290 0.629 
KLF4 38 0.0646 0.1237 0.629 
LIN28A 40 0.0560 0.1417 0.629 
POU5F1 40 0.0003 0.9142 0.937 
TAF11 35 0.0083 0.6034 0.937 
TP53 37 0.0038 0.7154 0.937 
UBE3A 35 0.0488 0.2020 0.629 

















Table S4-4. Summary statistics of gene expression analysis 
 High Samples Low Samples P-value FDR 
ASH2L 4 8 0.332 0.818 
BID 4 7 0.219 0.818 
DNMT3A 9 9 0.543 0.818 
EIF4A1 9 9 0.022 0.223 
GAPDH 8 9 0.708 0.944 
GNAS 9 9 0.485 0.818 
GRB10 5 7 0.404 0.818 
HDAC1 8 9 0.135 0.818 
HDAC2 4 6 0.555 0.818 
HDAC3 4 7 0.573 0.818 
HSP90AA1 9 9 0.280 0.818 
IGF2R 5 7 0.985 0.997 
KDM3A 8 8 0.425 0.818 
KLF4 9 9 0.002 0.034 
LIN28A 9 9 0.457 0.818 
POU5F1 9 9 0.828 0.974 
TAF11 7 9 0.997 0.997 
TP53 8 9 0.971 0.997 
UBE3A 7 9 0.479 0.818 
















Table S4-5. Gene symbols of genes analyzed in qPCR with functional classification and gene name 
Category and Gene Gene Name 
Apoptosis 
BAX BCL2 Associated X. Apoptosis Regulator 
BID BH3 Interacting Domain Death Agonist 
TP53 Tumor Protein P53 
Epigenetic Regulation 
ASH2L ASH2 Like, Histone Lysine Methyltransferase Complex Subunit 
DNMT3A DNA Methyltransferase 3A 
DNMT3B DNA Methyltransferase 3B 
HDAC1 Histone Deacetylase 1 
HDAC2 Histone Deacetylase 2 
HDAC3 Histone Deacetylase 3 
KDM3A Lysine Demethylase 3A 
Imprinted Genes 
GNAS GNAS Complex Locus 
GRB10 Growth Factor Receptor Bound Protein 10 
IGF2R Insulin Like Growth Factor 2 Receptor 
UBE3A Ubiquitin Protein Ligase E3A 
Pluripotency 
KLF4 Kruppel Like Factor 4 
LIN28 Lin-28 Homolog A 
POU5F1 POU Class 5 Homeobox 1 
SOX2 SRY-Box 2 
Trophoblast Differentiation and Function 
ETS2 ETS Proto-Oncogene 2, Transcription Factor 
Housekeeping 
EIF4A1 Eukaryotic translation Initiation Factor 4A1 
GAPDH Glyceraldehyde-3-Phospahete Dehydrogenase 
HSP90 Heat Shock Protein 90 
TAF11 TATA-Box Protein Associated Factor 11 










Table S4-6. Gene symbol of genes analyzed with qPCR with accession number used to 
design forward and reverse primers and respective primer sequences 




















































































































































































































































































































1 1 A Yes No 1.5 n/a 1 1 Yes n/a 
2 1 A Yes No 1.5 n/a 1 1 Yes n/a 
3 1 A Yes No 1 n/a 1 1 No n/a 
4 1 A Yes No 1 n/a 1 1 No n/a 
5 1 A Yes No 2 n/a 1 1 No n/a 
6 1 A Yes No 2 n/a 1 1 No n/a 
7 1 A Yes Yes 1 36.85 1 2 No n/a 
8 1 A Yes Yes 1 18.24 1 2 No n/a 
9 1 A Yes Yes 1 44.77 1 2 No n/a 
10 1 A Yes Yes 1 33.51 1 2 No n/a 
11 1 A Yes Yes 1 10.01 1 2 Yes n/a 
12 1 A Yes Yes 2 18.05 1 2 No n/a 
13 1 B Yes No 1.5 n/a 2 3 No n/a 
14 1 B Yes No 1 n/a 2 3 No n/a 
15 1 B Yes Yes 1.5 17.03 2 4 No n/a 
16 1 B Yes Yes 1 31.98 2 4 No n/a 
17 1 B Yes Yes 1 12.51 2 4 No n/a 
18 1 B Yes Yes 1 30.16 2 4 No n/a 
19 1 B Yes Yes 1 21.37 2 4 No n/a 
20 1 B Yes Yes 2 15.21 2 4 No n/a 
21 1 B Yes Yes 2 27.46 2 4 No n/a 
22 1 B Yes Yes 2 22.12 2 4 No n/a 
23 2 C Yes No 1 n/a 3 5 Yes 0.183 
24 2 C Yes No 1 n/a 3 5 No <0.000 
25 2 C Yes No 1 n/a 3 5 No <0.000 
26 2 C Yes Yes 1 32.71 3 6 Yes 0.486 
27 2 C Yes Yes 1 34.30 3 6 No <0.000 
28 2 C Yes Yes 1 21.64 3 6 No <0.000 
29 2 C Yes Yes 1 29.98 3 6 No <0.000 
30 2 C Yes Yes 1 49.05 3 6 No 0.081 
31 2 B Yes No 1 n/a 4 7 No <0.000 
32 2 B Yes No 1 n/a 4 7 No 0.230 
33 2 B Yes No 1 n/a 4 7 No <0.000 
34 2 B Yes No 1 n/a 4 7 No <0.000 
























































































































36 2 B Yes No 1 n/a 4 7 No 0.039 
37 2 B Yes Yes 1 41.10 4 8 No <0.000 
38 2 B Yes Yes 1 34.80 4 8 No <0.000 
39 2 B Yes Yes 1 48.44 4 8 No <0.000 
40 2 B Yes Yes 1 34.88 4 8 No <0.000 
41 2 B Yes Yes 1 32.28 4 8 No <0.000 
42 2 B Yes Yes 1 46.88 4 8 No <0.000 
43 2 B Yes Yes 1 58.48 4 8 No 0.526 
44 2 B Yes Yes 1 38.64 4 8 No 0.190 
45 2 B Yes Yes 1 53.56 4 8 No <0.000 
46 2 B Yes Yes 1 32.18 4 8 No 0.045 
47 3 D No No 1 n/a 5 9 Yes 1.166 
48 3 D No No 1 n/a 5 9 No <0.000 
49 3 D No No 1 n/a 5 9 Yes 0.676 
50 3 D No No 1 n/a 5 9 No 0.398 
51 3 D No No 1 n/a 5 9 No <0.000 
52 3 D No No 1 n/a 5 9 No 0.005 
53 3 D No No 1 n/a 5 9 No <0.000 
54 3 D No No 2 n/a 5 9 No <0.000 
55 3 D No No 2 n/a 5 9 Yes 0.654 
56 3 D No Yes 1 9.51 5 10 No 0.370 
57 3 D No Yes 1 16.42 5 10 No <0.000 
58 3 D No Yes 1 21.44 5 10 Yes 0.548 
59 3 D No Yes 1 24.07 5 10 No <0.000 
60 3 D No Yes 2 13.25 5 10 No <0.000 
61 3 D No Yes 2 20.03 5 10 No <0.000 
62 3 D Yes No 1 n/a 6 11 No <0.000 
63 3 D Yes No 1 n/a 6 11 No 0.647 
64 3 D Yes No 1 n/a 6 11 No 0.002 
65 3 D Yes No 1 n/a 6 11 No <0.000 
66 3 D Yes No 1 n/a 6 11 No <0.000 
67 3 D Yes No 2 n/a 6 11 No <0.000 
68 3 D Yes No 2 n/a 6 11 No <0.000 
69 3 D Yes No 2 n/a 6 11 No <0.000 
70 3 D Yes Yes 1 14.15 6 12 No <0.000 
























































































































72 3 D Yes Yes 1 32.30 6 12 Yes 0.683 
73 3 D Yes Yes 2 16.57 6 12 No <0.000 
74 3 D Yes Yes 2 30.61 6 12 Yes 0.539 
75 3 D Yes Yes 1.5 78.97 6 12 No <0.000 
76 4 E No Yes 1 91.56 7 13 No <0.000 
77 4 E No Yes 1 88.16 7 13 No <0.000 
78 4 E No Yes 1 91.34 7 13 No <0.000 
79 4 E No Yes 1 84.03 7 13 No <0.000 
80 4 E No Yes 2 41.92 8 14 Yes 0.803 
81 4 E Yes Yes 1 53.57 8 14 No <0.000 
82 4 E Yes Yes 1 68.81 8 14 Yes 0.585 
83 4 E Yes Yes 1 106.18 8 14 No <0.000 
84 4 E Yes Yes 2 41.2 8 14 No <0.000 
85 4 C No Yes 1 59.61 9 15 No <0.000 
86 4 C No Yes 1 102.04 9 15 No <0.000 
87 4 C No Yes 1 106 9 15 No <0.000 
88 4 C No Yes 1 43.15 9 15 Yes 0.723 
89 4 C No Yes 1 61.08 9 15 No <0.000 
90 4 C No Yes 2 56.93 9 15 No <0.000 
91 4 C Yes Yes 1 190.12 10 16 No <0.000 
92 4 C Yes Yes 1 37.35 10 16 Yes 0.803 
93 4 C Yes Yes 1 177.19 10 16 No <0.000 
94 4 C Yes Yes 1 29.60 10 16 No <0.000 
95 4 C Yes Yes 1 100.57 10 16 No 0.144 
96 4 C Yes Yes 1 76.14 10 16 No <0.000 
97 4 C Yes Yes 2 145.19 10 16 No <0.000 
98 4 C Yes Yes 1 125.77 10 16 No <0.000 
1 Some donor cells were treated with α-amanatin while others were not, marked in the column 
labeled “α-amanatin treatment.” 
2 Some embryos were stained with SR-FLICA, while others were not to serve as controls, listed 
in the “FLICA stained” column. 
3 Two technicians were used for embryo transfer, listed as technician 1 and 2.  A technician of 
1.5 indicates a transfer where one technician could not pass the pipette and a second technician 
stepped in for assistance.   
4 The well used for α-amanatin treatment and SR-FLICA staining are indicated.   
5 pregnancy outcome based on ultra-sound pregnancy diagnosis between days 
29-33 of gestation. 
6 PAG concentration on day 29-33 of gestation. 
251 
 
Fig S4-1. SR-FLICA stained porcine blastocysts.  Porcine day 6 SCNT blastocysts with 
low incidence of apoptosis (Panel A and B) and high incidence of apoptosis (Panel C and 
D) based on SR-FLICA staining, shown in red fluoresence.  Blastocysts have also been 
stained with Hoechst 33342 to indicate nuclei, shown in blue fluoresence.  Red indicates 


























































Fig. S4-2. Pregnancy rate from each cloning session (session A n = 22, session 2 n = 24, 





























Fig. 4-3. Pregnancy rate from each cell line used in cloning (A [A cloning session] n = 
A2, B [2 cloning sessions] total n = 26, C [2 cloning sessions] total n = 22, D [A cloning 


















 Abnormalities in cloned embryos and resulting pregnancies are believed to be the 
result of abnormal epigenetic reprogramming following somatic cell nuclear transfer 
(SCNT) and lead to failed establishment or maintenance of pregnancy.  However, some 
cloned embryos and resulting pregnancies result in relatively normal pregnancies and 
cloned offspring.  This led us to our hypothesis that in some cases, SCNT embryos 
undergo proper genome reprogramming, resulting in normal gene expression profiles, 
low levels of apoptosis, and normal development through gestation.  We proposed the use 
of active caspase activity to isolate the embryos with high levels of apoptosis, a result of 
aberrant epigenetic reprogramming and gene expression, to identify the embryos most 
likely to fail following embryo transfer.   
 We concluded that SR-FLICA (Immunohistochemistry Technologies, 
Bloomington, MN, USA) was an accurate, non-invasive, and non-toxic method to assess 
apoptosis through caspase activity in embryos.  By sorting day three porcine SCNT 
embryos by relative caspase activity, we were not able to isolate the most competent 
embryos based on blastocyst development rates and number of cells.  Day six porcine 
SCNT blastocysts with high and low levels of apoptosis did not show differences in gene 
expression in 65 genes analyzed through qPCR.  Taking a more global approach, day six 
porcine SCNT blastocysts with high and low incidence of apoptosis were evaluated for 
gene expression and DNA methylation patterns of the same individual blastocyst using 
RNA-seq and RRBS, respectively.  While there were differences in gene expression and 
differential methylation between blastocysts with high and low incidence of apoptosis, no 
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gene ontology pathways were identified.  Taken together with the relatively few 
differences between high and low apoptosis blastocysts, our data supported the 
hypothesis for a stochastic nature of reprogramming following SCNT where each 
individual blastocyst undergoes a unique epigenetic reprogramming and therefore has a 
unique gene expression profile.  Finally, embryo transfers showed that the analysis of the 
whole blastocyst for active caspase activity in bovine SCNT blastocysts was not useful to 
predicting the embryos that would be successful at achieving a pregnancy following 
transfer.   
 As with any study, the project had several limitations that should be 
acknowledged.  While DNA methylation and gene expression profiles provide answers to 
basic biology to understand how cloned embryos undergo reprogramming, the most 
applicable part of the project was determining if the approach of staining embryos with 
SR-FLICA would allow the identification of the most competent embryos.  However, we 
were not able to significantly increase pregnancy rate based by sorting high and low 
apoptosis blastocyst, even when performing 98 embryo transfers.  Because we used 
cloned embryos, there is an inherent flaw that the pregnancy rate is extremely low, a 
direct result of the inefficiency we are working to correct.  Additionally, from these 98 
transferred blastocysts, toxicity of SR-FLICA was also evaluated meaning not all of the 
embryos were stained and evaluated for level of apoptosis.  From 98 total transferred 
blastocysts, only 15 had an established pregnancy at the first pregnancy check 
approximately one month into gestation.  With the low number of established 
pregnancies, it would require many more transfers to show a significant difference in 
pregnancy rate, assuming that the trend for a higher pregnancy rate in the low apoptosis 
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blastocysts continues.  Another approach that could have been more definitive is to 
analyze SR-FLICA scores in in vitro fertilized (IVF) blastocysts which would have 
increased pregnancy rates following transfer compared to cloned blastocysts [1, 2].   
 A second limitation to the overall study design was the necessity to switch from 
molecular analysis in porcine blastocysts to embryo transfer evaluation in bovine 
blastocysts.  Due to technical challenges with synchronizing recipient gilts, estrus was 
never synchronized correctly to expect an embryo transfer to be successful in the porcine 
system.  In addition to the technical challenge of estrus synchronization in pigs, there is 
also the challenge of the sheer number of blastocysts that are required in porcine SCNT 
embryo transfers.  Previously reported porcine SCNT blastocyst transfers into a surrogate 
female transfer over 50 blastocysts per recipient [3, 4].  Because our goal was to compare 
the high to low apoptosis blastocyst, representing the top and bottom 20% or SR-FLICA 
scores, respectively, our study design ended up throwing out the middle 60% of 
blastocysts.  Even with minimizing the number of transferred blastocysts per gilt to 
approximately 25 per group, the number of embryos that had to be created was vast.  And 
as a result, the time required to analyze the embryos was quite excessive.  From a 
production standpoint, it would make more sense to transfer all produced blastocysts into 
a recipient gilt as there is no detriment in a pig to having multiple successful embryos as 
pigs are litter bearing in nature.  Therefore, the decision was made to perform the embryo 
transfer analysis in cattle where only one cloned blastocyst is transferred to avoid the risk 
of twin cloned pregnancies.  However, it is unclear how much can be inferred from the 
porcine molecular findings to the bovine system.  A review of DNA methylation in 
preimplantation embryos did point to species specific differences in epigenetic 
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reprogramming including timing and demethylation patterns [5], so a more thorough 
exploration into the epigenetic reprogramming of high and low apoptosis blastocysts in 
cattle could be necessary in the future.  
 The final and perhaps most significant limitation of the study is the inability to 
know if the observed apoptosis was truly a result of inadequate epigenetic 
reprogramming, as we assumed it was, or the result of another insult, such as in vitro 
culture conditions.  Previous studies have documented that in vitro produced embryos 
undergo increased levels of apoptosis compared to their in vivo produced counterparts [6, 
7].  The effects of in vitro culture could have been addressed by including IVF 
blastocysts, but rather we opted to include increased number of biological replicates of 
cloned and IVV embryos rather than including an IVF group.  However, from a practical 
view point of trying to increase the efficiency of SCNT as the end goal, I believe that the 
best approach would have been to produce SCNT embryos and transfer them 
immediately to a surrogate female.  Embryos cultured in vivo are known to be higher 
quality in terms of developmental potential and cell number [8].  There would have then 
been no question that the embryos were in their ideal culture conditions and any resulting 
apoptosis would have been the direct result of abnormalities in the embryo rather than 
response to the environmental conditions.  Embryos could be flushed at the blastocyst 
stage and the same experimental design could have been utilized.   
 While even the best studies will have their limitations, our study provided many 
novel techniques and findings which enhanced the field of epigenetic reprogramming and 
developmental competence of cloned embryos.  Our findings provided better 
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understanding of both the basic biology of epigenetic reprogramming in cloned embryos 
as well as the applicable evaluation of cloned blastocysts in attempt to increase the 
efficiency of the technology.  While numerous studies have compared SCNT embryos to 
IVF or in vivo produced embryos [9-12], very few studies have compared SCNT embryos 
to one another.  Those studies that have compared clones typically focus on differences 
past the preimplantation stage evaluating characteristics of the placenta [13, 14].   To the 
best of our knowledge, this is one of, if not the first, study to not only describe 
differences between “normal” and “abnormal” clones, but to compare individual cloned 
blastocysts in an attempt to isolate the most competent. 
 Additionally, the study had many technical novelties which provided unique data 
which has not previously been reported.  Again to the best of our knowledge, this is the 
first time that both genomic DNA and total RNA have been isolated from individual 
blastocysts and analyzed on a large scale.  Typically, pooled embryos have been used to 
overcome the challenge of such low abundance of DNA and RNA from individual 
blastocysts [15, 16].  Another more common approach has been to analyze individual 
embryos but evaluate specific regions or genes of interest, such as imprinted genes, rather 
than taking on a more global approach, which evaluates a much larger proportion of the 
genome [17, 18].  However, by isolating both DNA and RNA from individual cloned 
blastocysts and analyzing on a large scale, we were able to produce data that can better 
explain the nuances of epigenetic reprogramming in each individual embryo.   
 This is also the first reported use of reduced representation bisulfite sequencing 
(RRBS) for analysis between two phenotypically different groups rather than an 
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observational study in a livestock species.  Previous reports have utilized RRBS to report 
on differences in sperm, eggs, and early developing embryos in cattle [19].  Other studies 
have focused on the differences in methylation patterns between various tissues [20].  
However, this appears to be the first report of the use of RRBS to analyze DNA 
methylation patterns of porcine blastocysts.  Additionally, we believe that this is also the 
first report of comparing the methylome of individual blastocysts to each other, rather 
than to other embryonic stages of development.  We were also able to analyze a large 
number of individual blastocysts, providing a wealth of data on the DNA reprogramming 
that occurred in individual embryos. 
 While this study provided vast amounts of data that provided deeper 
understanding of both the basic biology and application of cloned blastocysts, there is of 
course always research that could be performed to follow up on the reported findings.  
Analysis for the incidence of apoptosis was performed on the whole blastocysts, where 
the average red pixel intensity for the entire area under the zona pellucida quantified the 
relative level of apoptosis.  By repeating the analysis, only focusing on the inner cell 
mass, the blastocysts which were classified as high and low incidence of apoptosis could 
have been completely different.  This change in up front analysis could have then 
affected the downstream outcomes, such as apoptosis level being predictive of pregnancy 
outcome.  Until a more thorough analysis was performed taking into account the different 
morphological areas of the embryo, it would not be possible to write off SR-FLICA 
staining as a potential indicator of embryo quality.  As technology continues to advance, 
it may also be possible to analyze DNA methylation and gene expression patterns on 
individual cells rather than on a whole blastocyst level.  It could be possible in the 
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epigenetic reprogramming of the early embryo, in which cells have started to divide and 
the reprogramming occurs vastly differently in each cell.  This could lead to a blastocyst 
with a mosaic pattern of DNA methylation and gene expression, which is obscured when 
analyzing the entire blastocyst.  A single cell approach could provide an even more 
complex story of epigenetic reprogramming. 
 Future studies should also incorporate larger numbers of individual blastocysts 
into the analyses.  While we believe that we exceeded the typical expectation of a handful 
of individual blastocysts per group, with more than 10 individual blastocysts included in 
each of our groups, there could always be more embryos included in the analysis.  From 
our data, it appeared that including more biological replicates in each group made it more 
difficult to determine differential gene expression and DNA methylation patterns.  
Typically, it would be assumed that more biological replicates would increase statistical 
power and lead to more statistical differences between groups.  However, because of the 
random nature of reprogramming in cloned blastocysts, increasing the number of 
biological replicates increases the amount of background noise and actually made it more 
challenging to identify genes and regions that were differentially expressed and 
methylated, respectively.  Therefore, by including a high number of biological replicates, 
those genes and regions that were found to be statistically differentially expressed or 
methylated between the groups could be extremely biologically relevant and so be 
established as the true  driving cause for the phenotypic difference. 
 Finally, future studies are needed to better understand why such a difference in 
apoptotic activity was identified in porcine compared to bovine blastocysts.  Visually, 
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there was a staggering difference in the amount of caspase activity in cloned blastocysts 
where the porcine blastocysts had much higher levels of caspase activity compared to the 
bovine blastocysts.  It would be fascinating to understand if these differences are the 
direct result of the embryo itself, perhaps differences in channels or pores result in the 
SR-FLICA being trapped in porcine blastocysts, whereas cow blastocysts are more 
efficient at clearing the SR-FLICA from the embryo.  Or it is possible that the apoptosis 
response is different as a result of different culture systems.  If this is the case, it would 
be interesting to understand if this pattern carries to other culture systems outside of the 
two used in our study.  Finally, it is possible that the difference in level of apoptosis was 
a direct result of the ability or inability for the embryos to undergo proper epigenetic 
reprogramming following somatic cell nuclear transfer.  Perhaps the cattle embryos are 
more efficient at epigenetic reprogramming after SCNT compared to the porcine embryos 
and as a result have a lower incidence of apoptosis.    
 In conclusion, this research provided a deeper understanding of the epigenetic 
reprogramming and gene expression of cloned porcine blastocysts with high and low 
incidence of apoptosis.  While statistically there was no increase in pregnancy rate 
between high and low apoptosis blastocysts, increased replication could provide the 
statistical power necessary to support the numeric increase in pregnancy rate in the low 
apoptosis blastocysts.  This research provided novel techniques and data to the field, 
including gene expression and methylation analysis of individual cloned blastocysts and 
comparison of cloned individual blastocysts to each other.  Limitations in study design 
included using a limited number of embryo transfers, utilizing two species throughout the 
study, and the inability to know the cause of increased apoptosis in the cloned embryos.  
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Future studies should focus on apoptosis in the different morphological regions of the 
blastocysts, species-specific differences in apoptosis levels, and include large number of 
biological replicates when using cloned embryos.   
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